{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "3d07c30a-1a0e-417c-a56c-ea735e971c36",
   "metadata": {},
   "source": [
    "#### TODO\n",
    "- Check how to get around article limit of 10000 if possible\n",
    "- Can use history server for other purposes?\n",
    "- What can be the advantage for using eutilities VS edirect / usecases?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "c226d5a2-203b-421d-a7af-3f8f58f68e51",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "None\n",
      "C:\\Users\\Gebruiker\\anaconda3\\Library\\ssl\\cacert.pem\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "print(os.environ.get('REQUESTS_CA_BUNDLE'))\n",
    "print(os.environ.get('SSL_CERT_FILE'))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "dca57a6a-9835-44fb-b94e-e6c3d9d2635a",
   "metadata": {},
   "outputs": [],
   "source": [
    "from Bio import Entrez\n",
    "import time"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "37344054-1aa8-4636-8fbc-b77b937e623f",
   "metadata": {},
   "outputs": [],
   "source": [
    "def build_query():\n",
    "    searchterm = input(\"Enter query search term: \")\n",
    "    article_type = ('[IT] AND (\"Clinical Trial\"[PT] OR \"Randomized Controlled Trial\"[PT] OR \"Meta-Analysis\"[PT] '\n",
    "                    'OR \"Systematic Review\"[PT] OR \"Comparative Study\"[PT] OR \"Observational Study\"[PT] '\n",
    "                    'OR \"Validation Study\"[PT] OR \"Review\"[PT])')\n",
    "    \n",
    "    full_query = searchterm + article_type\n",
    "    return full_query\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "76f8062d-5851-419b-8bbd-0b06ca44e325",
   "metadata": {},
   "outputs": [],
   "source": [
    "def history(full_query):\n",
    "    API_key = input(\"Enter API_key:\")\n",
    "\n",
    "    # Get number of data records\n",
    "    with Entrez.esearch(db=\"pubmed\", term=full_query, retmax=1, api_key=API_key, usehistory=\"y\") as handle:\n",
    "        results = Entrez.read(handle)\n",
    "        count = int(results[\"Count\"])\n",
    "        webenv = results[\"WebEnv\"]    \n",
    "        query_key = results[\"QueryKey\"]\n",
    "    \n",
    "    print(f\"Total articles found: {count}\")\n",
    "    print(f\"WebEnv: {webenv}, QueryKey: {query_key}\")\n",
    "    \n",
    "    return webenv, query_key, count, API_key\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "7748a14d-5739-46a9-9772-023856a66476",
   "metadata": {},
   "outputs": [],
   "source": [
    "def fetch_data(webenv, query_key, count, API_key, batchsize=5000):\n",
    "    article_data = []\n",
    "    max_records = min(count, 9999)\n",
    "\n",
    "    for start in range(0, max_records, batchsize):\n",
    "        print(f\"Records {start + 1} to {min(start + batchsize, count)}...\")\n",
    "        \n",
    "        # Request data from PubMed using efetch, and specify 'json' for retmode\n",
    "        with Entrez.efetch(db=\"pubmed\", query_key=query_key, webenv=webenv, retstart=start, retmax=batchsize, \n",
    "                           rettype=\"json\", api_key=API_key) as handle:\n",
    "            data = handle.read()\n",
    "            article_data.append(data)\n",
    "            \n",
    "            # Save data to a JSON file\n",
    "            filename = f\"pubmed_data_{start+1}_{min(start + batchsize, count)}.json\"\n",
    "            with open(filename, 'w') as file:\n",
    "                file.write(data.decode(\"utf-8\"))\n",
    "        \n",
    "        time.sleep(10)\n",
    "\n",
    "    print(\"Data fetching complete.\")\n",
    "    return article_data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "fdd2cdb2-2457-4e5d-a7ad-904be01b246e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdin",
     "output_type": "stream",
     "text": [
      "Enter emailadres: michael.viroux@gmail.com\n",
      "Enter query search term:  \"vitamin d\"\n",
      "Enter API_key: 6898e4b9cc65f86c658e0ffffad70d6c0209\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total articles found: 28741\n",
      "WebEnv: MCID_67af86c007a5a5787002475a, QueryKey: 1\n"
     ]
    },
    {
     "ename": "NameError",
     "evalue": "name 'fetch_data' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[1;32mIn[33], line 4\u001b[0m\n\u001b[0;32m      2\u001b[0m query \u001b[38;5;241m=\u001b[39m build_query()\n\u001b[0;32m      3\u001b[0m webenv, query_key, count, API_key \u001b[38;5;241m=\u001b[39m history(query)\n\u001b[1;32m----> 4\u001b[0m articles \u001b[38;5;241m=\u001b[39m fetch_data(webenv, query_key, count, API_key)\n",
      "\u001b[1;31mNameError\u001b[0m: name 'fetch_data' is not defined"
     ]
    }
   ],
   "source": [
    "Entrez.email = input(\"Enter emailadres:\")\n",
    "query = build_query()\n",
    "webenv, query_key, count, API_key = history(query)\n",
    "articles = fetch_data(webenv, query_key, count, API_key)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "f0b5e8fa-34b7-4b61-b233-6c59e001737a",
   "metadata": {},
   "outputs": [
    {
     "ename": "ModuleNotFoundError",
     "evalue": "No module named 'pandas'",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mModuleNotFoundError\u001b[0m                       Traceback (most recent call last)",
      "Cell \u001b[1;32mIn[22], line 1\u001b[0m\n\u001b[1;32m----> 1\u001b[0m \u001b[38;5;28;01mimport\u001b[39;00m \u001b[38;5;21;01mpandas\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m \u001b[38;5;21;01mpd\u001b[39;00m\n",
      "\u001b[1;31mModuleNotFoundError\u001b[0m: No module named 'pandas'"
     ]
    }
   ],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "cb97c048-82dd-4225-ba43-cba2bc7f0b14",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting pandas\n",
      "  Downloading pandas-2.2.3-cp312-cp312-win_amd64.whl.metadata (19 kB)\n",
      "Requirement already satisfied: numpy>=1.26.0 in c:\\users\\gebruiker\\anaconda3\\envs\\pubmed_data_analysis\\lib\\site-packages (from pandas) (2.2.2)\n",
      "Requirement already satisfied: python-dateutil>=2.8.2 in c:\\users\\gebruiker\\anaconda3\\envs\\pubmed_data_analysis\\lib\\site-packages (from pandas) (2.9.0.post0)\n",
      "Collecting pytz>=2020.1 (from pandas)\n",
      "  Using cached pytz-2025.1-py2.py3-none-any.whl.metadata (22 kB)\n",
      "Collecting tzdata>=2022.7 (from pandas)\n",
      "  Using cached tzdata-2025.1-py2.py3-none-any.whl.metadata (1.4 kB)\n",
      "Requirement already satisfied: six>=1.5 in c:\\users\\gebruiker\\anaconda3\\envs\\pubmed_data_analysis\\lib\\site-packages (from python-dateutil>=2.8.2->pandas) (1.16.0)\n",
      "Downloading pandas-2.2.3-cp312-cp312-win_amd64.whl (11.5 MB)\n",
      "   ---------------------------------------- 0.0/11.5 MB ? eta -:--:--\n",
      "   ------ --------------------------------- 1.8/11.5 MB 9.1 MB/s eta 0:00:02\n",
      "   ------------ --------------------------- 3.7/11.5 MB 9.5 MB/s eta 0:00:01\n",
      "   -------------------- ------------------- 6.0/11.5 MB 10.0 MB/s eta 0:00:01\n",
      "   --------------------------------- ------ 9.7/11.5 MB 12.1 MB/s eta 0:00:01\n",
      "   ---------------------------------------- 11.5/11.5 MB 12.0 MB/s eta 0:00:00\n",
      "Using cached pytz-2025.1-py2.py3-none-any.whl (507 kB)\n",
      "Using cached tzdata-2025.1-py2.py3-none-any.whl (346 kB)\n",
      "Installing collected packages: pytz, tzdata, pandas\n",
      "Successfully installed pandas-2.2.3 pytz-2025.1 tzdata-2025.1\n"
     ]
    }
   ],
   "source": [
    "!pip install pandas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "82c5d982-41af-4372-b788-917179cce293",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting lxml\n",
      "  Downloading lxml-5.3.0-cp312-cp312-win_amd64.whl.metadata (3.9 kB)\n",
      "Downloading lxml-5.3.0-cp312-cp312-win_amd64.whl (3.8 MB)\n",
      "   ---------------------------------------- 0.0/3.8 MB ? eta -:--:--\n",
      "   --------------------------- ------------ 2.6/3.8 MB 12.5 MB/s eta 0:00:01\n",
      "   ---------------------------------------- 3.8/3.8 MB 10.8 MB/s eta 0:00:00\n",
      "Installing collected packages: lxml\n",
      "Successfully installed lxml-5.3.0\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "!pip install lxml"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "82dc901a-0eb4-4115-a2e3-41734bf60cbf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'\\n    To retrieve more than 10,000 UIDs from databases other than PubMed, \\n    submit multiple esearch requests while incrementing the value of retstart (see Application 3). \\n    For PubMed, ESearch can only retrieve the first 10,000 records matching the query. \\n    To obtain more than 10,000 PubMed records, consider using <EDirect> that contains additional logic\\n    to batch PubMed search results automatically so that an arbitrary number can be retrieved.\\n    For details see https://www.ncbi.nlm.nih.gov/books/NBK25499/\\n'"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\"\"\"\n",
    "    To retrieve more than 10,000 UIDs from databases other than PubMed, \n",
    "    submit multiple esearch requests while incrementing the value of retstart (see Application 3). \n",
    "    For PubMed, ESearch can only retrieve the first 10,000 records matching the query. \n",
    "    To obtain more than 10,000 PubMed records, consider using <EDirect> that contains additional logic\n",
    "    to batch PubMed search results automatically so that an arbitrary number can be retrieved.\n",
    "    For details see https://www.ncbi.nlm.nih.gov/books/NBK25499/\n",
    "\"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "431c5ea4-a136-4e30-90fe-b484b44ab7ca",
   "metadata": {},
   "outputs": [
    {
     "name": "stdin",
     "output_type": "stream",
     "text": [
      "Enter emailadres: michael.viroux@gmail.com\n",
      "Enter query search term:  \"vitamin d\"\n",
      "Enter API_key: 6898e4b9cc65f86c658e0ffffad70d6c0209\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total articles found: 32688\n",
      "WebEnv: MCID_67ac943530c0976af50e07f5, QueryKey: 1\n",
      "Records 1 to 5000...\n",
      "Records 5001 to 10000...\n",
      "Data fetching complete.\n",
      "       PMID                                              Title  \\\n",
      "0  39934684  Association of aberrant mineral metabolic mark...   \n",
      "1  39934504  [Nonoperative treatment for the management of ...   \n",
      "2  39931432  Shining light on knee osteoarthritis: an overv...   \n",
      "3  39930022  Dietary supplements and prevention of preeclam...   \n",
      "4  39925524  Traumatic Anserine Folliculosis: A Case Report...   \n",
      "\n",
      "                                            Abstract  \\\n",
      "0  This meta-analysis aims to investigate the imp...   \n",
      "1  Today, there are several nonoperative treatmen...   \n",
      "2  The impact of knee osteoarthritis on individua...   \n",
      "3  Preeclampsia (PE) is a common pregnancy compli...   \n",
      "4  Traumatic anserine folliculosis (TAF) is a les...   \n",
      "\n",
      "                                             Authors  \\\n",
      "0  Liu Yao, Zhang Zhen Xing, Fu Chen Sheng, Ye Zh...   \n",
      "1  Horas Konstantin, Eidmann Annette, Stratos Ioa...   \n",
      "2  Zhang Di, Ye Miaoyu, Xu Yao, Jiang Luyu, Hu Ya...   \n",
      "3  Ushida Takafumi, Tano Sho, Matsuo Seiko, Fuma ...   \n",
      "4  Al Janahi Sara, Al Hammadi Mariam, AbdelHadi S...   \n",
      "\n",
      "                                             Journal  \\\n",
      "0                                     BMC nephrology   \n",
      "1                   Orthopadie (Heidelberg, Germany)   \n",
      "2                              Frontiers in medicine   \n",
      "3  Hypertension research : official journal of th...   \n",
      "4                                             Cureus   \n",
      "\n",
      "                                            Keywords  \\\n",
      "0  Humans, Fibroblast Growth Factor-23, Renal Ins...   \n",
      "1                                                      \n",
      "2                                                      \n",
      "3                                                      \n",
      "4                                                      \n",
      "\n",
      "                                            URL  \\\n",
      "0  https://www.ncbi.nlm.nih.gov/pubmed/39934684   \n",
      "1  https://www.ncbi.nlm.nih.gov/pubmed/39934504   \n",
      "2  https://www.ncbi.nlm.nih.gov/pubmed/39931432   \n",
      "3  https://www.ncbi.nlm.nih.gov/pubmed/39930022   \n",
      "4  https://www.ncbi.nlm.nih.gov/pubmed/39925524   \n",
      "\n",
      "                                        Affiliations  \n",
      "0  Department of Nephrology, Huadong Hospital, Fu...  \n",
      "1  Orthopädische Klinik König-Ludwig-Haus, Univer...  \n",
      "2  School of Acupuncture and Tuina, Chengdu Unive...  \n",
      "3  Department of Obstetrics and Gynecology, Nagoy...  \n",
      "4  Dermatology, Sheikh Khalifa Medical City, Abu ...  \n",
      "Data saved to pubmed_results.csv\n"
     ]
    }
   ],
   "source": [
    "from Bio import Entrez\n",
    "import time\n",
    "import pandas as pd\n",
    "import json\n",
    "\n",
    "def build_query():\n",
    "    searchterm = input(\"Enter query search term: \")\n",
    "    article_type = ('[IT] AND (\"Clinical Trial\"[PT] OR \"Randomized Controlled Trial\"[PT] OR \"Meta-Analysis\"[PT] '\n",
    "                    'OR \"Systematic Review\"[PT] OR \"Comparative Study\"[PT] OR \"Observational Study\"[PT] '\n",
    "                    'OR \"Validation Study\"[PT] OR \"Case Reports\"[PT] OR \"Review\"[PT])')\n",
    "\n",
    "    full_query = searchterm + article_type\n",
    "    return full_query\n",
    "\n",
    "\n",
    "def history(full_query):\n",
    "    API_key = input(\"Enter API_key:\")\n",
    "\n",
    "    # Get number of data records\n",
    "    with Entrez.esearch(db=\"pubmed\", term=query, retmax=1, api_key=API_key, usehistory=\"y\") as handle:\n",
    "        results = Entrez.read(handle)\n",
    "        count = int(results[\"Count\"])\n",
    "        webenv = results[\"WebEnv\"]\n",
    "        query_key = results[\"QueryKey\"]\n",
    "\n",
    "    print(f\"Total articles found: {count}\")\n",
    "    print(f\"WebEnv: {webenv}, QueryKey: {query_key}\")\n",
    "\n",
    "    return webenv, query_key, count, API_key\n",
    "\n",
    "\n",
    "def fetch_data(webenv, query_key, count, API_key, batchsize=5000):\n",
    "    max_records = min(count, 9999)\n",
    "    df = pd.DataFrame(columns=['PMID', 'Title', 'Abstract', 'Authors', 'Journal', 'Keywords', 'URL', 'Affiliations'])\n",
    "\n",
    "    for start in range(0, max_records, batchsize):\n",
    "        print(f\"Records {start + 1} to {min(start + batchsize, count)}...\")\n",
    "\n",
    "        # Request data from PubMed using efetch, and specify 'json' for retmode\n",
    "        with Entrez.efetch(db=\"pubmed\", query_key=query_key, webenv=webenv, retstart=start, retmax=batchsize,\n",
    "                           retmode=\"xml\", api_key=API_key) as handle:\n",
    "            data = Entrez.read(handle)\n",
    "\n",
    "            # Process each article\n",
    "            for record in data.get('PubmedArticle', []):\n",
    "                pmid = record['MedlineCitation']['PMID']\n",
    "                title = record['MedlineCitation']['Article']['ArticleTitle']\n",
    "\n",
    "                abstract = ' '.join(record['MedlineCitation']['Article']['Abstract']['AbstractText']) if 'Abstract' in \\\n",
    "                                    record['MedlineCitation']['Article'] and 'AbstractText' in \\\n",
    "                                    record['MedlineCitation']['Article']['Abstract'] else ''\n",
    "\n",
    "                authors = ', '.join(\n",
    "                    f\"{author.get('LastName', '')} {author.get('ForeName', '')}\".strip()\n",
    "                    for author in record['MedlineCitation']['Article'].get('AuthorList', [])\n",
    "                )\n",
    "\n",
    "                affiliations = []\n",
    "                for author in record['MedlineCitation']['Article'].get('AuthorList', []):\n",
    "                    if 'AffiliationInfo' in author and author['AffiliationInfo']:\n",
    "                        affiliations.append(author['AffiliationInfo'][0]['Affiliation'])\n",
    "                affiliations = '; '.join(set(affiliations))\n",
    "\n",
    "                journal = record['MedlineCitation']['Article']['Journal']['Title']\n",
    "                keywords = ', '.join(\n",
    "                    keyword['DescriptorName'] for keyword in record['MedlineCitation'].get('MeshHeadingList', [])\n",
    "                )\n",
    "                url = f\"https://www.ncbi.nlm.nih.gov/pubmed/{pmid}\"\n",
    "\n",
    "                # Append the data to the DataFrame\n",
    "                df.loc[len(df)] = [pmid, title, abstract, authors, journal, keywords, url, affiliations]\n",
    "\n",
    "        time.sleep(10)\n",
    "\n",
    "    print(\"Data fetching complete.\")\n",
    "    return df\n",
    "\n",
    "Entrez.email = input(\"Enter emailadres:\")\n",
    "query = build_query()\n",
    "webenv, query_key, count, API_key = history(query)\n",
    "\n",
    "\n",
    "if count > 0:\n",
    "    df = fetch_data(webenv, query_key, count, API_key)\n",
    "    print(df.head())  # Display a preview of the data\n",
    "    df.to_csv(\"pubmed_results.csv\", index=False)  # Save results to a CSV file\n",
    "    print(\"Data saved to pubmed_results.csv\")\n",
    "else:\n",
    "    print(\"No articles found.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "d360f777-51bc-49bf-aa1f-85f3d828939e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\n",
      "    \"MedlineCitation\": {\n",
      "        \"CitationSubset\": [\n",
      "            \"IM\"\n",
      "        ],\n",
      "        \"OtherAbstract\": [],\n",
      "        \"InvestigatorList\": [],\n",
      "        \"OtherID\": [],\n",
      "        \"KeywordList\": [\n",
      "            [\n",
      "                \"B cells\",\n",
      "                \"SARS-CoV-2\",\n",
      "                \"adaptive immunity\",\n",
      "                \"antibodies\",\n",
      "                \"mRNA vaccines\"\n",
      "            ]\n",
      "        ],\n",
      "        \"SpaceFlightMission\": [],\n",
      "        \"GeneralNote\": [],\n",
      "        \"PMID\": \"35759653\",\n",
      "        \"DateCompleted\": {\n",
      "            \"Year\": \"2022\",\n",
      "            \"Month\": \"06\",\n",
      "            \"Day\": \"29\"\n",
      "        },\n",
      "        \"DateRevised\": {\n",
      "            \"Year\": \"2024\",\n",
      "            \"Month\": \"12\",\n",
      "            \"Day\": \"05\"\n",
      "        },\n",
      "        \"Article\": {\n",
      "            \"ArticleDate\": [\n",
      "                {\n",
      "                    \"Year\": \"2022\",\n",
      "                    \"Month\": \"06\",\n",
      "                    \"Day\": \"27\"\n",
      "                }\n",
      "            ],\n",
      "            \"ELocationID\": [\n",
      "                \"e2204607119\",\n",
      "                \"10.1073/pnas.2204607119\"\n",
      "            ],\n",
      "            \"Language\": [\n",
      "                \"eng\"\n",
      "            ],\n",
      "            \"Journal\": {\n",
      "                \"ISSN\": \"1091-6490\",\n",
      "                \"JournalIssue\": {\n",
      "                    \"Volume\": \"119\",\n",
      "                    \"Issue\": \"28\",\n",
      "                    \"PubDate\": {\n",
      "                        \"Year\": \"2022\",\n",
      "                        \"Month\": \"Jul\",\n",
      "                        \"Day\": \"12\"\n",
      "                    }\n",
      "                },\n",
      "                \"Title\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n",
      "                \"ISOAbbreviation\": \"Proc Natl Acad Sci U S A\"\n",
      "            },\n",
      "            \"ArticleTitle\": \"Early human B cell signatures of the primary antibody response to mRNA vaccination.\",\n",
      "            \"Pagination\": {\n",
      "                \"StartPage\": \"e2204607119\",\n",
      "                \"MedlinePgn\": \"e2204607119\"\n",
      "            },\n",
      "            \"Abstract\": {\n",
      "                \"AbstractText\": [\n",
      "                    \"Messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective at inducing protective immunity. However, weak antibody responses are seen in some individuals, and cellular correlates of immunity remain poorly defined, especially for B cells. Here we used unbiased approaches to longitudinally dissect primary antibody, plasmablast, and memory B cell (MBC) responses to the two-dose mRNA-1273 vaccine in SARS-CoV-2-naive adults. Coordinated immunoglobulin A (IgA) and IgG antibody responses were preceded by bursts of spike-specific plasmablasts after both doses but earlier and more intensely after dose 2. While antibody and B cell cellular responses were generally robust, they also varied within the cohort and decreased over time after a dose-2 peak. Both antigen-nonspecific postvaccination plasmablast frequency after dose 1 and their spike-specific counterparts early after dose 2 correlated with subsequent antibody levels. This correlation between early plasmablasts and antibodies remained for titers measured at 6 months after vaccination. Several distinct antigen-specific MBC populations emerged postvaccination with varying kinetics, including two MBC populations that correlated with 2- and 6-month antibody titers. Both were IgG-expressing MBCs: one less mature, appearing as a correlate after the first dose, while the other MBC correlate showed a more mature and resting phenotype, emerging as a correlate later after dose 2. This latter MBC was also a major contributor to the sustained spike-specific MBC response observed at month 6. Thus, these plasmablasts and MBCs that emerged after both the first and second doses with distinct kinetics are potential determinants of the magnitude and durability of antibodies in response to mRNA-based vaccination.\"\n",
      "                ]\n",
      "            },\n",
      "            \"AuthorList\": [\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Kardava\",\n",
      "                    \"ForeName\": \"Lela\",\n",
      "                    \"Initials\": \"L\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Multiscale Systems Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Rachmaninoff\",\n",
      "                    \"ForeName\": \"Nicholas\",\n",
      "                    \"Initials\": \"N\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Multiscale Systems Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Lau\",\n",
      "                    \"ForeName\": \"William W\",\n",
      "                    \"Initials\": \"WW\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Buckner\",\n",
      "                    \"ForeName\": \"Clarisa M\",\n",
      "                    \"Initials\": \"CM\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Trihemasava\",\n",
      "                    \"ForeName\": \"Krittin\",\n",
      "                    \"Initials\": \"K\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Blazkova\",\n",
      "                    \"ForeName\": \"Jana\",\n",
      "                    \"Initials\": \"J\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Lopes de Assis\",\n",
      "                    \"ForeName\": \"Felipe\",\n",
      "                    \"Initials\": \"F\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Wang\",\n",
      "                    \"ForeName\": \"Wei\",\n",
      "                    \"Initials\": \"W\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Zhang\",\n",
      "                    \"ForeName\": \"Xiaozhen\",\n",
      "                    \"Initials\": \"X\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Institute for Bioscience and Biotechnology Research, Rockville, MD 20850.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Wang\",\n",
      "                    \"ForeName\": \"Yimeng\",\n",
      "                    \"Initials\": \"Y\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Institute for Bioscience and Biotechnology Research, Rockville, MD 20850.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Chiang\",\n",
      "                    \"ForeName\": \"Chi-I\",\n",
      "                    \"Initials\": \"CI\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Narpala\",\n",
      "                    \"ForeName\": \"Sandeep\",\n",
      "                    \"Initials\": \"S\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"McCormack\",\n",
      "                    \"ForeName\": \"Genevieve E\",\n",
      "                    \"Initials\": \"GE\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Multiscale Systems Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Liu\",\n",
      "                    \"ForeName\": \"Can\",\n",
      "                    \"Initials\": \"C\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Critical Care Medicine Department, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Seamon\",\n",
      "                    \"ForeName\": \"Catherine A\",\n",
      "                    \"Initials\": \"CA\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Sneller\",\n",
      "                    \"ForeName\": \"Michael C\",\n",
      "                    \"Initials\": \"MC\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"O'Connell\",\n",
      "                    \"ForeName\": \"Sarah\",\n",
      "                    \"Initials\": \"S\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Institute for Bioscience and Biotechnology Research, Rockville, MD 20850.\"\n",
      "                        },\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Department of Microbiology and Immunology and Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, MD 21201.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Li\",\n",
      "                    \"ForeName\": \"Yuxing\",\n",
      "                    \"Initials\": \"Y\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"McDermott\",\n",
      "                    \"ForeName\": \"Adrian B\",\n",
      "                    \"Initials\": \"AB\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Chun\",\n",
      "                    \"ForeName\": \"Tae-Wook\",\n",
      "                    \"Initials\": \"TW\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Fauci\",\n",
      "                    \"ForeName\": \"Anthony S\",\n",
      "                    \"Initials\": \"AS\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Multiscale Systems Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        },\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"NIH Center for Human Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Tsang\",\n",
      "                    \"ForeName\": \"John S\",\n",
      "                    \"Initials\": \"JS\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Moir\",\n",
      "                    \"ForeName\": \"Susan\",\n",
      "                    \"Initials\": \"S\"\n",
      "                }\n",
      "            ],\n",
      "            \"GrantList\": [\n",
      "                {\n",
      "                    \"GrantID\": \"R01 AI136756\",\n",
      "                    \"Acronym\": \"AI\",\n",
      "                    \"Agency\": \"NIAID NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"R41 AI147929\",\n",
      "                    \"Acronym\": \"AI\",\n",
      "                    \"Agency\": \"NIAID NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"R01 AI102766\",\n",
      "                    \"Acronym\": \"AI\",\n",
      "                    \"Agency\": \"NIAID NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"P30 AI036214\",\n",
      "                    \"Acronym\": \"AI\",\n",
      "                    \"Agency\": \"NIAID NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"R01 AI126587\",\n",
      "                    \"Acronym\": \"AI\",\n",
      "                    \"Agency\": \"NIAID NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                }\n",
      "            ],\n",
      "            \"PublicationTypeList\": [\n",
      "                \"Journal Article\",\n",
      "                \"Research Support, N.I.H., Extramural\",\n",
      "                \"Research Support, Non-U.S. Gov't\",\n",
      "                \"Research Support, N.I.H., Intramural\"\n",
      "            ]\n",
      "        },\n",
      "        \"MedlineJournalInfo\": {\n",
      "            \"Country\": \"United States\",\n",
      "            \"MedlineTA\": \"Proc Natl Acad Sci U S A\",\n",
      "            \"NlmUniqueID\": \"7505876\",\n",
      "            \"ISSNLinking\": \"0027-8424\"\n",
      "        },\n",
      "        \"ChemicalList\": [\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Immunoglobulin A\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Immunoglobulin G\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"RNA, Messenger\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"EPK39PL4R4\",\n",
      "                \"NameOfSubstance\": \"2019-nCoV Vaccine mRNA-1273\"\n",
      "            }\n",
      "        ],\n",
      "        \"CommentsCorrectionsList\": [\n",
      "            {\n",
      "                \"RefSource\": \"medRxiv. 2021 Jul 07:2021.07.06.21259528. doi: 10.1101/2021.07.06.21259528.\",\n",
      "                \"PMID\": \"34268520\"\n",
      "            }\n",
      "        ],\n",
      "        \"MeshHeadingList\": [\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"administration & dosage\",\n",
      "                    \"immunology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"2019-nCoV Vaccine mRNA-1273\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Antibody Formation\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"immunology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"B-Lymphocytes\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"prevention & control\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"COVID-19\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Humans\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Immunity, Cellular\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"blood\",\n",
      "                    \"immunology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Immunoglobulin A\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"blood\",\n",
      "                    \"immunology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Immunoglobulin G\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"administration & dosage\",\n",
      "                    \"immunology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"RNA, Messenger\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"immunology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"SARS-CoV-2\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Vaccination\"\n",
      "            }\n",
      "        ],\n",
      "        \"CoiStatement\": \"Competing interest statement: Y.W. is founder/CEO of ReVacc, Inc.\"\n",
      "    },\n",
      "    \"PubmedData\": {\n",
      "        \"ReferenceList\": [\n",
      "            {\n",
      "                \"ReferenceList\": [],\n",
      "                \"Reference\": [\n",
      "                    {\n",
      "                        \"Citation\": \"Chaudhary N., Weissman D., Whitehead K. A., mRNA vaccines for infectious diseases: Principles, delivery and clinical translation. Nat. Rev. Drug Discov. 20, 817\\u2013838 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8386155\",\n",
      "                            \"34433919\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Wrapp D., et al. , Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\\u20131263 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC7164637\",\n",
      "                            \"32075877\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Polack F. P., et al. ; C4591001 Clinical Trial Group, Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N. Engl. J. Med. 383, 2603\\u20132615 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC7745181\",\n",
      "                            \"33301246\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Baden L. R., et al. ; COVE Study Group, Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\\u2013416 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC7787219\",\n",
      "                            \"33378609\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Goel R. R., et al. , Distinct antibody and memory B cell responses in SARS-CoV-2 na\\u00efve and recovered individuals following mRNA vaccination. Sci. Immunol. 6, eabi6950 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8158969\",\n",
      "                            \"33858945\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Collier D. A., et al. ; CITIID-NIHR BioResource COVID-19 Collaboration, Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature 596, 417\\u2013422 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8373615\",\n",
      "                            \"34192737\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Boyarsky B. J., et al. , Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA 325, 2204\\u20132206 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8100911\",\n",
      "                            \"33950155\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Tsapepas D., Paget K., Mohan S., Cohen D. J., Husain S. A., Clinically significant COVID-19 following SARS-CoV-2 vaccination in kidney transplant recipients. Am. J. Kidney Dis. 78, 314\\u2013317 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8129995\",\n",
      "                            \"34019949\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Laidlaw B. J., Ellebedy A. H., The germinal centre B cell response to SARS-CoV-2. Nat. Rev. Immunol. 22, 7\\u201318 (2022).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8647067\",\n",
      "                            \"34873279\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Goel R. R., et al. ; UPenn COVID Processing Unit\\u2021, mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science 374, abm0829 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC9284784\",\n",
      "                            \"34648302\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Elsner R. A., Shlomchik M. J., Germinal center and extrafollicular B cell responses in vaccination, immunity, and autoimmunity. Immunity 53, 1136\\u20131150 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC7748291\",\n",
      "                            \"33326765\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Robinson M. J., Webster R. H., Tarlinton D. M., How intrinsic and extrinsic regulators of plasma cell survival might intersect for durable humoral immunity. Immunol. Rev. 296, 87\\u2013103 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"32592168\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kotliarov Y., et al. , Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus. Nat. Med. 26, 618\\u2013629 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8392163\",\n",
      "                            \"32094927\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Li G. M., et al. , Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc. Natl. Acad. Sci. U.S.A. 109, 9047\\u20139052 (2012).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3384143\",\n",
      "                            \"22615367\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Wrammert J., et al. , Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453, 667\\u2013671 (2008).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2515609\",\n",
      "                            \"18449194\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Tsang J. S., Utilizing population variation, vaccination, and systems biology to study human immunology. Trends Immunol. 36, 479\\u2013493 (2015).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4979540\",\n",
      "                            \"26187853\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Tsang J. S., et al. ; Baylor HIPC Center; CHI Consortium, Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell 157, 499\\u2013513 (2014).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4139290\",\n",
      "                            \"24725414\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Ellebedy A. H., et al. , Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination. Nat. Immunol. 17, 1226\\u20131234 (2016).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC5054979\",\n",
      "                            \"27525369\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Turner J. S., et al. , SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature 596, 109\\u2013113 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8935394\",\n",
      "                            \"34182569\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kim W., et al. , Germinal centre-driven maturation of B cell response to mRNA vaccination. Nature 604, 141\\u2013145 (2022).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC9204750\",\n",
      "                            \"35168246\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"R\\u00f6ltgen K., Boyd S. D., Antibody and B cell responses to SARS-CoV-2 infection and vaccination. Cell Host Microbe 29, 1063\\u20131075 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8233571\",\n",
      "                            \"34174992\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Pegu A., et al. ; mRNA-1273 Study Group\\u00a7, Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants. Science 373, 1372\\u20131377 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8691522\",\n",
      "                            \"34385356\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Stamatatos L., et al. , mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection. Science eabg9175 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8139425\",\n",
      "                            \"33766944\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Dan J. M., et al. , Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science 371, eabf4063 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC7919858\",\n",
      "                            \"33408181\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Gaebler C., et al. , Evolution of antibody immunity to SARS-CoV-2. Nature 591, 639\\u2013644 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8221082\",\n",
      "                            \"33461210\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sokal A., et al. , Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell 184, 1201\\u20131213.e14 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC7994111\",\n",
      "                            \"33571429\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Glass D. R., et al. , An integrated multi-omic single-cell atlas of human B cell identity. Immunity 53, 217\\u2013232.e5 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC7369630\",\n",
      "                            \"32668225\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sanz I., et al. , Challenges and opportunities for consistent classification of human B cell and plasma cell populations. Front. Immunol. 10, 2458 (2019).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC6813733\",\n",
      "                            \"31681331\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Baumgarth N., The shaping of a B cell pool maximally responsive to infections. Annu. Rev. Immunol. 39, 103\\u2013129 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"33472004\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Pape K. A., et al. , High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines. Cell Rep. 37, 109823 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8463313\",\n",
      "                            \"34610291\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Rodda L. B., et al. , Functional SARS-CoV-2-specific immune memory persists after mild COVID-19. Cell 184, 169\\u2013183.e17 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC7682481\",\n",
      "                            \"33296701\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Woodruff M. C., et al. , Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat. Immunol. 21, 1506\\u20131516 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC7739702\",\n",
      "                            \"33028979\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Wehr C., et al. , A new CD21low B cell population in the peripheral blood of patients with SLE. Clin. Immunol. 113, 161\\u2013171 (2004).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"15451473\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Arunachalam P. S., et al. , Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature 596, 410\\u2013416 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8761119\",\n",
      "                            \"34252919\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Berkowska M. A., et al. , Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood 118, 2150\\u20132158 (2011).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3342861\",\n",
      "                            \"21690558\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Horns F., et al. , Lineage tracing of human B cells reveals the in\\u00a0vivo landscape of human antibody class switching. eLife 5, e16578 (2016).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4970870\",\n",
      "                            \"27481325\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Deepak P., et al. , Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: A prospective cohort study. Ann. Intern. Med. 174, 1572\\u20131585 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8407518\",\n",
      "                            \"34461029\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Levin E. G., et al. , Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months. N. Engl. J. Med. 385, e84 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8522797\",\n",
      "                            \"34614326\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kuri-Cervantes L., et al. , Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci. Immunol. 5, eabd7114 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC7402634\",\n",
      "                            \"32669287\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sette A., Crotty S., Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 184, 861\\u2013880 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC7803150\",\n",
      "                            \"33497610\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Andrews S. F., et al. , Activation dynamics and immunoglobulin evolution of pre-existing and newly generated human memory B cell responses to influenza hemagglutinin. Immunity 51, 398\\u2013410.e5 (2019).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"31350180\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Jenks S. A., Cashman K. S., Woodruff M. C., Lee F. E., Sanz I., Extrafollicular responses in humans and SLE. Immunol. Rev. 288, 136\\u2013148 (2019).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC6422038\",\n",
      "                            \"30874345\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Mathew D., et al. ; UPenn COVID Processing Unit, Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science 369, eabc8511 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC7402624\",\n",
      "                            \"32669297\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Austin J. W., et al. , Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation. Sci. Transl. Med. 11, eaax0904 (2019).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC7479651\",\n",
      "                            \"31776286\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Jenks S. A., et al. , Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity 49, 725\\u2013739.e6 (2018).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC6217820\",\n",
      "                            \"30314758\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Knox J. J., Myles A., Cancro M. P., T-bet+ memory B cells: Generation, function, and fate. Immunol. Rev. 288, 149\\u2013160 (2019).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC6626622\",\n",
      "                            \"30874358\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Cho A., et al. , Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination. Nature 600, 517\\u2013522 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8674133\",\n",
      "                            \"34619745\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Purtha W. E., Tedder T. F., Johnson S., Bhattacharya D., Diamond M. S., Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants. J. Exp. Med. 208, 2599\\u20132606 (2011).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3244041\",\n",
      "                            \"22162833\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Payne R. P., et al. ; PITCH Consortium, Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine. Cell 184, 5699\\u20135714.e11 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8519781\",\n",
      "                            \"34735795\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Majdoubi A., et al. , A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2. JCI Insight 6, e146316 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8119195\",\n",
      "                            \"33720905\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Gu M., et al. , One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization. Emerg. Microbes Infect. 10, 2016\\u20132029 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC8567933\",\n",
      "                            \"34651563\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Buckner C. M., Kardava L., Moir S., Evaluation of B cell function in patients with HIV. Curr. Protoc. Immunol. 10.1002/0471142735.im1213s100 (2013).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"10.1002/0471142735.im1213s100\",\n",
      "                            \"23392635\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Buckner C. M., et al. , Maintenance of HIV-specific memory B-cell responses in elite controllers despite low viral burdens. J. Infect. Dis. 214, 390\\u2013398 (2016).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4936645\",\n",
      "                            \"27122593\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Van Gassen S., et al. , FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data. Cytometry A 87, 636\\u2013645 (2015).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"25573116\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Becht E.et al. ., . Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. 37, 38\\u201344 (2019).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"30531897\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kuznetsova A., Brockhoff P. B., Christensen R. H. B., lmerTest package: Tests in linear mixed effects models. J. Stat. Softw. 82, 1\\u201326 (2017).\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Benjamini Y., Hochberg Y., Controlling the false discovery rate\\u2014A practical and powerful approach to multiple testing. J Roy Stat Soc B Met 57, 289\\u2013300 (1995).\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Moir S., Fauci A. S., B-cell responses to HIV infection. Immunol. Rev. 275, 33\\u201348 (2017).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC5300048\",\n",
      "                            \"28133792\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Portugal S., Obeng-Adjei N., Moir S., Crompton P. D., Pierce S. K., Atypical memory B cells in human chronic infectious diseases: An interim report. Cell. Immunol. 321, 18\\u201325 (2017).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC5732066\",\n",
      "                            \"28735813\"\n",
      "                        ]\n",
      "                    }\n",
      "                ]\n",
      "            }\n",
      "        ],\n",
      "        \"History\": [\n",
      "            {\n",
      "                \"Year\": \"2022\",\n",
      "                \"Month\": \"6\",\n",
      "                \"Day\": \"27\",\n",
      "                \"Hour\": \"15\",\n",
      "                \"Minute\": \"13\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2022\",\n",
      "                \"Month\": \"6\",\n",
      "                \"Day\": \"28\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2022\",\n",
      "                \"Month\": \"6\",\n",
      "                \"Day\": \"30\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2022\",\n",
      "                \"Month\": \"6\",\n",
      "                \"Day\": \"27\"\n",
      "            }\n",
      "        ],\n",
      "        \"PublicationStatus\": \"ppublish\",\n",
      "        \"ArticleIdList\": [\n",
      "            \"35759653\",\n",
      "            \"PMC9282446\",\n",
      "            \"10.1073/pnas.2204607119\"\n",
      "        ]\n",
      "    }\n",
      "}\n",
      "{\n",
      "    \"MedlineCitation\": {\n",
      "        \"CitationSubset\": [\n",
      "            \"IM\"\n",
      "        ],\n",
      "        \"OtherAbstract\": [],\n",
      "        \"InvestigatorList\": [],\n",
      "        \"OtherID\": [],\n",
      "        \"KeywordList\": [],\n",
      "        \"SpaceFlightMission\": [],\n",
      "        \"GeneralNote\": [],\n",
      "        \"PMID\": \"34887575\",\n",
      "        \"DateCompleted\": {\n",
      "            \"Year\": \"2022\",\n",
      "            \"Month\": \"02\",\n",
      "            \"Day\": \"21\"\n",
      "        },\n",
      "        \"DateRevised\": {\n",
      "            \"Year\": \"2023\",\n",
      "            \"Month\": \"12\",\n",
      "            \"Day\": \"13\"\n",
      "        },\n",
      "        \"Article\": {\n",
      "            \"ArticleDate\": [\n",
      "                {\n",
      "                    \"Year\": \"2021\",\n",
      "                    \"Month\": \"12\",\n",
      "                    \"Day\": \"09\"\n",
      "                }\n",
      "            ],\n",
      "            \"ELocationID\": [\n",
      "                \"10.1038/s41591-021-01574-5\"\n",
      "            ],\n",
      "            \"Language\": [\n",
      "                \"eng\"\n",
      "            ],\n",
      "            \"Journal\": {\n",
      "                \"ISSN\": \"1546-170X\",\n",
      "                \"JournalIssue\": {\n",
      "                    \"Volume\": \"27\",\n",
      "                    \"Issue\": \"12\",\n",
      "                    \"PubDate\": {\n",
      "                        \"Year\": \"2021\",\n",
      "                        \"Month\": \"Dec\"\n",
      "                    }\n",
      "                },\n",
      "                \"Title\": \"Nature medicine\",\n",
      "                \"ISOAbbreviation\": \"Nat Med\"\n",
      "            },\n",
      "            \"ArticleTitle\": \"A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques.\",\n",
      "            \"Pagination\": {\n",
      "                \"StartPage\": \"2234\",\n",
      "                \"EndPage\": \"2245\",\n",
      "                \"MedlinePgn\": \"2234-2245\"\n",
      "            },\n",
      "            \"Abstract\": {\n",
      "                \"AbstractText\": [\n",
      "                    \"The development of a protective vaccine remains a top priority for the control of the HIV/AIDS pandemic. Here, we show that a messenger RNA (mRNA) vaccine co-expressing membrane-anchored HIV-1 envelope (Env) and simian immunodeficiency virus (SIV) Gag proteins to generate virus-like particles (VLPs) induces antibodies capable of broad neutralization and reduces the risk of infection in rhesus macaques. In mice, immunization with co-formulated env and gag mRNAs was superior to env mRNA alone in inducing neutralizing antibodies. Macaques were primed with a transmitted-founder clade-B env mRNA lacking the N276 glycan, followed by multiple booster immunizations with glycan-repaired autologous and subsequently bivalent heterologous envs (clades A and C). This regimen was highly immunogenic and elicited neutralizing antibodies against the most prevalent (tier-2) HIV-1 strains accompanied by robust anti-Env CD4<sup>+</sup> T\\u2009cell responses. Vaccinated animals had a 79% per-exposure risk reduction upon repeated low-dose mucosal challenges with heterologous tier-2 simian-human immunodeficiency virus (SHIV\\u2009AD8). Thus, the multiclade env-gag VLP mRNA platform represents a promising approach for the development of an HIV-1 vaccine.\"\n",
      "                ],\n",
      "                \"CopyrightInformation\": \"\\u00a9 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.\"\n",
      "            },\n",
      "            \"AuthorList\": [\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Zhang\",\n",
      "                    \"ForeName\": \"Peng\",\n",
      "                    \"Initials\": \"P\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Moderna Inc., Cambridge, MA, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [\n",
      "                        \"0000-0001-8836-181X\"\n",
      "                    ],\n",
      "                    \"LastName\": \"Narayanan\",\n",
      "                    \"ForeName\": \"Elisabeth\",\n",
      "                    \"Initials\": \"E\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [\n",
      "                        \"0000-0002-1347-6636\"\n",
      "                    ],\n",
      "                    \"LastName\": \"Liu\",\n",
      "                    \"ForeName\": \"Qingbo\",\n",
      "                    \"Initials\": \"Q\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Tsybovsky\",\n",
      "                    \"ForeName\": \"Yaroslav\",\n",
      "                    \"Initials\": \"Y\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Boswell\",\n",
      "                    \"ForeName\": \"Kristin\",\n",
      "                    \"Initials\": \"K\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Universit\\u00e9 de Montreal, Montreal, Quebec, Canada.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Ding\",\n",
      "                    \"ForeName\": \"Shilei\",\n",
      "                    \"Initials\": \"S\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Biostatistics Research Branch, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Hu\",\n",
      "                    \"ForeName\": \"Zonghui\",\n",
      "                    \"Initials\": \"Z\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Biostatistics Research Branch, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Follmann\",\n",
      "                    \"ForeName\": \"Dean\",\n",
      "                    \"Initials\": \"D\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Lin\",\n",
      "                    \"ForeName\": \"Yin\",\n",
      "                    \"Initials\": \"Y\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Miao\",\n",
      "                    \"ForeName\": \"Huiyi\",\n",
      "                    \"Initials\": \"H\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Schmeisser\",\n",
      "                    \"ForeName\": \"Hana\",\n",
      "                    \"Initials\": \"H\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Rogers\",\n",
      "                    \"ForeName\": \"Denise\",\n",
      "                    \"Initials\": \"D\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Moderna Inc., Cambridge, MA, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Falcone\",\n",
      "                    \"ForeName\": \"Samantha\",\n",
      "                    \"Initials\": \"S\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Moderna Inc., Cambridge, MA, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Elbashir\",\n",
      "                    \"ForeName\": \"Sayda M\",\n",
      "                    \"Initials\": \"SM\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Moderna Inc., Cambridge, MA, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Presnyak\",\n",
      "                    \"ForeName\": \"Vladimir\",\n",
      "                    \"Initials\": \"V\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Moderna Inc., Cambridge, MA, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Bahl\",\n",
      "                    \"ForeName\": \"Kapil\",\n",
      "                    \"Initials\": \"K\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Prabhakaran\",\n",
      "                    \"ForeName\": \"Madhu\",\n",
      "                    \"Initials\": \"M\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [\n",
      "                        \"0000-0001-9192-0440\"\n",
      "                    ],\n",
      "                    \"LastName\": \"Chen\",\n",
      "                    \"ForeName\": \"Xuejun\",\n",
      "                    \"Initials\": \"X\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [\n",
      "                        \"0000-0001-9015-3446\"\n",
      "                    ],\n",
      "                    \"LastName\": \"Sarfo\",\n",
      "                    \"ForeName\": \"Edward K\",\n",
      "                    \"Initials\": \"EK\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Ambrozak\",\n",
      "                    \"ForeName\": \"David R\",\n",
      "                    \"Initials\": \"DR\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Gautam\",\n",
      "                    \"ForeName\": \"Rajeev\",\n",
      "                    \"Initials\": \"R\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Martin\",\n",
      "                    \"ForeName\": \"Malcom A\",\n",
      "                    \"Initials\": \"MA\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Experimental Primate Virology Section, NIAID, Poolesville, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Swerczek\",\n",
      "                    \"ForeName\": \"Joanna\",\n",
      "                    \"Initials\": \"J\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Experimental Primate Virology Section, NIAID, Poolesville, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Herbert\",\n",
      "                    \"ForeName\": \"Richard\",\n",
      "                    \"Initials\": \"R\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Bioqual Inc., Rockville, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Weiss\",\n",
      "                    \"ForeName\": \"Deborah\",\n",
      "                    \"Initials\": \"D\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Bioqual Inc., Rockville, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Misamore\",\n",
      "                    \"ForeName\": \"Johnathan\",\n",
      "                    \"Initials\": \"J\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Moderna Inc., Cambridge, MA, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Ciaramella\",\n",
      "                    \"ForeName\": \"Giuseppe\",\n",
      "                    \"Initials\": \"G\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Moderna Inc., Cambridge, MA, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [\n",
      "                        \"0000-0002-7954-9674\"\n",
      "                    ],\n",
      "                    \"LastName\": \"Himansu\",\n",
      "                    \"ForeName\": \"Sunny\",\n",
      "                    \"Initials\": \"S\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Moderna Inc., Cambridge, MA, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Stewart-Jones\",\n",
      "                    \"ForeName\": \"Guillaume\",\n",
      "                    \"Initials\": \"G\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [\n",
      "                        \"0000-0003-0616-9117\"\n",
      "                    ],\n",
      "                    \"LastName\": \"McDermott\",\n",
      "                    \"ForeName\": \"Adrian\",\n",
      "                    \"Initials\": \"A\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Koup\",\n",
      "                    \"ForeName\": \"Richard A\",\n",
      "                    \"Initials\": \"RA\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Mascola\",\n",
      "                    \"ForeName\": \"John R\",\n",
      "                    \"Initials\": \"JR\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Universit\\u00e9 de Montreal, Montreal, Quebec, Canada.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Finzi\",\n",
      "                    \"ForeName\": \"Andr\\u00e9s\",\n",
      "                    \"Initials\": \"A\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Moderna Inc., Cambridge, MA, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Carfi\",\n",
      "                    \"ForeName\": \"Andrea\",\n",
      "                    \"Initials\": \"A\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, NIAID, NIH, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Fauci\",\n",
      "                    \"ForeName\": \"Anthony S\",\n",
      "                    \"Initials\": \"AS\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, NIAID, NIH, Bethesda, MD, USA. plusso@niaid.nih.gov.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [\n",
      "                        \"0000-0002-2813-4081\"\n",
      "                    ],\n",
      "                    \"LastName\": \"Lusso\",\n",
      "                    \"ForeName\": \"Paolo\",\n",
      "                    \"Initials\": \"P\"\n",
      "                }\n",
      "            ],\n",
      "            \"PublicationTypeList\": [\n",
      "                \"Journal Article\",\n",
      "                \"Research Support, N.I.H., Extramural\",\n",
      "                \"Research Support, N.I.H., Intramural\",\n",
      "                \"Research Support, Non-U.S. Gov't\"\n",
      "            ]\n",
      "        },\n",
      "        \"MedlineJournalInfo\": {\n",
      "            \"Country\": \"United States\",\n",
      "            \"MedlineTA\": \"Nat Med\",\n",
      "            \"NlmUniqueID\": \"9502015\",\n",
      "            \"ISSNLinking\": \"1078-8956\"\n",
      "        },\n",
      "        \"ChemicalList\": [\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Antibodies, Neutralizing\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"HIV Antibodies\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Vaccines, Synthetic\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"mRNA Vaccines\"\n",
      "            }\n",
      "        ],\n",
      "        \"CommentsCorrectionsList\": [\n",
      "            {\n",
      "                \"RefSource\": \"Nat Med. 2021 Dec;27(12):2082-2084. doi: 10.1038/s41591-021-01602-4.\",\n",
      "                \"PMID\": \"34887576\"\n",
      "            }\n",
      "        ],\n",
      "        \"MeshHeadingList\": [\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Animals\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"immunology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Antibodies, Neutralizing\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Genes, env\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Genes, gag\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"biosynthesis\",\n",
      "                    \"immunology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"HIV Antibodies\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"immunology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"HIV-1\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Immunization, Secondary\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Macaca mulatta\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Risk Factors\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"immunology\",\n",
      "                    \"prevention & control\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Simian Acquired Immunodeficiency Syndrome\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"administration & dosage\",\n",
      "                    \"immunology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Vaccines, Synthetic\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"administration & dosage\",\n",
      "                    \"immunology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"mRNA Vaccines\"\n",
      "            }\n",
      "        ]\n",
      "    },\n",
      "    \"PubmedData\": {\n",
      "        \"ReferenceList\": [\n",
      "            {\n",
      "                \"ReferenceList\": [],\n",
      "                \"Reference\": [\n",
      "                    {\n",
      "                        \"Citation\": \"Mascola, J. R. & Haynes, B. F. HIV-1 neutralizing antibodies: understanding nature\\u2019s pathways. Immunol. Rev. 254, 225\\u2013244 (2013).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23772623\",\n",
      "                            \"3738265\",\n",
      "                            \"10.1111/imr.12075\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kelsoe, G. & Haynes, B. F. Host controls of HIV broadly neutralizing antibody development. Immunol. Rev. 275, 79\\u201388 (2017).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"28133807\",\n",
      "                            \"5479487\",\n",
      "                            \"10.1111/imr.12508\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Burton, D. R. & Mascola, J. R. Antibody responses to envelope glycoproteins in HIV-1 infection. Nat. Immunol. 16, 571\\u2013576 (2015).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"25988889\",\n",
      "                            \"4834917\",\n",
      "                            \"10.1038/ni.3158\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Haynes, B. F., Burton, D. R. & Mascola, J. R. Multiple roles for HIV broadly neutralizing antibodies. Sci. Transl. Med. 11, eaaz2686 (2019).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"31666399\",\n",
      "                            \"7171597\",\n",
      "                            \"10.1126/scitranslmed.aaz2686\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Burton, D. R. & Hangartner, L. Broadly neutralizing antibodies to HIV and their role in vaccine design. Annu. Rev. Immunol. 34, 635\\u2013659 (2016).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"27168247\",\n",
      "                            \"6034635\",\n",
      "                            \"10.1146/annurev-immunol-041015-055515\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Excler, J. L. & Michael, N. L. Lessons from HIV-1 vaccine efficacy trials. Curr. Opin. HIV AIDS 11, 607\\u2013613 (2016).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"27537673\",\n",
      "                            \"10.1097/COH.0000000000000312\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Hessell, A. J., Malherbe, D. C. & Haigwood, N. L. Passive and active antibody studies in primates to inform HIV vaccines. Expert Rev. Vaccines 17, 127\\u2013144 (2018).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"29307225\",\n",
      "                            \"6587971\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Corey, L. et al. Immune correlates of vaccine protection against HIV-1 acquisition. Sci. Transl. Med. 7, 310rv317 (2015).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"10.1126/scitranslmed.aac7732\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Rerks-Ngarm, S. et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361, 2209\\u20132220 (2009).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"19843557\",\n",
      "                            \"10.1056/NEJMoa0908492\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Cohen, J. Combo of two HIV vaccines fails its big test. Science 367, 611\\u2013612 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"32029605\",\n",
      "                            \"10.1126/science.367.6478.611\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Easterhoff, D. et al. HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions. JCI Insight 5, e131437 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"7098725\",\n",
      "                            \"10.1172/jci.insight.131437\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sanders, R. W. et al. A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLoS Pathog. 9, e1003618 (2013).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24068931\",\n",
      "                            \"3777863\",\n",
      "                            \"10.1371/journal.ppat.1003618\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kwon, Y. D. et al. Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env. Nat. Struct. Mol. Biol. 22, 522\\u2013531 (2015).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"26098315\",\n",
      "                            \"4706170\",\n",
      "                            \"10.1038/nsmb.3051\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"de Taeye, S. W. et al. Immunogenicity of stabilized HIV-1 envelope trimers with reduced exposure of non-neutralizing epitopes. Cell 163, 1702\\u20131715 (2015).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"26687358\",\n",
      "                            \"4732737\",\n",
      "                            \"10.1016/j.cell.2015.11.056\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sullivan, J. T. et al. High-throughput protein engineering improves the antigenicity and stability of soluble HIV-1 envelope glycoprotein SOSIP trimers. J. Virol. 91, e00862-17 (2017).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"28878072\",\n",
      "                            \"5660478\",\n",
      "                            \"10.1128/JVI.00862-17\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Torrents de la Pe\\u00f1a, A. et al. Improving the immunogenicity of native-like HIV-1 envelope trimers by hyperstabilization. Cell Rep. 20, 1805\\u20131817 (2017).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"28834745\",\n",
      "                            \"5590011\",\n",
      "                            \"10.1016/j.celrep.2017.07.077\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Zhang, P. et al. Interdomain stabilization impairs CD4 binding and improves immunogenicity of the HIV-1 envelope trimer. Cell Host Microbe 23, 832\\u2013844 (2018).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"29902444\",\n",
      "                            \"6007033\",\n",
      "                            \"10.1016/j.chom.2018.05.002\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sanders, R. W. et al. HIV-1 neutralizing antibodies induced by native-like envelope trimers. Science 349, aac4223 (2015).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"26089353\",\n",
      "                            \"4498988\",\n",
      "                            \"10.1126/science.aac4223\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Klasse, P. J. et al. Sequential and simultaneous immunization of rabbits with HIV-1 envelope glycoprotein SOSIP.664 trimers from clades A, B and C. PLoS Pathog. 12, e1005864 (2016).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"27627672\",\n",
      "                            \"5023125\",\n",
      "                            \"10.1371/journal.ppat.1005864\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Hu, J. K. et al. Murine antibody responses to cleaved soluble HIV-1 envelope trimers are highly restricted in specificity. J. Virol. 89, 10383\\u201310398 (2015).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"26246566\",\n",
      "                            \"4580201\",\n",
      "                            \"10.1128/JVI.01653-15\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Zhou, T. et al. Quantification of the impact of the HIV-1-glycan shield on antibody elicitation. Cell Rep. 19, 719\\u2013732 (2017).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"28445724\",\n",
      "                            \"5538809\",\n",
      "                            \"10.1016/j.celrep.2017.04.013\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Pauthner, M. et al. Elicitation of robust tier 2 neutralizing antibody responses in nonhuman primates by HIV envelope trimer immunization using optimized approaches. Immunity 46, 1073\\u20131088 (2017).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"28636956\",\n",
      "                            \"5483234\",\n",
      "                            \"10.1016/j.immuni.2017.05.007\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"McCoy, L. E. et al. Holes in the glycan shield of the native HIV envelope are a target of trimer-elicited neutralizing antibodies. Cell Rep. 16, 2327\\u20132338 (2016).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"27545891\",\n",
      "                            \"5007210\",\n",
      "                            \"10.1016/j.celrep.2016.07.074\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kwong, P. & Mascola, J. P. HIV-1 vaccines based on antibody identification, B\\u2009cell ontogeny and epitope structure. Immunity 48, 855\\u2013871 (2018).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"29768174\",\n",
      "                            \"10.1016/j.immuni.2018.04.029\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kwong, P. D., DeKosky, B. J. & Ulmer, J. B. Antibody-guided structure-based vaccines. Semin. Immunol. 50, 101428 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"33246736\",\n",
      "                            \"10.1016/j.smim.2020.101428\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Xu, K. et al. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1. Nat. Med. 24, 857\\u2013867 (2018).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"29867235\",\n",
      "                            \"6358635\",\n",
      "                            \"10.1038/s41591-018-0042-6\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kong, R. et al. Antibody lineages with vaccine-induced antigen-binding hotspots develop broad HIV neutralization. Cell 178, 567\\u2013584 (2019).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"31348886\",\n",
      "                            \"6755680\",\n",
      "                            \"10.1016/j.cell.2019.06.030\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Steichen, J. M. et al. A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses. Science 366, eaax4380 (2019).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"31672916\",\n",
      "                            \"7092357\",\n",
      "                            \"10.1126/science.aax4380\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Saunders, K. O. et al. Targeted selection of HIV-specific antibody mutations by engineering B\\u2009cell maturation. Science 366, eaay7199 (2019).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"31806786\",\n",
      "                            \"7168753\",\n",
      "                            \"10.1126/science.aay7199\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Chen, X. et al. Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadth. Immunity 54, 324\\u2013339 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"33453152\",\n",
      "                            \"8020832\",\n",
      "                            \"10.1016/j.immuni.2020.12.014\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Bradley, T. et al. Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge. Nat. Commun. 8, 15711 (2017).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"28593989\",\n",
      "                            \"5472724\",\n",
      "                            \"10.1038/ncomms15711\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Barouch, D. H. et al. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19). Lancet 392, 232\\u2013243 (2018).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"30047376\",\n",
      "                            \"6192527\",\n",
      "                            \"10.1016/S0140-6736(18)31364-3\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Felber, B. K. et al. Co-immunization of DNA and protein in the same anatomical sites induces superior protective immune responses against SHIV challenge. Cell Rep. 31, 107624 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"32402293\",\n",
      "                            \"7329227\",\n",
      "                            \"10.1016/j.celrep.2020.107624\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Om, K. et al. Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge. PLoS Pathog. 16, e1008764 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"32881968\",\n",
      "                            \"7505435\",\n",
      "                            \"10.1371/journal.ppat.1008764\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Arunachalam, P. S. et al. T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers. Nat. Med. 26, 932\\u2013940 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"32393800\",\n",
      "                            \"7303014\",\n",
      "                            \"10.1038/s41591-020-0858-8\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Pardi, N. et al. Characterization of HIV-1 nucleoside-modified mRNA vaccines in rabbits and rhesus macaques. Mol. Ther. Nucleic Acids 15, 36\\u201347 (2019).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"30974332\",\n",
      "                            \"6454128\",\n",
      "                            \"10.1016/j.omtn.2019.03.003\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Moyo, N. et al. Efficient induction of T cells against conserved HIV-1 regions by mosaic vaccines delivered as self-amplifying mRNA. Mol. Ther. Methods Clin. Dev. 12, 32\\u201346 (2018).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"30547051\",\n",
      "                            \"6258890\",\n",
      "                            \"10.1016/j.omtm.2018.10.010\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Saunders, K. O. et al. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates. NPJ Vaccines 6, 50 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"33837212\",\n",
      "                            \"8035178\",\n",
      "                            \"10.1038/s41541-021-00307-6\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Pardi, N., Hogan, M. J., Porter, F. W. & Weissman, D. mRNA vaccines: a new era in vaccinology. Nat. Rev. Drug Discov. 17, 261\\u2013279 (2018).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"29326426\",\n",
      "                            \"5906799\",\n",
      "                            \"10.1038/nrd.2017.243\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Alameh, M.-G., Weissman, D. & Pardi, N. Messenger RNA-based vaccines against infectious diseases. Curr. Top. Microbiol. Immunol. https://doi.org/10.1007/82_2020_202 (2020).\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Corbett, K. S. et al. Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. N. Engl. J. Med. 383, 1544\\u20131555 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"32722908\",\n",
      "                            \"10.1056/NEJMoa2024671\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\\u20132615 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"33301246\",\n",
      "                            \"10.1056/NEJMoa2034577\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\\u2013416 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"33378609\",\n",
      "                            \"10.1056/NEJMoa2035389\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Manolova, V. et al. Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol. 38, 1404\\u20131413 (2008).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"18389478\",\n",
      "                            \"10.1002/eji.200737984\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Chen, C. W., Saubi, N. & Joseph-Munne, J. Design concepts of virus-like particle-based HIV-1 vaccines. Front. Immunol. 11, 573157 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"33117367\",\n",
      "                            \"7561392\",\n",
      "                            \"10.3389/fimmu.2020.573157\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Andersson, A. C., Schwerdtfeger, M. & Holst, P. J. Virus-like-vaccines against HIV. Vaccines 6, 10 (2018).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"5874651\",\n",
      "                            \"10.3390/vaccines6010010\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Effio, C. L. & Hubbuch, J. Next generation vaccines and vectors: designing downstream processes for recombinant protein-based virus-like particles. Biotechnol. J. 10, 715\\u2013727 (2015).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"25880158\",\n",
      "                            \"10.1002/biot.201400392\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Buonaguro, L. et al. High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A. Antiviral Res. 49, 35\\u201347 (2001).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"11166859\",\n",
      "                            \"10.1016/S0166-3542(00)00136-4\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Gheysen, D. et al. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59, 103\\u2013112 (1989).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"2676191\",\n",
      "                            \"10.1016/0092-8674(89)90873-8\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Haffar, O. et al. Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system. J. Virol. 64, 2653\\u20132659 (1990).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"2186175\",\n",
      "                            \"249443\",\n",
      "                            \"10.1128/jvi.64.6.2653-2659.1990\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Zhu, P. et al. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441, 847\\u2013852 (2006).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"16728975\",\n",
      "                            \"10.1038/nature04817\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Keele, B. F. et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl Acad. Sci. USA 105, 7552\\u20137557 (2008).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"18490657\",\n",
      "                            \"2387184\",\n",
      "                            \"10.1073/pnas.0802203105\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Voss, J. E. et al. Elicitation of neutralizing antibodies targeting the V2 apex of the HIV envelope trimer in a wild-type animal model. Cell Rep. 21, 222\\u2013235 (2017).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"28978475\",\n",
      "                            \"5640805\",\n",
      "                            \"10.1016/j.celrep.2017.09.024\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kothe, D. L. et al. Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins. Virology 360, 218\\u2013234 (2007).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"17097711\",\n",
      "                            \"10.1016/j.virol.2006.10.017\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Li, H. et al. Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques. Proc. Natl Acad. Sci. USA 113, 3413\\u20133422 (2016).\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"deCamp, A. et al. Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 88, 2489\\u20132507 (2014).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24352443\",\n",
      "                            \"3958090\",\n",
      "                            \"10.1128/JVI.02853-13\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Han, Q. et al. Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations. Nat. Commun. 10, 2898 (2019).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"31263112\",\n",
      "                            \"6602974\",\n",
      "                            \"10.1038/s41467-019-10899-2\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Crotty, S. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29, 621\\u2013663 (2011).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"21314428\",\n",
      "                            \"10.1146/annurev-immunol-031210-101400\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Gautam, R. et al. Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies. J. Virol. 86, 8516\\u20138526 (2012).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"22647691\",\n",
      "                            \"3421705\",\n",
      "                            \"10.1128/JVI.00644-12\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Gautam, R. et al. A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges. Nature 533, 105\\u2013109 (2016).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"27120156\",\n",
      "                            \"5127204\",\n",
      "                            \"10.1038/nature17677\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Gautam, R. et al. A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection. Nat. Med. 24, 610\\u2013616 (2018).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"29662199\",\n",
      "                            \"5989326\",\n",
      "                            \"10.1038/s41591-018-0001-2\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Cottrell, C. A. et al. Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates. PLoS Pathog. 16, e1008753 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"32866207\",\n",
      "                            \"7485981\",\n",
      "                            \"10.1371/journal.ppat.1008753\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"van Schooten, J. et al. Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates. PLoS Pathog. 17, e1009736 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"34432859\",\n",
      "                            \"8423243\",\n",
      "                            \"10.1371/journal.ppat.1009736\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Nogal, B. et al. Mapping polyclonal antibody responses in non-human primates vaccinated with HIV Env trimer subunit vaccines. Cell Rep. 30, 3755\\u20133765 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"32187547\",\n",
      "                            \"7153566\",\n",
      "                            \"10.1016/j.celrep.2020.02.061\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Haynes, B. F. et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 366, 1275\\u20131286 (2012).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"22475592\",\n",
      "                            \"3371689\",\n",
      "                            \"10.1056/NEJMoa1113425\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Jardine, J. G. et al. HIV-1 broadly neutralizing antibody precursor B\\u2009cells revealed by germline-targeting immunogen. Science 351, 1458\\u20131463 (2016).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"27013733\",\n",
      "                            \"4872700\",\n",
      "                            \"10.1126/science.aad9195\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Duan, H. et al. Glycan masking focuses immune responses to the HIV-1 CD4-binding site and enhances elicitation of VRC01-class precursor antibodies. Immunity 49, 301\\u2013311 (2018).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"30076101\",\n",
      "                            \"6896779\",\n",
      "                            \"10.1016/j.immuni.2018.07.005\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Prevost, J. et al. Incomplete downregulation of CD4 expression affects HIV-1 Env conformation and antibody-dependent cellular cytotoxicity responses. J. Virol. 92, e00484-18 (2018).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"29669829\",\n",
      "                            \"6002730\",\n",
      "                            \"10.1128/JVI.00484-18\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Richard, J. et al. Uninfected bystander cells impact the measurement of HIV-specific antibody-dependent cellular cytotoxicity responses. mBio 9, e00358-18 (2018).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"29559570\",\n",
      "                            \"5874913\",\n",
      "                            \"10.1128/mBio.00358-18\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Pardi, N. et al. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B\\u2009cell responses. J. Exp. Med. 215, 1571\\u20131588 (2018).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"29739835\",\n",
      "                            \"5987916\",\n",
      "                            \"10.1084/jem.20171450\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Garrido, C. et al. SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques. Sci. Immunol. 6, eabj3684 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"34131024\",\n",
      "                            \"8774290\",\n",
      "                            \"10.1126/sciimmunol.abj3684\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Painter, M. M. et al. Rapid induction of antigen-specific CD4(+) T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination. Immunity 54, 2133\\u20132142 (2021).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"34453880\",\n",
      "                            \"8361141\",\n",
      "                            \"10.1016/j.immuni.2021.08.001\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Locci, M. et al. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 39, 758\\u2013769 (2013).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24035365\",\n",
      "                            \"3996844\",\n",
      "                            \"10.1016/j.immuni.2013.08.031\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Moldt, B. et al. Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo. Proc. Natl Acad. Sci. USA 109, 18921\\u201318925 (2012).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23100539\",\n",
      "                            \"3503218\",\n",
      "                            \"10.1073/pnas.1214785109\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Montefiori, D. C. & Mascola, J. R. Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need? Curr. Opin. HIV AIDS 4, 347\\u2013351 (2009).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"20048696\",\n",
      "                            \"2879149\",\n",
      "                            \"10.1097/COH.0b013e32832f4a4d\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Parren, P. W. et al. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J. Virol. 75, 8340\\u20138347 (2001).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"11483779\",\n",
      "                            \"115078\",\n",
      "                            \"10.1128/JVI.75.17.8340-8347.2001\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Shingai, M. et al. Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques. J. Exp. Med. 211, 2061\\u20132074 (2014).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"25155019\",\n",
      "                            \"4172223\",\n",
      "                            \"10.1084/jem.20132494\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Pauthner, M. G. et al. Vaccine-induced protection from homologous tier 2 SHIV challenge in nonhuman primates depends on serum-neutralizing antibody titers. Immunity 50, 241\\u2013252 (2019).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"30552025\",\n",
      "                            \"6335502\",\n",
      "                            \"10.1016/j.immuni.2018.11.011\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Nelson, J. et al. Impact of mRNA chemistry and manufacturing process on innate immune activation. Sci. Adv. 6, eaaz6893 (2020).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"32637598\",\n",
      "                            \"7314518\",\n",
      "                            \"10.1126/sciadv.aaz6893\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Hassett, K. J. et al. Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Mol. Ther. Nucleic Acids 15, 1\\u201311 (2019).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"30785039\",\n",
      "                            \"6383180\",\n",
      "                            \"10.1016/j.omtn.2019.01.013\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Bahl, K. et al. Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses. Mol. Ther. 25, 1316\\u20131327 (2017).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"28457665\",\n",
      "                            \"5475249\",\n",
      "                            \"10.1016/j.ymthe.2017.03.035\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Roederer, M., Nozzi, J. L. & Nason, M. C. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79, 167\\u2013174 (2011).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"21265010\",\n",
      "                            \"3072288\",\n",
      "                            \"10.1002/cyto.a.21015\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Vassena, L. et al. Treatment with IL-7 prevents the decline of circulating CD4+ T cells during the acute phase of SIV infection in rhesus macaques. PLoS Pathog. 8, e1002636 (2012).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"22511868\",\n",
      "                            \"3325214\",\n",
      "                            \"10.1371/journal.ppat.1002636\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Scheres, S. H. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519\\u2013530 (2012).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23000701\",\n",
      "                            \"3690530\",\n",
      "                            \"10.1016/j.jsb.2012.09.006\"\n",
      "                        ]\n",
      "                    }\n",
      "                ]\n",
      "            }\n",
      "        ],\n",
      "        \"History\": [\n",
      "            {\n",
      "                \"Year\": \"2021\",\n",
      "                \"Month\": \"6\",\n",
      "                \"Day\": \"9\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2021\",\n",
      "                \"Month\": \"10\",\n",
      "                \"Day\": \"6\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2021\",\n",
      "                \"Month\": \"12\",\n",
      "                \"Day\": \"11\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2022\",\n",
      "                \"Month\": \"2\",\n",
      "                \"Day\": \"22\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2021\",\n",
      "                \"Month\": \"12\",\n",
      "                \"Day\": \"10\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"35\"\n",
      "            }\n",
      "        ],\n",
      "        \"PublicationStatus\": \"ppublish\",\n",
      "        \"ArticleIdList\": [\n",
      "            \"34887575\",\n",
      "            \"10.1038/s41591-021-01574-5\",\n",
      "            \"10.1038/s41591-021-01574-5\"\n",
      "        ]\n",
      "    }\n",
      "}\n",
      "{\n",
      "    \"MedlineCitation\": {\n",
      "        \"CitationSubset\": [\n",
      "            \"IM\"\n",
      "        ],\n",
      "        \"OtherAbstract\": [],\n",
      "        \"InvestigatorList\": [],\n",
      "        \"OtherID\": [],\n",
      "        \"KeywordList\": [\n",
      "            [\n",
      "                \"HIV\",\n",
      "                \"immune activation\",\n",
      "                \"provirus\"\n",
      "            ]\n",
      "        ],\n",
      "        \"SpaceFlightMission\": [],\n",
      "        \"GeneralNote\": [],\n",
      "        \"PMID\": \"32029589\",\n",
      "        \"DateCompleted\": {\n",
      "            \"Year\": \"2020\",\n",
      "            \"Month\": \"07\",\n",
      "            \"Day\": \"10\"\n",
      "        },\n",
      "        \"DateRevised\": {\n",
      "            \"Year\": \"2020\",\n",
      "            \"Month\": \"07\",\n",
      "            \"Day\": \"10\"\n",
      "        },\n",
      "        \"Article\": {\n",
      "            \"ArticleDate\": [\n",
      "                {\n",
      "                    \"Year\": \"2020\",\n",
      "                    \"Month\": \"02\",\n",
      "                    \"Day\": \"06\"\n",
      "                }\n",
      "            ],\n",
      "            \"ELocationID\": [\n",
      "                \"10.1073/pnas.1917876117\"\n",
      "            ],\n",
      "            \"Language\": [\n",
      "                \"eng\"\n",
      "            ],\n",
      "            \"Journal\": {\n",
      "                \"ISSN\": \"1091-6490\",\n",
      "                \"JournalIssue\": {\n",
      "                    \"Volume\": \"117\",\n",
      "                    \"Issue\": \"7\",\n",
      "                    \"PubDate\": {\n",
      "                        \"Year\": \"2020\",\n",
      "                        \"Month\": \"Feb\",\n",
      "                        \"Day\": \"18\"\n",
      "                    }\n",
      "                },\n",
      "                \"Title\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n",
      "                \"ISOAbbreviation\": \"Proc Natl Acad Sci U S A\"\n",
      "            },\n",
      "            \"ArticleTitle\": \"Defective HIV-1 proviruses produce viral proteins.\",\n",
      "            \"Pagination\": {\n",
      "                \"StartPage\": \"3704\",\n",
      "                \"EndPage\": \"3710\",\n",
      "                \"MedlinePgn\": \"3704-3710\"\n",
      "            },\n",
      "            \"Abstract\": {\n",
      "                \"AbstractText\": [\n",
      "                    \"HIV-1 proviruses persist in the CD4<sup>+</sup> T cells of HIV-infected individuals despite years of combination antiretroviral therapy (cART) with suppression of HIV-1 RNA levels <40 copies/mL. Greater than 95% of these proviruses detected in circulating peripheral blood mononuclear cells (PBMCs) are referred to as \\\"defective\\\" by virtue of having large internal deletions and lethal genetic mutations. As these defective proviruses are unable to encode intact and replication-competent viruses, they have long been thought of as biologically irrelevant \\\"graveyard\\\" of viruses with little significance to HIV-1 pathogenesis. Contrary to this notion, we have recently demonstrated that these defective proviruses are not silent, are capable of transcribing novel unspliced forms of HIV-RNA transcripts with competent open reading frames (ORFs), and can be found in the peripheral blood CD4<sup>+</sup> T cells of patients at all stages of HIV-1 infection. In the present study, by an approach of combining serial dilutions of CD4<sup>+</sup> T cells and T cell-cloning technologies, we are able to demonstrate that defective proviruses that persist in HIV-infected individuals during suppressive cART are translationally competent and produce the HIV-1 Gag and Nef proteins. The HIV-RNA transcripts expressed from these defective proviruses may trigger an element of innate immunity. Likewise, the viral proteins coded in the defective proviruses may form extracellular virus-like particles and may trigger immune responses. The persistent production of HIV-1 proteins in the absence of viral replication helps explain persistent immune activation despite HIV-1 levels below detection, and also presents new challenges to HIV-1 eradication.\"\n",
      "                ],\n",
      "                \"CopyrightInformation\": \"Copyright \\u00a9 2020 the Author(s). Published by PNAS.\"\n",
      "            },\n",
      "            \"AuthorList\": [\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Imamichi\",\n",
      "                    \"ForeName\": \"Hiromi\",\n",
      "                    \"Initials\": \"H\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Smith\",\n",
      "                    \"ForeName\": \"Mindy\",\n",
      "                    \"Initials\": \"M\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Adelsberger\",\n",
      "                    \"ForeName\": \"Joseph W\",\n",
      "                    \"Initials\": \"JW\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Izumi\",\n",
      "                    \"ForeName\": \"Taisuke\",\n",
      "                    \"Initials\": \"T\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Scrimieri\",\n",
      "                    \"ForeName\": \"Francesca\",\n",
      "                    \"Initials\": \"F\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Sherman\",\n",
      "                    \"ForeName\": \"Brad T\",\n",
      "                    \"Initials\": \"BT\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Rehm\",\n",
      "                    \"ForeName\": \"Catherine A\",\n",
      "                    \"Initials\": \"CA\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Imamichi\",\n",
      "                    \"ForeName\": \"Tomozumi\",\n",
      "                    \"Initials\": \"T\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Pau\",\n",
      "                    \"ForeName\": \"Alice\",\n",
      "                    \"Initials\": \"A\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Department of Microbiology and Immunology, Georgetown University School of Medicine, Washington, DC 20057.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Catalfamo\",\n",
      "                    \"ForeName\": \"Marta\",\n",
      "                    \"Initials\": \"M\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; afauci@niaid.nih.gov clane@niaid.nih.gov.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Fauci\",\n",
      "                    \"ForeName\": \"Anthony S\",\n",
      "                    \"Initials\": \"AS\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; afauci@niaid.nih.gov clane@niaid.nih.gov.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Lane\",\n",
      "                    \"ForeName\": \"H Clifford\",\n",
      "                    \"Initials\": \"HC\"\n",
      "                }\n",
      "            ],\n",
      "            \"GrantList\": [\n",
      "                {\n",
      "                    \"GrantID\": \"HHSN261200800001E\",\n",
      "                    \"Acronym\": \"CA\",\n",
      "                    \"Agency\": \"NCI NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                }\n",
      "            ],\n",
      "            \"PublicationTypeList\": [\n",
      "                \"Journal Article\",\n",
      "                \"Research Support, N.I.H., Extramural\",\n",
      "                \"Research Support, N.I.H., Intramural\"\n",
      "            ]\n",
      "        },\n",
      "        \"MedlineJournalInfo\": {\n",
      "            \"Country\": \"United States\",\n",
      "            \"MedlineTA\": \"Proc Natl Acad Sci U S A\",\n",
      "            \"NlmUniqueID\": \"7505876\",\n",
      "            \"ISSNLinking\": \"0027-8424\"\n",
      "        },\n",
      "        \"ChemicalList\": [\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Viral Proteins\"\n",
      "            }\n",
      "        ],\n",
      "        \"MeshHeadingList\": [\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"virology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"CD4-Positive T-Lymphocytes\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"virology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"HIV Infections\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"genetics\",\n",
      "                    \"metabolism\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"HIV-1\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Humans\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"virology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Leukocytes, Mononuclear\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Male\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Middle Aged\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"genetics\",\n",
      "                    \"metabolism\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Proviruses\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"genetics\",\n",
      "                    \"metabolism\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Viral Proteins\"\n",
      "            }\n",
      "        ],\n",
      "        \"CoiStatement\": \"The authors declare no competing interest.\"\n",
      "    },\n",
      "    \"PubmedData\": {\n",
      "        \"ReferenceList\": [\n",
      "            {\n",
      "                \"ReferenceList\": [],\n",
      "                \"Reference\": [\n",
      "                    {\n",
      "                        \"Citation\": \"Imai H., et al. , A defective proviral DNA with a 2.6-kb deletion of human immunodeficiency virus type 1 (HIV-1) in a persistently HIV-1 infected cell clone. Virus Genes 5, 81\\u201388 (1991).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"2017879\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Li Y., et al. , Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and -defective viral genomes. J. Virol. 65, 3973\\u20133985 (1991).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC248827\",\n",
      "                            \"1830110\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sanchez G., Xu X., Chermann J. C., Hirsch I., Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals. J. Virol. 71, 2233\\u20132240 (1997).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC191331\",\n",
      "                            \"9032358\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Ho Y. C., et al. , Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155, 540\\u2013551 (2013).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3896327\",\n",
      "                            \"24243014\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Imamichi H., et al. , Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy. Proc. Natl. Acad. Sci. U.S.A. 113, 8783\\u20138788 (2016).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4978246\",\n",
      "                            \"27432972\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Bruner K. M., et al. , Defective proviruses rapidly accumulate during acute HIV-1 infection. Nat. Med. 22, 1043\\u20131049 (2016).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC5014606\",\n",
      "                            \"27500724\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Buzon M. J., et al. , Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells. J. Virol. 88, 10056\\u201310065 (2014).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4136362\",\n",
      "                            \"24965451\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Josefsson L., et al. , The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time. Proc. Natl. Acad. Sci. U.S.A. 110, E4987\\u2013E4996 (2013).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3870728\",\n",
      "                            \"24277811\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Murray J. M., et al. ; PINT Study Team , HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy. J. Virol. 88, 3516\\u20133526 (2014).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3957951\",\n",
      "                            \"24403590\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Imamichi H., et al. , Lifespan of effector memory CD4+ T cells determined by replication-incompetent integrated HIV-1 provirus. AIDS 28, 1091\\u20131099 (2014).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24492253\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kearney M. F., et al. , Origin of rebound plasma HIV includes cells with identical proviruses that are transcriptionally active before stopping of antiretroviral therapy. J. Virol. 90, 1369\\u20131376 (2015).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4719635\",\n",
      "                            \"26581989\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Finzi D., Plaeger S. F., Dieffenbach C. W., Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis. Clin. Vaccine Immunol. 13, 715\\u2013721 (2006).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC1489566\",\n",
      "                            \"16829607\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Besson G. J., et al. , HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy. Clin. Infect. Dis. 59, 1312\\u20131321 (2014).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4200019\",\n",
      "                            \"25073894\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Golob J. L., et al. , HIV DNA levels and decay in a cohort of 111 long-term virally suppressed patients. AIDS 32, 2113\\u20132118 (2018).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC6136948\",\n",
      "                            \"30005008\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Mendoza D., et al. , Comprehensive analysis of unique cases with extraordinary control over HIV replication. Blood 119, 4645\\u20134655 (2012).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3367872\",\n",
      "                            \"22490332\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Pollack R. A., et al. , Defective HIV-1 proviruses are expressed and can be recognized by cytotoxic T lymphocytes, which shape the proviral landscape. Cell Host Microbe 21, 494\\u2013506.e4 (2017).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC5433942\",\n",
      "                            \"28407485\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Boulware D. R., et al. ; INSIGHT Study Group , Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J. Infect. Dis. 203, 1637\\u20131646 (2011).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3096784\",\n",
      "                            \"21592994\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kuller L. H., et al. ; INSIGHT SMART Study Group , Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 5, e203 (2008).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2570418\",\n",
      "                            \"18942885\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Silverberg M. J., et al. , Risk of cancers during interrupted antiretroviral therapy in the SMART study. AIDS 21, 1957\\u20131963 (2007).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"17721103\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Gallo R. C., et al. , Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500\\u2013503 (1984).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"6200936\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Shaw G. M., et al. , Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science 226, 1165\\u20131171 (1984).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"6095449\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Takebe Y., Telesnitsky A., Evidence for the acquisition of multi-drug resistance in an HIV-1 clinical isolate via human sequence transduction. Virology 351, 1\\u20136 (2006).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2213631\",\n",
      "                            \"16777167\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Han Y., et al. , Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. Cell Host Microbe 4, 134\\u2013146 (2008).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2604135\",\n",
      "                            \"18692773\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Bullen C. K., Laird G. M., Durand C. M., Siliciano J. D., Siliciano R. F., New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo. Nat. Med. 20, 425\\u2013429 (2014).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3981911\",\n",
      "                            \"24658076\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Pasternak A. O., et al. , Minor contribution of chimeric host-HIV readthrough transcripts to the level of HIV cell-associated gag RNA. J. Virol. 90, 1148\\u20131151 (2015).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4702708\",\n",
      "                            \"26559833\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Gl\\u00fcck J. M., Hoffmann S., Koenig B. W., Willbold D., Single vector system for efficient N-myristoylation of recombinant proteins in E. coli. PLoS One 5, e10081 (2010).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2852408\",\n",
      "                            \"20404920\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Morgan C. R., Miglionico B. V., Engen J. R., Effects of HIV-1 Nef on human N-myristoyltransferase 1. Biochemistry 50, 3394\\u20133403 (2011).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3086299\",\n",
      "                            \"21449607\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Roberts J. D., Bebenek K., Kunkel T. A., The accuracy of reverse transcriptase from HIV-1. Science 242, 1171\\u20131173 (1988).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"2460925\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Preston B. D., Poiesz B. J., Loeb L. A., Fidelity of HIV-1 reverse transcriptase. Science 242, 1168\\u20131171 (1988).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"2460924\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Hu W. S., Hughes S. H., HIV-1 reverse transcription. Cold Spring Harb. Perspect. Med. 2, a006882 (2012).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3475395\",\n",
      "                            \"23028129\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Nelson P. N., et al. , Demystified. Human endogenous retroviruses. Mol. Pathol. 56, 11\\u201318 (2003).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC1187282\",\n",
      "                            \"12560456\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kurth R., Bannert N., Beneficial and detrimental effects of human endogenous retroviruses. Int. J. Cancer 126, 306\\u2013314 (2010).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"19795446\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Hohn O., Hanke K., Bannert N., HERV-K(HML-2), the best preserved family of HERVs: Endogenization, expression, and implications in health and disease. Front. Oncol. 3, 246 (2013).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3778440\",\n",
      "                            \"24066280\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Young G. R., Stoye J. P., Kassiotis G., Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis. BioEssays 35, 794\\u2013803 (2013).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4352332\",\n",
      "                            \"23864388\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Collins K. L., Baltimore D., HIV\\u2019s evasion of the cellular immune response. Immunol. Rev. 168, 65\\u201374 (1999).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"10399065\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Mann J. K., et al. , Nef-mediated down-regulation of CD4 and HLA class I in HIV-1 subtype C infection: Association with disease progression and influence of immune pressure. Virology 468\\u2013470, 214\\u2013225 (2014).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4252354\",\n",
      "                            \"25193656\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Pawlak E. N., Dikeakos J. D., HIV-1 Nef: A master manipulator of the membrane trafficking machinery mediating immune evasion. Biochim. Biophys. Acta 1850, 733\\u2013741 (2015).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"25585010\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Dirk B. S., et al. , HIV-1 Nef sequesters MHC-I intracellularly by targeting early stages of endocytosis and recycling. Sci. Rep. 6, 37021 (2016).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC5107982\",\n",
      "                            \"27841315\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Howcroft T. K., Strebel K., Martin M. A., Singer D. S., Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 260, 1320\\u20131322 (1993).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"8493575\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kamp W., Berk M. B., Visser C. J., Nottet H. S., Mechanisms of HIV-1 to escape from the host immune surveillance. Eur. J. Clin. Invest. 30, 740\\u2013746 (2000).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"10964167\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Wang T., et al. , Intracellular Nef detected in peripheral blood mononuclear cells from HIV patients. AIDS Res. Hum. Retroviruses 31, 217\\u2013220 (2015).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4313413\",\n",
      "                            \"25062432\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Ferdin J., et al. , Viral protein Nef is detected in plasma of half of HIV-infected adults with undetectable plasma HIV RNA. PLoS One 13, e0191613 (2018).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC5783402\",\n",
      "                            \"29364927\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Persaud D., et al. , Absence of detectable HIV-1 viremia after treatment cessation in an infant. N. Engl. J. Med. 369, 1828\\u20131835 (2013).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3954754\",\n",
      "                            \"24152233\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Schindelin J., et al. , Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676\\u2013682 (2012).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3855844\",\n",
      "                            \"22743772\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Xufr\\u00e9 C., et al. , Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients. Int. Immunol. 25, 563\\u2013574 (2013).\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23929911\"\n",
      "                        ]\n",
      "                    }\n",
      "                ]\n",
      "            }\n",
      "        ],\n",
      "        \"History\": [\n",
      "            {\n",
      "                \"Year\": \"2020\",\n",
      "                \"Month\": \"2\",\n",
      "                \"Day\": \"8\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2020\",\n",
      "                \"Month\": \"7\",\n",
      "                \"Day\": \"11\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2020\",\n",
      "                \"Month\": \"2\",\n",
      "                \"Day\": \"8\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2020\",\n",
      "                \"Month\": \"2\",\n",
      "                \"Day\": \"6\"\n",
      "            }\n",
      "        ],\n",
      "        \"PublicationStatus\": \"ppublish\",\n",
      "        \"ArticleIdList\": [\n",
      "            \"32029589\",\n",
      "            \"PMC7035625\",\n",
      "            \"10.1073/pnas.1917876117\",\n",
      "            \"1917876117\"\n",
      "        ]\n",
      "    }\n",
      "}\n",
      "{\n",
      "    \"MedlineCitation\": {\n",
      "        \"CitationSubset\": [\n",
      "            \"IM\"\n",
      "        ],\n",
      "        \"OtherAbstract\": [],\n",
      "        \"InvestigatorList\": [],\n",
      "        \"OtherID\": [],\n",
      "        \"KeywordList\": [\n",
      "            [\n",
      "                \"cardiovascular disease\",\n",
      "                \"celebrity influence\",\n",
      "                \"consumer behavior\",\n",
      "                \"deceptive promotions\",\n",
      "                \"fake celebrity endorsement\",\n",
      "                \"false health advertisements\",\n",
      "                \"health care\",\n",
      "                \"health-related products and procedures\",\n",
      "                \"legitimate health products\"\n",
      "            ]\n",
      "        ],\n",
      "        \"SpaceFlightMission\": [],\n",
      "        \"GeneralNote\": [],\n",
      "        \"PMID\": \"31599648\",\n",
      "        \"DateCompleted\": {\n",
      "            \"Year\": \"2020\",\n",
      "            \"Month\": \"09\",\n",
      "            \"Day\": \"02\"\n",
      "        },\n",
      "        \"DateRevised\": {\n",
      "            \"Year\": \"2020\",\n",
      "            \"Month\": \"09\",\n",
      "            \"Day\": \"02\"\n",
      "        },\n",
      "        \"Article\": {\n",
      "            \"ArticleDate\": [\n",
      "                {\n",
      "                    \"Year\": \"2019\",\n",
      "                    \"Month\": \"10\",\n",
      "                    \"Day\": \"10\"\n",
      "                }\n",
      "            ],\n",
      "            \"ELocationID\": [\n",
      "                \"10.2217/fca-2019-0020\"\n",
      "            ],\n",
      "            \"Language\": [\n",
      "                \"eng\"\n",
      "            ],\n",
      "            \"Journal\": {\n",
      "                \"ISSN\": \"1744-8298\",\n",
      "                \"JournalIssue\": {\n",
      "                    \"Volume\": \"15\",\n",
      "                    \"Issue\": \"6\",\n",
      "                    \"PubDate\": {\n",
      "                        \"Year\": \"2019\",\n",
      "                        \"Month\": \"Nov\"\n",
      "                    }\n",
      "                },\n",
      "                \"Title\": \"Future cardiology\",\n",
      "                \"ISOAbbreviation\": \"Future Cardiol\"\n",
      "            },\n",
      "            \"ArticleTitle\": \"Impact of unauthorized celebrity endorsements on cardiovascular healthcare.\",\n",
      "            \"Pagination\": {\n",
      "                \"StartPage\": \"387\",\n",
      "                \"EndPage\": \"390\",\n",
      "                \"MedlinePgn\": \"387-390\"\n",
      "            },\n",
      "            \"AuthorList\": [\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 55902, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Mookadam\",\n",
      "                    \"ForeName\": \"Farouk\",\n",
      "                    \"Initials\": \"F\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Department of Surgery, Columbia/New York Presbyterian Medical Center, New York, NY 10032, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Oz\",\n",
      "                    \"ForeName\": \"Mehmet\",\n",
      "                    \"Initials\": \"M\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Department of Internal Medicine, Dow University of Health Sciences, Karachi, 74200, Pakistan.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Siddiqi\",\n",
      "                    \"ForeName\": \"Tariq Jamal\",\n",
      "                    \"Initials\": \"TJ\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Department of Education, Mayo Clinic, Phoenix, AZ 55902, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Almader-Douglas\",\n",
      "                    \"ForeName\": \"Diana\",\n",
      "                    \"Initials\": \"D\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Department of Environmental Health & Engineering, Johns\\u00a0Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Crupain\",\n",
      "                    \"ForeName\": \"Michael\",\n",
      "                    \"Initials\": \"M\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Department of Internal Medicine, John H Stroger Jr. Hospital of Cook County, Chicago, IL\\u00a060612, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Khan\",\n",
      "                    \"ForeName\": \"Muhammad Shahzeb\",\n",
      "                    \"Initials\": \"MS\"\n",
      "                }\n",
      "            ],\n",
      "            \"PublicationTypeList\": [\n",
      "                \"Editorial\"\n",
      "            ]\n",
      "        },\n",
      "        \"MedlineJournalInfo\": {\n",
      "            \"Country\": \"England\",\n",
      "            \"MedlineTA\": \"Future Cardiol\",\n",
      "            \"NlmUniqueID\": \"101239345\",\n",
      "            \"ISSNLinking\": \"1479-6678\"\n",
      "        },\n",
      "        \"MeshHeadingList\": [\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"therapy\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Cardiovascular Diseases\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Consumer Behavior\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"legislation & jurisprudence\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Delivery of Health Care\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Famous Persons\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Humans\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Surveys and Questionnaires\"\n",
      "            }\n",
      "        ]\n",
      "    },\n",
      "    \"PubmedData\": {\n",
      "        \"ReferenceList\": [],\n",
      "        \"History\": [\n",
      "            {\n",
      "                \"Year\": \"2019\",\n",
      "                \"Month\": \"10\",\n",
      "                \"Day\": \"11\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2020\",\n",
      "                \"Month\": \"9\",\n",
      "                \"Day\": \"4\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2019\",\n",
      "                \"Month\": \"10\",\n",
      "                \"Day\": \"11\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            }\n",
      "        ],\n",
      "        \"PublicationStatus\": \"ppublish\",\n",
      "        \"ArticleIdList\": [\n",
      "            \"31599648\",\n",
      "            \"10.2217/fca-2019-0020\"\n",
      "        ]\n",
      "    }\n",
      "}\n",
      "{\n",
      "    \"MedlineCitation\": {\n",
      "        \"CitationSubset\": [\n",
      "            \"IM\"\n",
      "        ],\n",
      "        \"OtherAbstract\": [],\n",
      "        \"InvestigatorList\": [],\n",
      "        \"OtherID\": [],\n",
      "        \"KeywordList\": [],\n",
      "        \"SpaceFlightMission\": [],\n",
      "        \"GeneralNote\": [],\n",
      "        \"PMID\": \"28002559\",\n",
      "        \"DateCompleted\": {\n",
      "            \"Year\": \"2019\",\n",
      "            \"Month\": \"05\",\n",
      "            \"Day\": \"27\"\n",
      "        },\n",
      "        \"DateRevised\": {\n",
      "            \"Year\": \"2019\",\n",
      "            \"Month\": \"05\",\n",
      "            \"Day\": \"27\"\n",
      "        },\n",
      "        \"Article\": {\n",
      "            \"ArticleDate\": [],\n",
      "            \"ELocationID\": [\n",
      "                \"10.1001/jamacardio.2016.5177\"\n",
      "            ],\n",
      "            \"Language\": [\n",
      "                \"eng\"\n",
      "            ],\n",
      "            \"Journal\": {\n",
      "                \"ISSN\": \"2380-6591\",\n",
      "                \"JournalIssue\": {\n",
      "                    \"Volume\": \"2\",\n",
      "                    \"Issue\": \"2\",\n",
      "                    \"PubDate\": {\n",
      "                        \"Year\": \"2017\",\n",
      "                        \"Month\": \"Feb\",\n",
      "                        \"Day\": \"01\"\n",
      "                    }\n",
      "                },\n",
      "                \"Title\": \"JAMA cardiology\",\n",
      "                \"ISOAbbreviation\": \"JAMA Cardiol\"\n",
      "            },\n",
      "            \"ArticleTitle\": \"Association Between Human Immunodeficiency Virus Infection and Cardiovascular Diseases: Finding a Solution to Double Jeopardy.\",\n",
      "            \"Pagination\": {\n",
      "                \"StartPage\": \"123\",\n",
      "                \"EndPage\": \"124\",\n",
      "                \"MedlinePgn\": \"123-124\"\n",
      "            },\n",
      "            \"AuthorList\": [\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Hadigan\",\n",
      "                    \"ForeName\": \"Colleen\",\n",
      "                    \"Initials\": \"C\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Paules\",\n",
      "                    \"ForeName\": \"Catharine I\",\n",
      "                    \"Initials\": \"CI\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Fauci\",\n",
      "                    \"ForeName\": \"Anthony S\",\n",
      "                    \"Initials\": \"AS\"\n",
      "                }\n",
      "            ],\n",
      "            \"PublicationTypeList\": [\n",
      "                \"Journal Article\",\n",
      "                \"Comment\"\n",
      "            ]\n",
      "        },\n",
      "        \"MedlineJournalInfo\": {\n",
      "            \"Country\": \"United States\",\n",
      "            \"MedlineTA\": \"JAMA Cardiol\",\n",
      "            \"NlmUniqueID\": \"101676033\"\n",
      "        },\n",
      "        \"CommentsCorrectionsList\": [\n",
      "            {\n",
      "                \"RefSource\": \"JAMA Cardiol. 2017 Feb 1;2(2):155-162. doi: 10.1001/jamacardio.2016.4494.\",\n",
      "                \"PMID\": \"28002550\"\n",
      "            }\n",
      "        ],\n",
      "        \"MeshHeadingList\": [\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Acquired Immunodeficiency Syndrome\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Cardiovascular Diseases\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"HIV\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"HIV Infections\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Humans\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Myocardial Infarction\"\n",
      "            }\n",
      "        ]\n",
      "    },\n",
      "    \"PubmedData\": {\n",
      "        \"ReferenceList\": [],\n",
      "        \"History\": [\n",
      "            {\n",
      "                \"Year\": \"2016\",\n",
      "                \"Month\": \"12\",\n",
      "                \"Day\": \"22\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2019\",\n",
      "                \"Month\": \"5\",\n",
      "                \"Day\": \"28\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2016\",\n",
      "                \"Month\": \"12\",\n",
      "                \"Day\": \"22\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            }\n",
      "        ],\n",
      "        \"PublicationStatus\": \"ppublish\",\n",
      "        \"ArticleIdList\": [\n",
      "            \"28002559\",\n",
      "            \"10.1001/jamacardio.2016.5177\",\n",
      "            \"2593746\"\n",
      "        ]\n",
      "    }\n",
      "}\n",
      "{\n",
      "    \"MedlineCitation\": {\n",
      "        \"CitationSubset\": [\n",
      "            \"IM\"\n",
      "        ],\n",
      "        \"OtherAbstract\": [],\n",
      "        \"InvestigatorList\": [],\n",
      "        \"OtherID\": [],\n",
      "        \"KeywordList\": [\n",
      "            [\n",
      "                \"HIV-1\",\n",
      "                \"activation\",\n",
      "                \"latency\",\n",
      "                \"provirus\"\n",
      "            ]\n",
      "        ],\n",
      "        \"SpaceFlightMission\": [],\n",
      "        \"GeneralNote\": [],\n",
      "        \"PMID\": \"27432972\",\n",
      "        \"DateCompleted\": {\n",
      "            \"Year\": \"2018\",\n",
      "            \"Month\": \"02\",\n",
      "            \"Day\": \"05\"\n",
      "        },\n",
      "        \"DateRevised\": {\n",
      "            \"Year\": \"2024\",\n",
      "            \"Month\": \"09\",\n",
      "            \"Day\": \"22\"\n",
      "        },\n",
      "        \"Article\": {\n",
      "            \"ArticleDate\": [\n",
      "                {\n",
      "                    \"Year\": \"2016\",\n",
      "                    \"Month\": \"07\",\n",
      "                    \"Day\": \"18\"\n",
      "                }\n",
      "            ],\n",
      "            \"ELocationID\": [\n",
      "                \"10.1073/pnas.1609057113\"\n",
      "            ],\n",
      "            \"Language\": [\n",
      "                \"eng\"\n",
      "            ],\n",
      "            \"Journal\": {\n",
      "                \"ISSN\": \"1091-6490\",\n",
      "                \"JournalIssue\": {\n",
      "                    \"Volume\": \"113\",\n",
      "                    \"Issue\": \"31\",\n",
      "                    \"PubDate\": {\n",
      "                        \"Year\": \"2016\",\n",
      "                        \"Month\": \"Aug\",\n",
      "                        \"Day\": \"02\"\n",
      "                    }\n",
      "                },\n",
      "                \"Title\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n",
      "                \"ISOAbbreviation\": \"Proc Natl Acad Sci U S A\"\n",
      "            },\n",
      "            \"ArticleTitle\": \"Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy.\",\n",
      "            \"Pagination\": {\n",
      "                \"StartPage\": \"8783\",\n",
      "                \"EndPage\": \"8788\",\n",
      "                \"MedlinePgn\": \"8783-8\"\n",
      "            },\n",
      "            \"Abstract\": {\n",
      "                \"AbstractText\": [\n",
      "                    \"Despite years of plasma HIV-RNA levels <40 copies per milliliter during combination antiretroviral therapy (cART), the majority of HIV-infected patients exhibit persistent seropositivity to HIV-1 and evidence of immune activation. These patients also show persistence of proviruses of HIV-1 in circulating peripheral blood mononuclear cells. Many of these proviruses have been characterized as defective and thus thought to contribute little to HIV-1 pathogenesis. By combining 5'LTR-to-3'LTR single-genome amplification and direct amplicon sequencing, we have identified the presence of \\\"defective\\\" proviruses capable of transcribing novel unspliced HIV-RNA (usHIV-RNA) species in patients at all stages of HIV-1 infection. Although these novel usHIV-RNA transcripts had exon structures that were different from those of the known spliced HIV-RNA variants, they maintained translationally competent ORFs, involving elements of gag, pol, env, rev, and nef to encode a series of novel HIV-1 chimeric proteins. These novel usHIV-RNAs were detected in five of five patients, including four of four patients with prolonged viral suppression of HIV-RNA levels <40 copies per milliliter for more than 6 y. Our findings suggest that the persistent defective proviruses of HIV-1 are not \\\"silent,\\\" but rather may contribute to HIV-1 pathogenesis by stimulating host-defense pathways that target foreign nucleic acids and proteins.\"\n",
      "                ]\n",
      "            },\n",
      "            \"AuthorList\": [\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Imamichi\",\n",
      "                    \"ForeName\": \"Hiromi\",\n",
      "                    \"Initials\": \"H\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Clinical Services Program, Applied and Development Research Directorate, Leidos Biomedical Research, Inc., Frederick, MD 21072;\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Dewar\",\n",
      "                    \"ForeName\": \"Robin L\",\n",
      "                    \"Initials\": \"RL\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Clinical Services Program, Applied and Development Research Directorate, Leidos Biomedical Research, Inc., Frederick, MD 21072;\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Adelsberger\",\n",
      "                    \"ForeName\": \"Joseph W\",\n",
      "                    \"Initials\": \"JW\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Rehm\",\n",
      "                    \"ForeName\": \"Catherine A\",\n",
      "                    \"Initials\": \"CA\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104;\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"O'Doherty\",\n",
      "                    \"ForeName\": \"Una\",\n",
      "                    \"Initials\": \"U\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Applications and Collaborations, Pacific Biosciences, Menlo Park, CA 94025.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Paxinos\",\n",
      "                    \"ForeName\": \"Ellen E\",\n",
      "                    \"Initials\": \"EE\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; afauci@niaid.nih.gov.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Fauci\",\n",
      "                    \"ForeName\": \"Anthony S\",\n",
      "                    \"Initials\": \"AS\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Lane\",\n",
      "                    \"ForeName\": \"H Clifford\",\n",
      "                    \"Initials\": \"HC\"\n",
      "                }\n",
      "            ],\n",
      "            \"DataBankList\": [\n",
      "                {\n",
      "                    \"DataBankName\": \"GENBANK\",\n",
      "                    \"AccessionNumberList\": [\n",
      "                        \"KU677989\",\n",
      "                        \"KU678196\"\n",
      "                    ]\n",
      "                }\n",
      "            ],\n",
      "            \"GrantList\": [\n",
      "                {\n",
      "                    \"GrantID\": \"HHSN261200800001C\",\n",
      "                    \"Acronym\": \"CA\",\n",
      "                    \"Agency\": \"NCI NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"HHSN261200800001E\",\n",
      "                    \"Acronym\": \"CA\",\n",
      "                    \"Agency\": \"NCI NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"R01 AI120011\",\n",
      "                    \"Acronym\": \"AI\",\n",
      "                    \"Agency\": \"NIAID NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                }\n",
      "            ],\n",
      "            \"PublicationTypeList\": [\n",
      "                \"Journal Article\",\n",
      "                \"Research Support, N.I.H., Extramural\"\n",
      "            ]\n",
      "        },\n",
      "        \"MedlineJournalInfo\": {\n",
      "            \"Country\": \"United States\",\n",
      "            \"MedlineTA\": \"Proc Natl Acad Sci U S A\",\n",
      "            \"NlmUniqueID\": \"7505876\",\n",
      "            \"ISSNLinking\": \"0027-8424\"\n",
      "        },\n",
      "        \"ChemicalList\": [\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Anti-Retroviral Agents\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"DNA, Viral\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"RNA, Viral\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Viral Proteins\"\n",
      "            }\n",
      "        ],\n",
      "        \"MeshHeadingList\": [\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Anti-Retroviral Agents\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"genetics\",\n",
      "                    \"metabolism\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"DNA, Viral\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Gene Expression Regulation, Viral\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"drug therapy\",\n",
      "                    \"virology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"HIV Infections\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"drug effects\",\n",
      "                    \"genetics\",\n",
      "                    \"physiology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"HIV-1\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Humans\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"virology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Leukocytes, Mononuclear\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"drug effects\",\n",
      "                    \"genetics\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Proviruses\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"genetics\",\n",
      "                    \"metabolism\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"RNA, Viral\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"genetics\",\n",
      "                    \"metabolism\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Viral Proteins\"\n",
      "            }\n",
      "        ],\n",
      "        \"CoiStatement\": \"The authors declare no conflict of interest.\"\n",
      "    },\n",
      "    \"PubmedData\": {\n",
      "        \"ReferenceList\": [\n",
      "            {\n",
      "                \"ReferenceList\": [],\n",
      "                \"Reference\": [\n",
      "                    {\n",
      "                        \"Citation\": \"DHHS Panel on Antiretoviral Guidelines for Adults and Adolescents  2015 Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Department of Health and Human Services. Available at  https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Accessed July 1, 2016.\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Murray JM, et al. PINT Study Team HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy. J Virol. 2014;88(6):3516\\u20133526.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3957951\",\n",
      "                            \"24403590\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Josefsson L, et al. The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time. Proc Natl Acad Sci USA. 2013;110(51):E4987\\u2013E4996.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3870728\",\n",
      "                            \"24277811\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Buzon MJ, et al. Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells. J Virol. 2014;88(17):10056\\u201310065.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4136362\",\n",
      "                            \"24965451\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Mendoza D, et al. Comprehensive analysis of unique cases with extraordinary control over HIV replication. Blood. 2012;119(20):4645\\u20134655.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3367872\",\n",
      "                            \"22490332\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kuller LH, et al. INSIGHT SMART Study Group Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5(10):e203.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2570418\",\n",
      "                            \"18942885\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sandler NG, et al. INSIGHT SMART Study Group Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203(6):780\\u2013790.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3071127\",\n",
      "                            \"21252259\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Wilson EM, et al. Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study) Investigators Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210(9):1396\\u20131406.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4207864\",\n",
      "                            \"24813472\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Hey-Cunningham WJ, et al. PINT study team Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels. AIDS. 2015;29(8):911\\u2013919.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"25730509\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Catalfamo M, et al. HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc Natl Acad Sci USA. 2008;105(50):19851\\u201319856.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2596741\",\n",
      "                            \"19060209\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"H\\u00fctter G, et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med. 2009;360(7):692\\u2013698.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"19213682\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Henrich TJ, et al. Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. J Infect Dis. 2013;207(11):1694\\u20131702.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3636784\",\n",
      "                            \"23460751\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Ho YC, et al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell. 2013;155(3):540\\u2013551.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3896327\",\n",
      "                            \"24243014\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Imamichi H, et al. Lifespan of effector memory CD4+ T cells determined by replication-incompetent integrated HIV-1 provirus. AIDS. 2014;28(8):1091\\u20131099.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24492253\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sanchez G, Xu X, Chermann JC, Hirsch I. Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals. J Virol. 1997;71(3):2233\\u20132240.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC191331\",\n",
      "                            \"9032358\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Li Y, et al. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and -defective viral genomes. J Virol. 1991;65(8):3973\\u20133985.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC248827\",\n",
      "                            \"1830110\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Temin HM. Retrovirus variation and reverse transcription: Abnormal strand transfers result in retrovirus genetic variation. Proc Natl Acad Sci USA. 1993;90(15):6900\\u20136903.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC47042\",\n",
      "                            \"7688465\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Hu WS, Hughes SH. HIV-1 reverse transcription. Cold Spring Harb Perspect Med. 2012;2(10):a006882.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3475395\",\n",
      "                            \"23028129\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Rausch JW, Le Grice SF. \\u2018Binding, bending and bonding\\u2019: Polypurine tract-primed initiation of plus-strand DNA synthesis in human immunodeficiency virus. Int J Biochem Cell Biol. 2004;36(9):1752\\u20131766.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"15183342\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Takebe Y, Telesnitsky A. Evidence for the acquisition of multi-drug resistance in an HIV-1 clinical isolate via human sequence transduction. Virology. 2006;351(1):1\\u20136.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2213631\",\n",
      "                            \"16777167\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Pasternak AO, et al. Minor contribution of chimeric host-HIV readthrough transcripts to the level of HIV cell-associated gag RNA. J Virol. 2015;90(2):1148\\u20131151.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4702708\",\n",
      "                            \"26559833\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Han Y, et al. Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. Cell Host Microbe. 2008;4(2):134\\u2013146.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2604135\",\n",
      "                            \"18692773\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Wagner TA, et al. HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. Science. 2014;345(6196):570\\u2013573.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4230336\",\n",
      "                            \"25011556\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Maldarelli F, et al. HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science. 2014;345(6193):179\\u2013183.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4262401\",\n",
      "                            \"24968937\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Cohn LB, et al. HIV-1 integration landscape during latent and active infection. Cell. 2015;160(3):420\\u2013432.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4371550\",\n",
      "                            \"25635456\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"von Stockenstrom S, et al. Longitudinal genetic characterization reveals that cell proliferation maintains a persistent HIV type 1 DNA pool during effective HIV therapy. J Infect Dis. 2015;212(4):596\\u2013607.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4539896\",\n",
      "                            \"25712966\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kearney MF, et al. Origin of rebound plasma HIV includes cells with identical proviruses that are transcriptionally active before stopping of antiretroviral therapy. J Virol. 2015;90(3):1369\\u20131376.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4719635\",\n",
      "                            \"26581989\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Saliou JM, et al. Role of RNA structure and protein factors in the control of HIV-1 splicing. Front Biosci (Landmark Ed) 2009;14:2714\\u20132729.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"19273230\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Ocwieja KE, et al. Dynamic regulation of HIV-1 mRNA populations analyzed by single-molecule enrichment and long-read sequencing. Nucleic Acids Res. 2012;40(20):10345\\u201310355.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3488221\",\n",
      "                            \"22923523\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Carrera C, Pinilla M, P\\u00e9rez-Alvarez L, Thomson MM. Identification of unusual and novel HIV type 1 spliced transcripts generated in vivo. AIDS Res Hum Retroviruses. 2010;26(7):815\\u2013820.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"20624070\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Cullen BR. Human immunodeficiency virus: Nuclear RNA export unwound. Nature. 2005;433(7021):26\\u201327.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"15635396\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Maldarelli F, Martin MA, Strebel K. Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: Novel level of gene regulation. J Virol. 1991;65(11):5732\\u20135743.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC250233\",\n",
      "                            \"1656066\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Cochrane AW, et al. Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J Virol. 1991;65(10):5305\\u20135313.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC249010\",\n",
      "                            \"1895385\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Imamichi H, et al.  2014 Cryptic transcription of HIV-RNA species from \\u201cdefective\\u201d proviruses: A novel pathway for persistent immune activation in patients with HIV-1 infection and mechanism for persistent seropositivity despite \\u201cundetectable\\u201d levels of virus. 20th International AIDS Conference, Melbourne, Australia, July 20\\u201325, 2014. Oral abstract WEAA0206LB. Available at  pag.aids2014.org/Abstracts.aspx?AID=11347. Accessed July 1, 2016.\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Shan L, et al. A novel PCR assay for quantification of HIV-1 RNA. J Virol. 2013;87(11):6521\\u20136525.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3648108\",\n",
      "                            \"23536672\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Lassen KG, Ramyar KX, Bailey JR, Zhou Y, Siliciano RF. Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells. PLoS Pathog. 2006;2(7):e68.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC1487174\",\n",
      "                            \"16839202\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Gaschen B, Kuiken C, Korber B, Foley B. Retrieval and on-the-fly alignment of sequence fragments from the HIV database. Bioinformatics. 2001;17(5):415\\u2013418.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"11331235\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Larsson A. AliView: a fast and lightweight alignment viewer and editor for large datasets. Bioinformatics. 2014;30(22):3276\\u20133278.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4221126\",\n",
      "                            \"25095880\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Salminen MO, et al. Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology. 1995;213(1):80\\u201386.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"7483282\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Carr JK, et al. The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon. Virology. 2001;286(1):168\\u2013181.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"11448170\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Laukkanen T, et al. Virtually full-length subtype F and F/D recombinant HIV-1 from Africa and South America. Virology. 2000;269(1):95\\u2013104.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"10725202\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Falcone EL, et al. Cerebrospinal fluid HIV-1 compartmentalization in a patient with AIDS and acute varicella-zoster virus meningomyeloradiculitis. Clin Infect Dis. 2013;57(5):e135\\u2013e142.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3739464\",\n",
      "                            \"23728149\"\n",
      "                        ]\n",
      "                    }\n",
      "                ]\n",
      "            }\n",
      "        ],\n",
      "        \"History\": [\n",
      "            {\n",
      "                \"Year\": \"2016\",\n",
      "                \"Month\": \"7\",\n",
      "                \"Day\": \"20\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2016\",\n",
      "                \"Month\": \"7\",\n",
      "                \"Day\": \"20\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2018\",\n",
      "                \"Month\": \"2\",\n",
      "                \"Day\": \"6\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2017\",\n",
      "                \"Month\": \"2\",\n",
      "                \"Day\": \"2\"\n",
      "            }\n",
      "        ],\n",
      "        \"PublicationStatus\": \"ppublish\",\n",
      "        \"ArticleIdList\": [\n",
      "            \"27432972\",\n",
      "            \"PMC4978246\",\n",
      "            \"10.1073/pnas.1609057113\",\n",
      "            \"1609057113\"\n",
      "        ]\n",
      "    }\n",
      "}\n",
      "{\n",
      "    \"MedlineCitation\": {\n",
      "        \"CitationSubset\": [\n",
      "            \"IM\"\n",
      "        ],\n",
      "        \"OtherAbstract\": [],\n",
      "        \"InvestigatorList\": [],\n",
      "        \"OtherID\": [],\n",
      "        \"KeywordList\": [],\n",
      "        \"SpaceFlightMission\": [],\n",
      "        \"GeneralNote\": [],\n",
      "        \"PMID\": \"25961438\",\n",
      "        \"DateCompleted\": {\n",
      "            \"Year\": \"2015\",\n",
      "            \"Month\": \"10\",\n",
      "            \"Day\": \"01\"\n",
      "        },\n",
      "        \"DateRevised\": {\n",
      "            \"Year\": \"2022\",\n",
      "            \"Month\": \"03\",\n",
      "            \"Day\": \"18\"\n",
      "        },\n",
      "        \"Article\": {\n",
      "            \"ArticleDate\": [],\n",
      "            \"ELocationID\": [\n",
      "                \"10.7326/M15-0530\"\n",
      "            ],\n",
      "            \"Language\": [\n",
      "                \"eng\"\n",
      "            ],\n",
      "            \"Journal\": {\n",
      "                \"ISSN\": \"1539-3704\",\n",
      "                \"JournalIssue\": {\n",
      "                    \"Volume\": \"163\",\n",
      "                    \"Issue\": \"2\",\n",
      "                    \"PubDate\": {\n",
      "                        \"Year\": \"2015\",\n",
      "                        \"Month\": \"Jul\",\n",
      "                        \"Day\": \"21\"\n",
      "                    }\n",
      "                },\n",
      "                \"Title\": \"Annals of internal medicine\",\n",
      "                \"ISOAbbreviation\": \"Ann Intern Med\"\n",
      "            },\n",
      "            \"ArticleTitle\": \"Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States.\",\n",
      "            \"Pagination\": {\n",
      "                \"StartPage\": \"81\",\n",
      "                \"EndPage\": \"90\",\n",
      "                \"MedlinePgn\": \"81-90\"\n",
      "            },\n",
      "            \"Abstract\": {\n",
      "                \"AbstractText\": [\n",
      "                    \"More than 26,000 cases of Ebola virus disease (EVD) have been reported in western Africa, with high mortality. Several patients have been medically evacuated to hospitals in the United States and Europe. Detailed clinical data are limited on the clinical course and management of patients with EVD outside western Africa.\",\n",
      "                    \"To describe the clinical characteristics and management of a cluster of patients with EVD, including the first cases of Ebola virus (EBOV) infection acquired in the United States.\",\n",
      "                    \"Retrospective clinical case series.\",\n",
      "                    \"Three U.S. hospitals in September and October 2014.\",\n",
      "                    \"First imported EVD case identified in the United States and 2 secondary EVD cases acquired in the United States in critical care nurses who cared for the index case patient.\",\n",
      "                    \"Clinical recovery, EBOV RNA level, resolution of Ebola viremia, survival with discharge from hospital, or death.\",\n",
      "                    \"The index patient had high EBOV RNA levels, developed respiratory and renal failure requiring critical care support, and died. Both patients with secondary EBOV infection had nonspecific signs and symptoms and developed moderate illness; EBOV RNA levels were moderate, and both patients recovered.\",\n",
      "                    \"Both surviving patients received uncontrolled treatment with multiple investigational agents, including convalescent plasma, which limits generalizability of the results.\",\n",
      "                    \"Early diagnosis, prompt initiation of supportive medical care, and moderate clinical illness likely contributed to successful outcomes in both survivors. The inability to determine the potential benefit of investigational therapies and the effect of patient-specific factors that may have contributed to less severe illness highlight the need for controlled clinical studies of these interventions, especially in the setting of a high level of supportive medical care.\",\n",
      "                    \"None.\"\n",
      "                ]\n",
      "            },\n",
      "            \"AuthorList\": [\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Liddell\",\n",
      "                    \"ForeName\": \"Allison M\",\n",
      "                    \"Initials\": \"AM\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Davey\",\n",
      "                    \"ForeName\": \"Richard T\",\n",
      "                    \"Initials\": \"RT\",\n",
      "                    \"Suffix\": \"Jr\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Mehta\",\n",
      "                    \"ForeName\": \"Aneesh K\",\n",
      "                    \"Initials\": \"AK\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Varkey\",\n",
      "                    \"ForeName\": \"Jay B\",\n",
      "                    \"Initials\": \"JB\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Kraft\",\n",
      "                    \"ForeName\": \"Colleen S\",\n",
      "                    \"Initials\": \"CS\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Tseggay\",\n",
      "                    \"ForeName\": \"Gebre K\",\n",
      "                    \"Initials\": \"GK\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Badidi\",\n",
      "                    \"ForeName\": \"Oghenetega\",\n",
      "                    \"Initials\": \"O\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Faust\",\n",
      "                    \"ForeName\": \"Andrew C\",\n",
      "                    \"Initials\": \"AC\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Brown\",\n",
      "                    \"ForeName\": \"Katia V\",\n",
      "                    \"Initials\": \"KV\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Suffredini\",\n",
      "                    \"ForeName\": \"Anthony F\",\n",
      "                    \"Initials\": \"AF\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Barrett\",\n",
      "                    \"ForeName\": \"Kevin\",\n",
      "                    \"Initials\": \"K\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Wolcott\",\n",
      "                    \"ForeName\": \"Mark J\",\n",
      "                    \"Initials\": \"MJ\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Marconi\",\n",
      "                    \"ForeName\": \"Vincent C\",\n",
      "                    \"Initials\": \"VC\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Lyon\",\n",
      "                    \"ForeName\": \"G Marshall\",\n",
      "                    \"Initials\": \"GM\",\n",
      "                    \"Suffix\": \"3rd\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Weinstein\",\n",
      "                    \"ForeName\": \"Gary L\",\n",
      "                    \"Initials\": \"GL\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Weinmeister\",\n",
      "                    \"ForeName\": \"Kenney\",\n",
      "                    \"Initials\": \"K\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Sutton\",\n",
      "                    \"ForeName\": \"Shelby\",\n",
      "                    \"Initials\": \"S\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Hazbun\",\n",
      "                    \"ForeName\": \"Munir\",\n",
      "                    \"Initials\": \"M\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Albari\\u00f1o\",\n",
      "                    \"ForeName\": \"C\\u00e9sar G\",\n",
      "                    \"Initials\": \"CG\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Reed\",\n",
      "                    \"ForeName\": \"Zachary\",\n",
      "                    \"Initials\": \"Z\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Cannon\",\n",
      "                    \"ForeName\": \"Debi\",\n",
      "                    \"Initials\": \"D\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Str\\u00f6her\",\n",
      "                    \"ForeName\": \"Ute\",\n",
      "                    \"Initials\": \"U\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Feldman\",\n",
      "                    \"ForeName\": \"Mark\",\n",
      "                    \"Initials\": \"M\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Ribner\",\n",
      "                    \"ForeName\": \"Bruce S\",\n",
      "                    \"Initials\": \"BS\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Lane\",\n",
      "                    \"ForeName\": \"H Clifford\",\n",
      "                    \"Initials\": \"HC\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Fauci\",\n",
      "                    \"ForeName\": \"Anthony S\",\n",
      "                    \"Initials\": \"AS\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Uyeki\",\n",
      "                    \"ForeName\": \"Timothy M\",\n",
      "                    \"Initials\": \"TM\"\n",
      "                }\n",
      "            ],\n",
      "            \"GrantList\": [\n",
      "                {\n",
      "                    \"GrantID\": \"UL1 TR000454\",\n",
      "                    \"Acronym\": \"TR\",\n",
      "                    \"Agency\": \"NCATS NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"UL1TR000454\",\n",
      "                    \"Acronym\": \"TR\",\n",
      "                    \"Agency\": \"NCATS NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                }\n",
      "            ],\n",
      "            \"PublicationTypeList\": [\n",
      "                \"Case Reports\",\n",
      "                \"Journal Article\",\n",
      "                \"Research Support, N.I.H., Extramural\"\n",
      "            ]\n",
      "        },\n",
      "        \"MedlineJournalInfo\": {\n",
      "            \"Country\": \"United States\",\n",
      "            \"MedlineTA\": \"Ann Intern Med\",\n",
      "            \"NlmUniqueID\": \"0372351\",\n",
      "            \"ISSNLinking\": \"0003-4819\"\n",
      "        },\n",
      "        \"ChemicalList\": [\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"RNA, Viral\"\n",
      "            }\n",
      "        ],\n",
      "        \"MeshHeadingList\": [\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Adult\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"methods\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Critical Care\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Early Diagnosis\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"genetics\",\n",
      "                    \"metabolism\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Ebolavirus\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Fatal Outcome\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Female\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"diagnosis\",\n",
      "                    \"therapy\",\n",
      "                    \"virology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Hemorrhagic Fever, Ebola\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Humans\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Male\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"blood\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"RNA, Viral\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"etiology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Renal Insufficiency\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"etiology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Respiratory Insufficiency\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Retrospective Studies\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Texas\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"diagnosis\",\n",
      "                    \"therapy\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Viremia\"\n",
      "            }\n",
      "        ]\n",
      "    },\n",
      "    \"PubmedData\": {\n",
      "        \"ReferenceList\": [\n",
      "            {\n",
      "                \"ReferenceList\": [],\n",
      "                \"Reference\": [\n",
      "                    {\n",
      "                        \"Citation\": \"Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magas-souba N, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med. 2014;371:1418\\u20131425. [PMID: 24738640]\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24738640\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, et al. KGH Lassa Fever Program. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med. 2014;371:2092\\u20132100. [PMID: 25353969]\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4318555\",\n",
      "                            \"25353969\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Bah EI, Lamah MC, Fletcher T, Jacob ST, Brett-Major DM, Sall AA, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med. 2015;372:40\\u201347. [PMID: 25372658]\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"25372658\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"WHO Ebola Response Team. Ebola virus disease in West Africa\\u2014the first 9 months of the epidemic and forward projections. N Engl J Med. 2014;371:1481\\u20131495. [PMID: 25244186]\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4235004\",\n",
      "                            \"25244186\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"World Health Organization. Ebola Situation Report\\u20136 May 2015. Geneva: World Health Organization; 2015.  Accessed at  http://apps.who.int/iris/bitstream/10665/164523/1/roadmapsitrep_6May15_eng.pdf\\non 6 May 2015.\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Agua-Agum J, Ariyarajah A, Aylward B, Blake IM, Brennan R, Cori A, et al. WHO Ebola Response Team. West African Ebola epidemic after one year\\u2013slowing but not yet under control [Letter] N Engl J Med. 2015;372:584\\u2013587. [PMID: 25539446]\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4368109\",\n",
      "                            \"25539446\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Naval Medical Research Center. Ebola Zaire (EZ1) rRT-PCR (Taq-Man\\u00ae) Assay on ABI\\u00ae 7500 Fast Dx,\\nLightCycler\\u00ae, and JBAIDS. Instruction Booklet. 2014 Accessed at  www.fda.gov/downloads/MedicalDevices/Safety/EmergencySituations/UCM418802.pdf on 17\\nApril 2015.\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Towner JS, Sealy TK, Ksiazek TG, Nichol ST. High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis. 2007;196(Suppl 2):S205\\u2013S212. [PMID: 17940951]\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"17940951\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Ksiazek TG, Rollin PE, Williams AJ, Bressler DS, Martin ML, Swane-poel R, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(Suppl 1):S177\\u2013S187. [PMID: 9988182]\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"9988182\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Trombley AR, Wachter L, Garrison J, Buckley-Beason VA, Jahrling J, Hensley LE, et al. Comprehensive panel of real-time Taq-Man polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg. 2010;82:954\\u2013960. [PMID: 20439981]\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2861391\",\n",
      "                            \"20439981\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Centers for Disease Control and Prevention. What U.S. Hospitals Need to Know to Prepare for Ebola Virus Disease. Atlanta, GA: Centers for Disease Control and Prevention; 2014.  Accessed at  http://emergency.cdc.gov/coca/transcripts/2014/call-transcript-080514.asp\\non 17 April 2015.\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, et al. Emory Serious Communicable Diseases Unit. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med. 2014;371:2402\\u20132409. [PMID: 25390460]\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"25390460\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kreuels B, Wichmann D, Emmerich P, Schmidt-Chanasit J, de Heer G, Kluge S, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med. 2014;371:2394\\u20132401. [PMID: 25337633]\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"25337633\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Wolf T, Kann G, Becker S, Stephan C, Brodt HR, de Leuw P, et al. Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care. Lancet. 2014 [PMID: 25534190]\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"25534190\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Parra JM, Salmero\\u00f3 n OJ, Velasco M. The first case of Ebola virus disease acquired outside Africa [Letter] N Engl J Med. 2014;371:2439\\u20132440. [PMID: 25409262]\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"25409262\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A. Ebola virus disease in West Africa\\u2013clinical manifestations and management. N Engl J Med. 2014;371:2054\\u20132057. [PMID: 25372854]\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"25372854\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, et al. CMX001-201 Clinical Study Group. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med. 2013;369:1227\\u20131236. [PMID: 24066743]\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24066743\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Fowler RA, Fletcher T, Fischer WA, 2nd, Lamontagne F, Jacob S, Brett-Major D, et al. Caring for critically ill patients with Ebola virus disease Perspectives from West Africa. Am J Respir Crit Care Med. 2014;190:733\\u2013737. [PMID: 25166884]\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"25166884\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Ansumana R, Jacobsen KH, Sahr F, Idris M, Bangura H, Boie-Jalloh M, et al. Ebola in Freetown area, Sierra Leone\\u2014a case study of 581 patients [Letter] N Engl J Med. 2015;372:587\\u2013588. [PMID: 25539447]\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"25539447\"\n",
      "                        ]\n",
      "                    }\n",
      "                ]\n",
      "            }\n",
      "        ],\n",
      "        \"History\": [\n",
      "            {\n",
      "                \"Year\": \"2015\",\n",
      "                \"Month\": \"5\",\n",
      "                \"Day\": \"12\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2015\",\n",
      "                \"Month\": \"5\",\n",
      "                \"Day\": \"12\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2015\",\n",
      "                \"Month\": \"10\",\n",
      "                \"Day\": \"2\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2016\",\n",
      "                \"Month\": \"1\",\n",
      "                \"Day\": \"24\"\n",
      "            }\n",
      "        ],\n",
      "        \"PublicationStatus\": \"ppublish\",\n",
      "        \"ArticleIdList\": [\n",
      "            \"25961438\",\n",
      "            \"NIHMS743262\",\n",
      "            \"PMC4724427\",\n",
      "            \"10.7326/M15-0530\",\n",
      "            \"2292050\"\n",
      "        ]\n",
      "    }\n",
      "}\n",
      "{\n",
      "    \"MedlineCitation\": {\n",
      "        \"CitationSubset\": [\n",
      "            \"IM\"\n",
      "        ],\n",
      "        \"OtherAbstract\": [],\n",
      "        \"InvestigatorList\": [],\n",
      "        \"OtherID\": [],\n",
      "        \"KeywordList\": [],\n",
      "        \"SpaceFlightMission\": [],\n",
      "        \"GeneralNote\": [],\n",
      "        \"PMID\": \"25706232\",\n",
      "        \"DateCompleted\": {\n",
      "            \"Year\": \"2015\",\n",
      "            \"Month\": \"04\",\n",
      "            \"Day\": \"07\"\n",
      "        },\n",
      "        \"DateRevised\": {\n",
      "            \"Year\": \"2024\",\n",
      "            \"Month\": \"06\",\n",
      "            \"Day\": \"15\"\n",
      "        },\n",
      "        \"Article\": {\n",
      "            \"ArticleDate\": [],\n",
      "            \"ELocationID\": [\n",
      "                \"10.1001/jama.2015.1373\"\n",
      "            ],\n",
      "            \"Language\": [\n",
      "                \"eng\"\n",
      "            ],\n",
      "            \"Journal\": {\n",
      "                \"ISSN\": \"1538-3598\",\n",
      "                \"JournalIssue\": {\n",
      "                    \"Volume\": \"313\",\n",
      "                    \"Issue\": \"12\",\n",
      "                    \"PubDate\": {\n",
      "                        \"MedlineDate\": \"2015 Mar 24-31\"\n",
      "                    }\n",
      "                },\n",
      "                \"Title\": \"JAMA\",\n",
      "                \"ISOAbbreviation\": \"JAMA\"\n",
      "            },\n",
      "            \"ArticleTitle\": \"Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection.\",\n",
      "            \"Pagination\": {\n",
      "                \"StartPage\": \"1232\",\n",
      "                \"EndPage\": \"1239\",\n",
      "                \"MedlinePgn\": \"1232-9\"\n",
      "            },\n",
      "            \"Abstract\": {\n",
      "                \"AbstractText\": [\n",
      "                    \"There is an unmet need for interferon- and ribavirin-free treatment for chronic hepatitis C virus (HCV) infection in patients co-infected with human immunodeficiency virus (HIV).\",\n",
      "                    \"To evaluate the rates of sustained virologic response (SVR) and adverse events in previously untreated patients with HCV genotype 1 and HIV co-infection following a 12-week treatment of the fixed-dose combination of ledipasvir and sofosbuvir.\",\n",
      "                    \"Open-label, single-center, phase 2b pilot study of previously untreated, noncirrhotic patients with HCV genotype 1 and HIV co-infection conducted at the Clinical Research Center of the National Institutes of Health, Bethesda, Maryland, from June 2013 to September 2014. Patients included those receiving antiretroviral therapy with HIV RNA values of 50 copies/mL or fewer and a CD4 T-lymphocyte count of 100 cells/mL or greater or patients with untreated HIV infection with a CD4 T-lymphocyte count of 500 cells/mL or greater. Serial measurements of safety parameters, virologic and host immune correlates, and adherence were performed.\",\n",
      "                    \"Fifty patients with HCV genotype 1 never before treated for HCV were prescribed a fixed-dose combination of ledipasvir (90 mg) and sofosbuvir (400 mg) once daily for 12 weeks.\",\n",
      "                    \"The primary study outcome was the proportion of patients with sustained viral response (plasma HCV RNA level <12 IU/mL) 12 weeks after end of treatment.\",\n",
      "                    \"Forty-nine of 50 participants (98% [95% CI, 89% to 100%]) achieved SVR 12 weeks after end of treatment, whereas 1 patient experienced relapse at week 4 following treatment. In the patient with relapse, deep sequencing revealed a resistance associated mutation in the NS5A region conferring resistance to NS5A inhibitors, such as ledipasvir. The most common adverse events were nasal congestion (16% of patients) and myalgia (14%). There were no discontinuations or serious adverse events attributable to study drug.\",\n",
      "                    \"In this open-label, uncontrolled, pilot study enrolling patients co-infected with HCV genotype 1 and HIV, administration of an oral combination of ledipasvir and sofosbuvir for 12 weeks was associated with high rates of SVR after treatment completion. Larger studies that also include patients with cirrhosis and lower CD4 T-cell counts are required to understand if the results of this study generalize to all patients co-infected with HCV and HIV.\",\n",
      "                    \"clinicaltrials.gov Identifier:NCT01878799.\"\n",
      "                ]\n",
      "            },\n",
      "            \"AuthorList\": [\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Division of Infectious Diseases, Institute of Human Virology, University of Maryland, Baltimore2Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland3Gilead Sciences Inc, F.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Osinusi\",\n",
      "                    \"ForeName\": \"Anu\",\n",
      "                    \"Initials\": \"A\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Townsend\",\n",
      "                    \"ForeName\": \"Kerry\",\n",
      "                    \"Initials\": \"K\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland5Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc (formerly SAIC-Frederick, Inc), Frederick Nationa.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Kohli\",\n",
      "                    \"ForeName\": \"Anita\",\n",
      "                    \"Initials\": \"A\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Division of Infectious Diseases, Institute of Human Virology, University of Maryland, Baltimore2Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Nelson\",\n",
      "                    \"ForeName\": \"Amy\",\n",
      "                    \"Initials\": \"A\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Seamon\",\n",
      "                    \"ForeName\": \"Cassie\",\n",
      "                    \"Initials\": \"C\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland6Department of Microbiology and Immunology, Medical University of South Carolina College of Medicine, Charleston.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Meissner\",\n",
      "                    \"ForeName\": \"Eric G\",\n",
      "                    \"Initials\": \"EG\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Institute of Biostatistics and Mathematical Modeling, Johann Wolfgang Goethe University, Frankfurt, Germany.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Bon\",\n",
      "                    \"ForeName\": \"Dimitra\",\n",
      "                    \"Initials\": \"D\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Division of Infectious Diseases, Institute of Human Virology, University of Maryland, Baltimore5Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc (formerly SAIC-Frederick, Inc), Frederick National Laborato.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Silk\",\n",
      "                    \"ForeName\": \"Rachel\",\n",
      "                    \"Initials\": \"R\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Division of Infectious Diseases, Institute of Human Virology, University of Maryland, Baltimore5Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc (formerly SAIC-Frederick, Inc), Frederick National Laborato.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Gross\",\n",
      "                    \"ForeName\": \"Chloe\",\n",
      "                    \"Initials\": \"C\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Division of Infectious Diseases, Institute of Human Virology, University of Maryland, Baltimore5Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc (formerly SAIC-Frederick, Inc), Frederick National Laborato.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Price\",\n",
      "                    \"ForeName\": \"Angie\",\n",
      "                    \"Initials\": \"A\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Division of Infectious Diseases, Institute of Human Virology, University of Maryland, Baltimore.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Sajadi\",\n",
      "                    \"ForeName\": \"Mohammad\",\n",
      "                    \"Initials\": \"M\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Sidharthan\",\n",
      "                    \"ForeName\": \"Sreetha\",\n",
      "                    \"Initials\": \"S\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Sims\",\n",
      "                    \"ForeName\": \"Zayani\",\n",
      "                    \"Initials\": \"Z\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Institute of Biostatistics and Mathematical Modeling, Johann Wolfgang Goethe University, Frankfurt, Germany.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Herrmann\",\n",
      "                    \"ForeName\": \"Eva\",\n",
      "                    \"Initials\": \"E\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Unity Health Care Inc, Washington, DC.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Hogan\",\n",
      "                    \"ForeName\": \"John\",\n",
      "                    \"Initials\": \"J\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Unity Health Care Inc, Washington, DC.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Teferi\",\n",
      "                    \"ForeName\": \"Gebeyehu\",\n",
      "                    \"Initials\": \"G\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Division of Infectious Diseases, Institute of Human Virology, University of Maryland, Baltimore.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Talwani\",\n",
      "                    \"ForeName\": \"Rohit\",\n",
      "                    \"Initials\": \"R\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Proschan\",\n",
      "                    \"ForeName\": \"Michael\",\n",
      "                    \"Initials\": \"M\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Family and Medical Counseling Services, Washington, DC.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Jenkins\",\n",
      "                    \"ForeName\": \"Veronica\",\n",
      "                    \"Initials\": \"V\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Department of Pathology, National Cancer Institute, Rockville, Maryland.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Kleiner\",\n",
      "                    \"ForeName\": \"David E\",\n",
      "                    \"Initials\": \"DE\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, Bethesda, Maryland.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Wood\",\n",
      "                    \"ForeName\": \"Brad J\",\n",
      "                    \"Initials\": \"BJ\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Gilead Sciences Inc, Foster City, California.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Subramanian\",\n",
      "                    \"ForeName\": \"G Mani\",\n",
      "                    \"Initials\": \"GM\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Gilead Sciences Inc, Foster City, California.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Pang\",\n",
      "                    \"ForeName\": \"Phillip S\",\n",
      "                    \"Initials\": \"PS\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Gilead Sciences Inc, Foster City, California.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"McHutchison\",\n",
      "                    \"ForeName\": \"John G\",\n",
      "                    \"Initials\": \"JG\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Polis\",\n",
      "                    \"ForeName\": \"Michael A\",\n",
      "                    \"Initials\": \"MA\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Fauci\",\n",
      "                    \"ForeName\": \"Anthony S\",\n",
      "                    \"Initials\": \"AS\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Masur\",\n",
      "                    \"ForeName\": \"Henry\",\n",
      "                    \"Initials\": \"H\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Division of Infectious Diseases, Institute of Human Virology, University of Maryland, Baltimore2Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Kottilil\",\n",
      "                    \"ForeName\": \"Shyam\",\n",
      "                    \"Initials\": \"S\"\n",
      "                }\n",
      "            ],\n",
      "            \"DataBankList\": [\n",
      "                {\n",
      "                    \"DataBankName\": \"ClinicalTrials.gov\",\n",
      "                    \"AccessionNumberList\": [\n",
      "                        \"NCT01878799\"\n",
      "                    ]\n",
      "                }\n",
      "            ],\n",
      "            \"GrantList\": [\n",
      "                {\n",
      "                    \"GrantID\": \"ZID BC011242\",\n",
      "                    \"Acronym\": \"ImNIH\",\n",
      "                    \"Agency\": \"Intramural NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"Z01 AI000390\",\n",
      "                    \"Acronym\": \"ImNIH\",\n",
      "                    \"Agency\": \"Intramural NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"HHSN261200800001E\",\n",
      "                    \"Acronym\": \"CA\",\n",
      "                    \"Agency\": \"NCI NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"HHSN261200800001C\",\n",
      "                    \"Acronym\": \"CA\",\n",
      "                    \"Agency\": \"NCI NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"Z01 BC010686\",\n",
      "                    \"Acronym\": \"ImNIH\",\n",
      "                    \"Agency\": \"Intramural NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                }\n",
      "            ],\n",
      "            \"PublicationTypeList\": [\n",
      "                \"Clinical Trial, Phase II\",\n",
      "                \"Journal Article\",\n",
      "                \"Research Support, N.I.H., Extramural\",\n",
      "                \"Research Support, Non-U.S. Gov't\"\n",
      "            ]\n",
      "        },\n",
      "        \"MedlineJournalInfo\": {\n",
      "            \"Country\": \"United States\",\n",
      "            \"MedlineTA\": \"JAMA\",\n",
      "            \"NlmUniqueID\": \"7501160\",\n",
      "            \"ISSNLinking\": \"0098-7484\"\n",
      "        },\n",
      "        \"ChemicalList\": [\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Antiviral Agents\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Benzimidazoles\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Fluorenes\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"RNA, Viral\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"013TE6E4WV\",\n",
      "                \"NameOfSubstance\": \"ledipasvir\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"E2OU15WN0N\",\n",
      "                \"NameOfSubstance\": \"Uridine Monophosphate\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"WJ6CA3ZU8B\",\n",
      "                \"NameOfSubstance\": \"Sofosbuvir\"\n",
      "            }\n",
      "        ],\n",
      "        \"CommentsCorrectionsList\": [\n",
      "            {\n",
      "                \"RefSource\": \"JAMA. 2015 Mar 24-31;313(12):1217-8. doi: 10.1001/jama.2015.1111.\",\n",
      "                \"PMID\": \"25705993\"\n",
      "            },\n",
      "            {\n",
      "                \"RefSource\": \"JAMA. 2015 Jul 14;314(2):186. doi: 10.1001/jama.2015.6618.\",\n",
      "                \"PMID\": \"26172899\"\n",
      "            },\n",
      "            {\n",
      "                \"RefSource\": \"JAMA. 2015 Jul 14;314(2):186-7. doi: 10.1001/jama.2015.6621.\",\n",
      "                \"PMID\": \"26172900\"\n",
      "            }\n",
      "        ],\n",
      "        \"MeshHeadingList\": [\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Administration, Oral\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Adult\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Antiviral Agents\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"adverse effects\",\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Benzimidazoles\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Coinfection\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Drug Therapy, Combination\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Female\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"adverse effects\",\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Fluorenes\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Genotype\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"drug therapy\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"HIV Infections\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"genetics\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Hepacivirus\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"drug therapy\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Hepatitis C, Chronic\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Humans\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Male\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Middle Aged\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"chemically induced\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Myalgia\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"RNA, Viral\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Sofosbuvir\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Treatment Outcome\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"adverse effects\",\n",
      "                    \"analogs & derivatives\",\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Uridine Monophosphate\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Viral Load\"\n",
      "            }\n",
      "        ]\n",
      "    },\n",
      "    \"PubmedData\": {\n",
      "        \"ReferenceList\": [\n",
      "            {\n",
      "                \"ReferenceList\": [],\n",
      "                \"Reference\": [\n",
      "                    {\n",
      "                        \"Citation\": \"Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013; 57(4):1333\\u20131342.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23172780\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Limketkai BN, Mehta SH, Sutcliffe CG, et al. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA. 2012;308 (4):370\\u2013378.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3807214\",\n",
      "                            \"22820790\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Weber R, Sabin CA, Friis-M\\u00f8ller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006;166(15):1632\\u20131641.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"16908797\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sulkowski MS, Sherman KE, Dieterich DT, et al. Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial. Ann Intern Med. 2013; 159(2):86\\u201396.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23685940\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Chung RT, Andersen J, Volberding P, et al.; AIDS Clinical Trials Group A5071 Study Team. Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med. 2004; 351(5):451\\u2013459.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4113392\",\n",
      "                            \"15282352\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al.; APRICOT Study Group. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med. 2004;351(5): 438\\u2013450.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"15282351\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Carrat F, Bani-Sadr F, Pol S, et al.; ANRS HCO2 RIBAVIC Study Team. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA. 2004;292 (23):2839\\u20132848.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"15598915\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sulkowski M, Pol S, Mallolas J, et al.; P05411 Study Investigators. Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial. Lancet Infect Dis. 2013;13(7):597\\u2013605.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23768747\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sulkowski MS. Current management of hepatitis C virus infection in patients with HIV co-infection. J Infect Dis. 2013;207(suppl 1):S26\\u2013S32.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3565592\",\n",
      "                            \"23390302\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Olysio (R) (simeprevir) [package insert]. http://www.olysio.com/shared/product/olysio/prescribing-information.pdf.\\n2013. \\nAccessed December 2, 2014.\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Solvadi (R) (sofosbuvir) [package insert]. http://www.gilead.com/\\u223c/media/Files/pdfs/medicines/liver-disease/sovaldi/sovaldi_pi.pdf.\\n2013. \\nAccessed December 2, 2014.\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sulkowski MS, Naggie S, Lalezari J, et al.; PHOTON-1 Investigators. Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection. JAMA. 2014;312(4):353\\u2013361.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4997358\",\n",
      "                            \"25038354\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Osinusi A, Meissner EG, Lee YJ, et al. Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial [published correction appears in JAMA. 2013;310(18):1987]. JAMA. 2013; 310(8):804\\u2013811.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4254410\",\n",
      "                            \"23982366\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Afdhal N, Reddy KR, Nelson DR, et al.; ION-2 Investigators. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. N Engl J Med. 2014;370(16):1483\\u20131493.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24725238\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Afdhal N, Zeuzem S, Kwo P, et al.; ION-1 Investigators. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med. 2014;370(20):1889\\u20131898.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24725239\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604\\u2013612.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2763564\",\n",
      "                            \"19414839\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events. Version 1.0. National Institute of Allergy and Infectious Diseases website. http://www.niaid.nih.gov/LabsAndResources/resources/DAIDSClinRsrch/Documents/daidsaegradingtable.pdf.\\n2009. \\nAccessed February 9, 2015.\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Prokunina-Olsson L, Muchmore B, Tang W, et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet. 2013;45(2):164\\u2013171.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3793390\",\n",
      "                            \"23291588\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009; 461(7262):399\\u2013401.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"19684573\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1(5):431\\u2013435.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"7308988\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Guedj J, Neumann AU. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics. J Theor Biol. 2010;267(3):330\\u2013340.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"20831874\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Guedj J, Rong L, Dahari H, Perelson AS. A perspective on modelling hepatitis C virus infection. J Viral Hepat. 2010;17(12):825\\u2013833.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3070361\",\n",
      "                            \"20723038\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Ninomiya M, Ueno Y, Funayama R, et al. Use of illumina deep sequencing technology to differentiate hepatitis C virus variants. J Clin Microbiol. 2012;50(3):857\\u2013866.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3295113\",\n",
      "                            \"22205816\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Dieterich D, Rockstroh JK, Orkin C, et al. Simeprevir (TMC435) with pegylated interferon/ribavirin in patients coinfected with HCV genotype 1 and HIV-1: a phase 3 study. Clin Infect Dis. 2014;59(11):1579\\u20131587.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"25192745\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Lawitz E, Lalezari JP, Hassanein T, et al. Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial. Lancet Infect Dis. 2013;13(5):401\\u2013408.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23499158\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kowdley KV, Gordon SC, Reddy KR, et al.; ION-3 Investigators. Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. N Engl J Med. 2014;370(20):1879\\u20131888.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24720702\"\n",
      "                        ]\n",
      "                    }\n",
      "                ]\n",
      "            }\n",
      "        ],\n",
      "        \"History\": [\n",
      "            {\n",
      "                \"Year\": \"2015\",\n",
      "                \"Month\": \"2\",\n",
      "                \"Day\": \"24\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2015\",\n",
      "                \"Month\": \"2\",\n",
      "                \"Day\": \"24\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2015\",\n",
      "                \"Month\": \"4\",\n",
      "                \"Day\": \"8\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2021\",\n",
      "                \"Month\": \"1\",\n",
      "                \"Day\": \"4\"\n",
      "            }\n",
      "        ],\n",
      "        \"PublicationStatus\": \"ppublish\",\n",
      "        \"ArticleIdList\": [\n",
      "            \"25706232\",\n",
      "            \"NIHMS1652237\",\n",
      "            \"PMC7780246\",\n",
      "            \"10.1001/jama.2015.1373\",\n",
      "            \"2173266\"\n",
      "        ]\n",
      "    }\n",
      "}\n",
      "{\n",
      "    \"MedlineCitation\": {\n",
      "        \"CitationSubset\": [\n",
      "            \"IM\"\n",
      "        ],\n",
      "        \"OtherAbstract\": [],\n",
      "        \"InvestigatorList\": [],\n",
      "        \"OtherID\": [],\n",
      "        \"KeywordList\": [],\n",
      "        \"SpaceFlightMission\": [],\n",
      "        \"GeneralNote\": [],\n",
      "        \"PMID\": \"25591505\",\n",
      "        \"DateCompleted\": {\n",
      "            \"Year\": \"2015\",\n",
      "            \"Month\": \"04\",\n",
      "            \"Day\": \"08\"\n",
      "        },\n",
      "        \"DateRevised\": {\n",
      "            \"Year\": \"2024\",\n",
      "            \"Month\": \"06\",\n",
      "            \"Day\": \"15\"\n",
      "        },\n",
      "        \"Article\": {\n",
      "            \"ArticleDate\": [\n",
      "                {\n",
      "                    \"Year\": \"2015\",\n",
      "                    \"Month\": \"01\",\n",
      "                    \"Day\": \"13\"\n",
      "                }\n",
      "            ],\n",
      "            \"ELocationID\": [\n",
      "                \"10.1016/S0140-6736(14)61228-9\",\n",
      "                \"S0140-6736(14)61228-9\"\n",
      "            ],\n",
      "            \"Language\": [\n",
      "                \"eng\"\n",
      "            ],\n",
      "            \"Journal\": {\n",
      "                \"ISSN\": \"1474-547X\",\n",
      "                \"JournalIssue\": {\n",
      "                    \"Volume\": \"385\",\n",
      "                    \"Issue\": \"9973\",\n",
      "                    \"PubDate\": {\n",
      "                        \"Year\": \"2015\",\n",
      "                        \"Month\": \"Mar\",\n",
      "                        \"Day\": \"21\"\n",
      "                    }\n",
      "                },\n",
      "                \"Title\": \"Lancet (London, England)\",\n",
      "                \"ISOAbbreviation\": \"Lancet\"\n",
      "            },\n",
      "            \"ArticleTitle\": \"Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study.\",\n",
      "            \"Pagination\": {\n",
      "                \"StartPage\": \"1107\",\n",
      "                \"EndPage\": \"1113\",\n",
      "                \"MedlinePgn\": \"1107-13\"\n",
      "            },\n",
      "            \"Abstract\": {\n",
      "                \"AbstractText\": [\n",
      "                    \"Direct-acting antiviral drugs have a high cure rate and favourable tolerability for patients with hepatitis C virus (HCV). Shorter courses could improve affordability and adherence. Sofosbuvir and ledipasvir with ribavirin have high efficacy when taken for 8 weeks but not for 6 weeks. We assessed whether the addition of a third direct-acting antiviral drug to sofosbuvir and ledipasvir would allow a shorter treatment duration.\",\n",
      "                    \"In this single-centre, open-label, phase 2A trial, we sequentially enrolled treatment-naive patients with HCV genotype 1 infection into three treatment groups: 12 weeks of sofosbuvir and ledipasvir; 6 weeks of sofosbuvir, ledipasvir, and GS-9669; or 6 weeks of sofosbuvir, ledipasvir, and GS-9451. Patients and investigators were not masked to treatment assignment. The primary endpoint was the propotion of patients with sustained viral response at 12 weeks after treatment completion (SVR12), assessed by serum HCV RNA concentrations lower than 43 IU/mL (the lower limit of quantification). We did an intention-to-treat analysis for the primary endpoint and adverse events. This study is registered with ClinicalTrials.gov, number NCT01805882.\",\n",
      "                    \"Between Jan 11, 2013, and Dec 17, 2013, we enrolled 60 patients, and sequentially assigned them into three groups of 20. We noted an SVR12 in all 20 patients (100%, 95% CI 83-100) allocated to sofosbuvir and ledipasvir for 12 weeks; in 19 (95%, 75-100) of the 20 patients allocated to sofosbuvir, ledipasvir, and GS-9669 for 6 weeks (one patient relapsed 2 weeks after completion of treatment); and in 19 (95%, 75-100%) of the 20 patients allocated to sofosbuvir, ledipasvir, and GS-9451 for 6 weeks (one patient was lost to follow-up after reaching sustained viral response at 4 weeks). Most adverse events were mild and no patients discontinued treatment. Two serious adverse events occurred (pain after a post-treatment liver biopsy and vertigo), both unrelated to study drugs.\",\n",
      "                    \"In this small proof-of-concept study, two different three-drug regimens that were given for 6 weeks resulted in high cure rates for HCV infection with excellent tolerability. Addition of a third potent direct-acting antiviral drug can reduce the duration of treatment required to achieve sustained viral response in patients with chronic HCV genotype 1 infection without cirrhosis.\",\n",
      "                    \"National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute and Clinical Center Intramural Program, German Research Foundation, National Institutes of Health, Gilead Sciences.\"\n",
      "                ],\n",
      "                \"CopyrightInformation\": \"Copyright \\u00a9 2015 Elsevier Ltd. All rights reserved.\"\n",
      "            },\n",
      "            \"AuthorList\": [\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, MD, USA; Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Kohli\",\n",
      "                    \"ForeName\": \"Anita\",\n",
      "                    \"Initials\": \"A\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA; Department of Medicine, Dalhousie University, Halifax, NS, Canada.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Osinusi\",\n",
      "                    \"ForeName\": \"Anuoluwapo\",\n",
      "                    \"Initials\": \"A\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Sims\",\n",
      "                    \"ForeName\": \"Zayani\",\n",
      "                    \"Initials\": \"Z\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Nelson\",\n",
      "                    \"ForeName\": \"Amy\",\n",
      "                    \"Initials\": \"A\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Meissner\",\n",
      "                    \"ForeName\": \"Eric G\",\n",
      "                    \"Initials\": \"EG\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, USA; Department of Medicine, Dalhousie University, Halifax, NS, Canada.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Barrett\",\n",
      "                    \"ForeName\": \"Lisa L\",\n",
      "                    \"Initials\": \"LL\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Institute of Biostatistics and Mathematical Modeling, Johann Wolfgang Goethe University, Frankfurt, Germany.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Bon\",\n",
      "                    \"ForeName\": \"Dimitra\",\n",
      "                    \"Initials\": \"D\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Marti\",\n",
      "                    \"ForeName\": \"Miriam M\",\n",
      "                    \"Initials\": \"MM\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Silk\",\n",
      "                    \"ForeName\": \"Rachel\",\n",
      "                    \"Initials\": \"R\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Kotb\",\n",
      "                    \"ForeName\": \"Colleen\",\n",
      "                    \"Initials\": \"C\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Gross\",\n",
      "                    \"ForeName\": \"Chloe\",\n",
      "                    \"Initials\": \"C\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Jolley\",\n",
      "                    \"ForeName\": \"Tim A\",\n",
      "                    \"Initials\": \"TA\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Sidharthan\",\n",
      "                    \"ForeName\": \"Sreetha\",\n",
      "                    \"Initials\": \"S\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Petersen\",\n",
      "                    \"ForeName\": \"Tess\",\n",
      "                    \"Initials\": \"T\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Townsend\",\n",
      "                    \"ForeName\": \"Kerry\",\n",
      "                    \"Initials\": \"K\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Egerson\",\n",
      "                    \"ForeName\": \"D'Andrea\",\n",
      "                    \"Initials\": \"D\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Kapoor\",\n",
      "                    \"ForeName\": \"Rama\",\n",
      "                    \"Initials\": \"R\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Spurlin\",\n",
      "                    \"ForeName\": \"Emily\",\n",
      "                    \"Initials\": \"E\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Sneller\",\n",
      "                    \"ForeName\": \"Michael\",\n",
      "                    \"Initials\": \"M\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Proschan\",\n",
      "                    \"ForeName\": \"Michael\",\n",
      "                    \"Initials\": \"M\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Institute of Biostatistics and Mathematical Modeling, Johann Wolfgang Goethe University, Frankfurt, Germany.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Herrmann\",\n",
      "                    \"ForeName\": \"Eva\",\n",
      "                    \"Initials\": \"E\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Kwan\",\n",
      "                    \"ForeName\": \"Richard\",\n",
      "                    \"Initials\": \"R\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Unity Health Care, Washington DC, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Teferi\",\n",
      "                    \"ForeName\": \"Gebeyehu\",\n",
      "                    \"Initials\": \"G\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Division of Infectious Diseases, Institute of Human Virology, University of Maryland, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Talwani\",\n",
      "                    \"ForeName\": \"Rohit\",\n",
      "                    \"Initials\": \"R\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA; The National Cancer Institute, National Institutes of Health, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Diaz\",\n",
      "                    \"ForeName\": \"Gabbie\",\n",
      "                    \"Initials\": \"G\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Pathology, National Cancer Institute, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Kleiner\",\n",
      "                    \"ForeName\": \"David E\",\n",
      "                    \"Initials\": \"DE\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Wood\",\n",
      "                    \"ForeName\": \"Brad J\",\n",
      "                    \"Initials\": \"BJ\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Unity Health Care, Washington DC, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Chavez\",\n",
      "                    \"ForeName\": \"Jose\",\n",
      "                    \"Initials\": \"J\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Unity Health Care, Washington DC, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Abbott\",\n",
      "                    \"ForeName\": \"Stephen\",\n",
      "                    \"Initials\": \"S\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Gilead Sciences, CA, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Symonds\",\n",
      "                    \"ForeName\": \"William T\",\n",
      "                    \"Initials\": \"WT\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Gilead Sciences, CA, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Subramanian\",\n",
      "                    \"ForeName\": \"G Mani\",\n",
      "                    \"Initials\": \"GM\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Gilead Sciences, CA, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Pang\",\n",
      "                    \"ForeName\": \"Phillip S\",\n",
      "                    \"Initials\": \"PS\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Gilead Sciences, CA, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"McHutchison\",\n",
      "                    \"ForeName\": \"John\",\n",
      "                    \"Initials\": \"J\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Polis\",\n",
      "                    \"ForeName\": \"Michael A\",\n",
      "                    \"Initials\": \"MA\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Fauci\",\n",
      "                    \"ForeName\": \"Anthony S\",\n",
      "                    \"Initials\": \"AS\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, MD, USA.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Masur\",\n",
      "                    \"ForeName\": \"Henry\",\n",
      "                    \"Initials\": \"H\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, USA. Electronic address: skottilil@niaid.nih.gov.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Kottilil\",\n",
      "                    \"ForeName\": \"Shyam\",\n",
      "                    \"Initials\": \"S\"\n",
      "                }\n",
      "            ],\n",
      "            \"DataBankList\": [\n",
      "                {\n",
      "                    \"DataBankName\": \"ClinicalTrials.gov\",\n",
      "                    \"AccessionNumberList\": [\n",
      "                        \"NCT01805882\"\n",
      "                    ]\n",
      "                }\n",
      "            ],\n",
      "            \"GrantList\": [\n",
      "                {\n",
      "                    \"GrantID\": \"Z01 AI000390-24\",\n",
      "                    \"Acronym\": \"ImNIH\",\n",
      "                    \"Agency\": \"Intramural NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"HHSN261200800001C\",\n",
      "                    \"Acronym\": \"CA\",\n",
      "                    \"Agency\": \"NCI NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"HHSN261200800001E\",\n",
      "                    \"Acronym\": \"CA\",\n",
      "                    \"Agency\": \"NCI NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"Z01 AI000390-25\",\n",
      "                    \"Acronym\": \"ImNIH\",\n",
      "                    \"Agency\": \"Intramural NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"HHSN261200800001E\",\n",
      "                    \"Acronym\": \"CA\",\n",
      "                    \"Agency\": \"NCI NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                }\n",
      "            ],\n",
      "            \"PublicationTypeList\": [\n",
      "                \"Clinical Trial, Phase II\",\n",
      "                \"Journal Article\",\n",
      "                \"Research Support, N.I.H., Extramural\",\n",
      "                \"Research Support, N.I.H., Intramural\",\n",
      "                \"Research Support, Non-U.S. Gov't\"\n",
      "            ]\n",
      "        },\n",
      "        \"MedlineJournalInfo\": {\n",
      "            \"Country\": \"England\",\n",
      "            \"MedlineTA\": \"Lancet\",\n",
      "            \"NlmUniqueID\": \"2985213R\",\n",
      "            \"ISSNLinking\": \"0140-6736\"\n",
      "        },\n",
      "        \"ChemicalList\": [\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Antiviral Agents\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Benzimidazoles\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Fluorenes\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Furans\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"GS-9451\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"GS-9669\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Quinolines\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"RNA, Viral\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Thiophenes\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"013TE6E4WV\",\n",
      "                \"NameOfSubstance\": \"ledipasvir\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"49717AWG6K\",\n",
      "                \"NameOfSubstance\": \"Ribavirin\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"E2OU15WN0N\",\n",
      "                \"NameOfSubstance\": \"Uridine Monophosphate\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"WJ6CA3ZU8B\",\n",
      "                \"NameOfSubstance\": \"Sofosbuvir\"\n",
      "            }\n",
      "        ],\n",
      "        \"CommentsCorrectionsList\": [\n",
      "            {\n",
      "                \"RefSource\": \"Lancet. 2015 Mar 21;385(9973):1054-5. doi: 10.1016/S0140-6736(14)61600-7.\",\n",
      "                \"PMID\": \"25591504\"\n",
      "            }\n",
      "        ],\n",
      "        \"MeshHeadingList\": [\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Aged\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Antiviral Agents\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Benzimidazoles\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Cohort Studies\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"methods\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Drug Therapy, Combination\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Female\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Fluorenes\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Furans\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"genetics\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Hepacivirus\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"drug therapy\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Hepatitis C, Chronic\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Humans\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Intention to Treat Analysis\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Male\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Middle Aged\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Quinolines\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"blood\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"RNA, Viral\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Ribavirin\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Sofosbuvir\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Thiophenes\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Treatment Outcome\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"analogs & derivatives\",\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Uridine Monophosphate\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Viral Load\"\n",
      "            }\n",
      "        ],\n",
      "        \"CoiStatement\": \"<b>CONFLICT OF INTEREST STATEMENT</b>. William T. Symonds, Phillip Pang, G. Mani Subramanian and John G. McHutchison are employees of Gilead Pharmaceuticals. Rohit Talwani has served as a speaker for Merck and performs research funded by Vertex pharmaceuticals. Jose Chavez is a Member of the Regional Advisory Boards for Abbott, Bristol-Myers Squibb and Gilead. Gebeyehu Teferi serves on the Gilead and Merck Advisory Boards and as a speaker for Gilead.\"\n",
      "    },\n",
      "    \"PubmedData\": {\n",
      "        \"ReferenceList\": [\n",
      "            {\n",
      "                \"ReferenceList\": [],\n",
      "                \"Reference\": [\n",
      "                    {\n",
      "                        \"Citation\": \"Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333\\u201342.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23172780\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Seminars in liver disease. 2000;20(1):17\\u201335.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"10895429\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kowdley KV, Lawitz E, Crespo I, Hassanein T, Davis MN, Demicco M, et al. Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial. Lancet. 2013;13(5):401\\u20138.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23499440\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sherman KE, Flamm SL, Afdhal NH, Nelson DR, Sulkowski MS, Everson GT, et al. Response-guided telaprevir combination treatment for hepatitis C virus infection. The New England journal of medicine. 2011;365(11):1014\\u201324.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3809077\",\n",
      "                            \"21916639\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kwo PY, Lawitz EJ, McCone J, Schiff ER, Vierling JM, Pound D, et al. Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial. Lancet. 2010;376(9742):705\\u201316.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"20692693\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sulkowski M, Gardiner DF, Rodriguez-Torres M, Reddy R, et al. Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection. NEJM. 2014;370:211\\u201321.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24428467\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Lawitz E, Poordad FF, Pang PS, Hyland RH, Ding X, Mo H, et al. Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial. Lancet. 2014;383(9916):515\\u201323.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24209977\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Gane EJ, Stedman CA, Hyland RH, Ding X, Svarovskaia E, Subramanian GM, et al. Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir plus the NS5A Inhibitor Ledipasvir or the NS5B Non-nucleoside Inhibitor GS-9669 Against HCV Genotype 1 Infection. Gastroenterology. 2013\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24262278\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Lawitz E, Gruener LHD, et al. A novel NS5B non-nucleoside thumb site II inhibitor, demonstrates potent antiviral activity, favorable safety profile and potential for once-daily dosing. J Hepatol. 2012;52(Suppl 2):S471.\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Lawitz EJ, Hill JM, Marbury T, Demicco MP, Delaney W, Yang J, et al. A Phase I, randomized, placebo-controlled, 3-day, ascending-dose study of GS-9451, an NS3/4A protease inhibitor, in genotype 1 hepatitis C patients. Antiviral therapy. 2013;18(3):311\\u20139.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23047118\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1(5):431\\u20135.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"7308988\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Guedj J, Neumann AU. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics. Journal of theoretical biology. 2010;267(3):330\\u201340.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"20831874\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Guedj J, Dahari H, Rong L, Sansone ND, Nettles RE, Cotler SJ, et al. Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(10):3991\\u20136.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3593898\",\n",
      "                            \"23431163\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Conover WJ. Practical Nonparametric Statistics. 3. 1999.\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Lawitz E, Mangia A, Wyles D, Rodriguez-Torres M, Hassanein T, Gordon SC, et al. Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection. The New England journal of medicine. 2013\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23607594\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Fried MW, Buti M, Dore GJ, Flisiak R, Ferenci P, Jacobson I, et al. Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naive genotype 1 hepatitis C: The randomized PILLAR study. Hepatology. 2013;58(6):1918\\u201329.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4112500\",\n",
      "                            \"23907700\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Gane EJ, Stedman CA, Hyland RH, Ding X, Svarovskaia E, Symonds WT, et al. Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C. The New England journal of medicine. 2013;368(1):34\\u201344.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23281974\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Osinusi A, Meissner EG, Lee YJ, Bon D, Heytens L, Nelson A, et al. Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial. JAMA : the journal of the American Medical Association. 2013;310(8):804\\u201311.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4254410\",\n",
      "                            \"23982366\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Lawitz E, Poordad F, Kowdley KV, Cohen DE, Podsadecki T, Siggelkow S, et al. A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1. J Hepatol. 2013;59(1):18\\u201323.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23439262\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Everson GT, Sims KD, Rodriguez-Torres M, Hezode C, Lawitz E, Bourliere M, et al. Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection. Gastroenterology. 2014;146(2):420\\u20139.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24184132\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Hill A, Khoo S, Fortunak J, Simmons B, Ford N. Minimum costs for producing Hepatitis C Direct Acting Antivirals, for use in large-scale treatment access programs in developing countries. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3952605\",\n",
      "                            \"24399087\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kowdley KV, Gordon SC, Reddy KR, Rossaro L, Bernstein DE, Lawitz E, et al. Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. The New England journal of medicine. 2014;370(20):1879\\u201388.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24720702\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kowdley KV, Lawitz E, Poordad F, Cohen DE, Nelson DR, Zeuzem S, et al. Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1. The New England journal of medicine. 2014;370(3):222\\u201332.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24428468\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sunovion. Latuda (lurasidone): package insert. Marlborough: Sunovion; 2010.\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Afdhal N, Reddy KR, Nelson DR, Lawitz E, Gordon SC, Schiff E, et al. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. The New England journal of medicine. 2014;370(16):1483\\u201393.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24725238\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. The New England journal of medicine. 2014;370(20):1889\\u201398.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24725239\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Chayama K, Takahashi S, Toyota J, Karino Y, Ikeda K, Ishikawa H, et al. Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders. Hepatology. 2012;55(3):742\\u20138.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"21987462\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Lok AS, Gardiner DF, Lawitz E, Martorell C, Everson GT, Ghalib R, et al. Preliminary study of two antiviral agents for hepatitis C genotype 1. The New England journal of medicine. 2012;366(3):216\\u201324.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"22256805\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Poordad F, Lawitz E, Kowdley KV, Cohen DE, Podsadecki T, Siggelkow S, et al. Exploratory study of oral combination antiviral therapy for hepatitis C. The New England journal of medicine. 2013;368(1):45\\u201353.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23281975\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Suzuki Y, Ikeda K, Suzuki F, Toyota J, Karino Y, Chayama K, et al. Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options. J Hepatol. 2013;58(4):655\\u201362.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23183526\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Zeuzem S, Buggisch P, Agarwal K, Marcellin P, Sereni D, Klinker H, et al. The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C. Hepatology. 2012;55(3):749\\u201358.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"22006408\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Zeuzem S, Soriano V, Asselah T, Bronowicki JP, Lohse AW, Mullhaupt B, et al. Faldaprevir and deleobuvir for HCV genotype 1 infection. The New England journal of medicine. 2013;369(7):630\\u20139.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23944300\"\n",
      "                        ]\n",
      "                    }\n",
      "                ]\n",
      "            }\n",
      "        ],\n",
      "        \"History\": [\n",
      "            {\n",
      "                \"Year\": \"2015\",\n",
      "                \"Month\": \"1\",\n",
      "                \"Day\": \"17\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2015\",\n",
      "                \"Month\": \"1\",\n",
      "                \"Day\": \"17\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2015\",\n",
      "                \"Month\": \"4\",\n",
      "                \"Day\": \"9\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2016\",\n",
      "                \"Month\": \"3\",\n",
      "                \"Day\": \"21\"\n",
      "            }\n",
      "        ],\n",
      "        \"PublicationStatus\": \"ppublish\",\n",
      "        \"ArticleIdList\": [\n",
      "            \"25591505\",\n",
      "            \"NIHMS674560\",\n",
      "            \"PMC4427052\",\n",
      "            \"10.1016/S0140-6736(14)61228-9\",\n",
      "            \"S0140-6736(14)61228-9\"\n",
      "        ]\n",
      "    }\n",
      "}\n",
      "{\n",
      "    \"MedlineCitation\": {\n",
      "        \"CitationSubset\": [\n",
      "            \"IM\"\n",
      "        ],\n",
      "        \"OtherAbstract\": [],\n",
      "        \"InvestigatorList\": [],\n",
      "        \"OtherID\": [],\n",
      "        \"KeywordList\": [],\n",
      "        \"SpaceFlightMission\": [],\n",
      "        \"GeneralNote\": [],\n",
      "        \"PMID\": \"25364884\",\n",
      "        \"DateCompleted\": {\n",
      "            \"Year\": \"2014\",\n",
      "            \"Month\": \"12\",\n",
      "            \"Day\": \"29\"\n",
      "        },\n",
      "        \"DateRevised\": {\n",
      "            \"Year\": \"2024\",\n",
      "            \"Month\": \"06\",\n",
      "            \"Day\": \"15\"\n",
      "        },\n",
      "        \"Article\": {\n",
      "            \"ArticleDate\": [],\n",
      "            \"ELocationID\": [\n",
      "                \"10.7326/M14-1211\"\n",
      "            ],\n",
      "            \"Language\": [\n",
      "                \"eng\"\n",
      "            ],\n",
      "            \"Journal\": {\n",
      "                \"ISSN\": \"1539-3704\",\n",
      "                \"JournalIssue\": {\n",
      "                    \"Volume\": \"161\",\n",
      "                    \"Issue\": \"9\",\n",
      "                    \"PubDate\": {\n",
      "                        \"Year\": \"2014\",\n",
      "                        \"Month\": \"Nov\",\n",
      "                        \"Day\": \"04\"\n",
      "                    }\n",
      "                },\n",
      "                \"Title\": \"Annals of internal medicine\",\n",
      "                \"ISOAbbreviation\": \"Ann Intern Med\"\n",
      "            },\n",
      "            \"ArticleTitle\": \"Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot study.\",\n",
      "            \"Pagination\": {\n",
      "                \"StartPage\": \"634\",\n",
      "                \"EndPage\": \"638\",\n",
      "                \"MedlinePgn\": \"634-8\"\n",
      "            },\n",
      "            \"Abstract\": {\n",
      "                \"AbstractText\": [\n",
      "                    \"The interferon (IFN)-free regimen of sofosbuvir and ribavirin for 24 weeks was recently approved to treat chronic hepatitis C virus (HCV) genotype 1 (GT-1) infection for patients ineligible for IFN. However, sofosbuvir plus ribavirin therapy is associated with relapse in 15% to 30% of patients with HCV GT-1. Neither the mechanism of relapse nor the optimal re-treatment strategy for these patients is defined.\",\n",
      "                    \"To assess the safety and efficacy of sofosbuvir plus ledipasvir in patients with chronic HCV GT-1 that relapsed after sofosbuvir plus ribavirin therapy.\",\n",
      "                    \"Phase 2a, open-label study. (ClinicalTrials.gov: NCT01805882).\",\n",
      "                    \"Single U.S site.\",\n",
      "                    \"14 patients with HCV GT-1 that relapsed after treatment with sofosbuvir plus ribavirin for 24 weeks were re-treated with sofosbuvir plus ledipasvir for 12 weeks.\",\n",
      "                    \"HCV RNA concentration and population sequencing to detect NS5B S282T mutations.\",\n",
      "                    \"All 14 patients treated with sofosbuvir plus ledipasvir for 12 weeks achieved a sustained virologic response, including 7 with advanced liver disease (Knodell Histology Activity Index score of 3 or 4) and 1 with a detectable NS5B S282T mutation after sofosbuvir plus ribavirin therapy. Sofosbuvir plus ledipasvir was well-tolerated with few adverse events. Four grade 3 events (elevated serum creatinine in a patient with baseline renal insufficiency, hypercholesterolemia, and hypophosphatemia) occurred. There were no grade 4 events or treatment discontinuations.\",\n",
      "                    \"Small sample size.\",\n",
      "                    \"The fixed-dose combination of sofosbuvir plus ledipasvir was efficacious in a small cohort of patients with HCV GT-1 that relapsed after sofosbuvir plus ribavirin therapy, even in the setting of advanced liver disease. Larger studies are needed to confirm these preliminary efficacy results.\",\n",
      "                    \"National Institute of Allergy and Infectious Diseases, National Institutes of Health, National Cancer Institute, and Gilead Sciences.\"\n",
      "                ]\n",
      "            },\n",
      "            \"AuthorList\": [\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Osinusi\",\n",
      "                    \"ForeName\": \"Anu\",\n",
      "                    \"Initials\": \"A\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Kohli\",\n",
      "                    \"ForeName\": \"Anita\",\n",
      "                    \"Initials\": \"A\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Marti\",\n",
      "                    \"ForeName\": \"Miriam M\",\n",
      "                    \"Initials\": \"MM\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Nelson\",\n",
      "                    \"ForeName\": \"Amy\",\n",
      "                    \"Initials\": \"A\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Zhang\",\n",
      "                    \"ForeName\": \"Xiaozhen\",\n",
      "                    \"Initials\": \"X\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Meissner\",\n",
      "                    \"ForeName\": \"Eric G\",\n",
      "                    \"Initials\": \"EG\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Silk\",\n",
      "                    \"ForeName\": \"Rachel\",\n",
      "                    \"Initials\": \"R\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Townsend\",\n",
      "                    \"ForeName\": \"Kerry\",\n",
      "                    \"Initials\": \"K\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Pang\",\n",
      "                    \"ForeName\": \"Phillip S\",\n",
      "                    \"Initials\": \"PS\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Subramanian\",\n",
      "                    \"ForeName\": \"G Mani\",\n",
      "                    \"Initials\": \"GM\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"McHutchison\",\n",
      "                    \"ForeName\": \"John G\",\n",
      "                    \"Initials\": \"JG\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Fauci\",\n",
      "                    \"ForeName\": \"Anthony S\",\n",
      "                    \"Initials\": \"AS\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Masur\",\n",
      "                    \"ForeName\": \"Henry\",\n",
      "                    \"Initials\": \"H\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Kottilil\",\n",
      "                    \"ForeName\": \"Shyam\",\n",
      "                    \"Initials\": \"S\"\n",
      "                }\n",
      "            ],\n",
      "            \"DataBankList\": [\n",
      "                {\n",
      "                    \"DataBankName\": \"ClinicalTrials.gov\",\n",
      "                    \"AccessionNumberList\": [\n",
      "                        \"NCT00047385\",\n",
      "                        \"NCT01805882\",\n",
      "                        \"NCT00047385\"\n",
      "                    ]\n",
      "                }\n",
      "            ],\n",
      "            \"GrantList\": [\n",
      "                {\n",
      "                    \"GrantID\": \"HHSN261200800001C\",\n",
      "                    \"Acronym\": \"CA\",\n",
      "                    \"Agency\": \"NCI NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"HHSN261200800001E\",\n",
      "                    \"Acronym\": \"CA\",\n",
      "                    \"Agency\": \"NCI NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"NIH0010192010\",\n",
      "                    \"Acronym\": \"ImNIH\",\n",
      "                    \"Agency\": \"Intramural NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                },\n",
      "                {\n",
      "                    \"GrantID\": \"Z99 CL999999\",\n",
      "                    \"Acronym\": \"ImNIH\",\n",
      "                    \"Agency\": \"Intramural NIH HHS\",\n",
      "                    \"Country\": \"United States\"\n",
      "                }\n",
      "            ],\n",
      "            \"PublicationTypeList\": [\n",
      "                \"Clinical Trial, Phase II\",\n",
      "                \"Journal Article\",\n",
      "                \"Research Support, N.I.H., Extramural\",\n",
      "                \"Research Support, N.I.H., Intramural\",\n",
      "                \"Research Support, Non-U.S. Gov't\"\n",
      "            ]\n",
      "        },\n",
      "        \"MedlineJournalInfo\": {\n",
      "            \"Country\": \"United States\",\n",
      "            \"MedlineTA\": \"Ann Intern Med\",\n",
      "            \"NlmUniqueID\": \"0372351\",\n",
      "            \"ISSNLinking\": \"0003-4819\"\n",
      "        },\n",
      "        \"ChemicalList\": [\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Antiviral Agents\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Benzimidazoles\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"Fluorenes\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"RNA, Viral\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"013TE6E4WV\",\n",
      "                \"NameOfSubstance\": \"ledipasvir\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"49717AWG6K\",\n",
      "                \"NameOfSubstance\": \"Ribavirin\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"E2OU15WN0N\",\n",
      "                \"NameOfSubstance\": \"Uridine Monophosphate\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"WJ6CA3ZU8B\",\n",
      "                \"NameOfSubstance\": \"Sofosbuvir\"\n",
      "            }\n",
      "        ],\n",
      "        \"MeshHeadingList\": [\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Aged\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"adverse effects\",\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Antiviral Agents\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"adverse effects\",\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Benzimidazoles\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Drug Therapy, Combination\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"adverse effects\",\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Fluorenes\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Genotype\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"genetics\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Hepacivirus\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"blood\",\n",
      "                    \"drug therapy\",\n",
      "                    \"virology\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Hepatitis C, Chronic\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Humans\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Male\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Middle Aged\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Mutation\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"blood\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"RNA, Viral\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Recurrence\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Ribavirin\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Sofosbuvir\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"adverse effects\",\n",
      "                    \"analogs & derivatives\",\n",
      "                    \"therapeutic use\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"Uridine Monophosphate\"\n",
      "            }\n",
      "        ]\n",
      "    },\n",
      "    \"PubmedData\": {\n",
      "        \"ReferenceList\": [\n",
      "            {\n",
      "                \"ReferenceList\": [],\n",
      "                \"Reference\": [\n",
      "                    {\n",
      "                        \"Citation\": \"Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. 2010;138(2):513\\u201321.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"19861128\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156(4):271\\u20138.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"22351712\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Fried MW, Buti M, Dore GJ, Flisiak R, Ferenci P, Jacobson I, et al. Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naive genotype 1 hepatitis C: The randomized PILLAR study. Hepatology. 2013:0.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4112500\",\n",
      "                            \"23907700\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Gane EJ, Stedman CA, Hyland RH, Ding X, Svarovskaia E, Symonds WT, et al. Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C. N Engl J Med. 2013;368(1):34\\u201344.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23281974\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Lawitz E, Gane EJ. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med. 2013;369(7):678\\u20139.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"23944316\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Olysio. Olysio (simeprevir) capsules: US prescribing information. 2013 Nov;  http://www.olysio.com/\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sovaldi. Sovaldi (sofosbuvir) tablets: US prescribing information. 2013 Dec;  http://www.sovaldi.com/\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Osinusi A, Meissner EG, Lee YJ, Bon D, Heytens L, Nelson A, et al. Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial. JAMA. 2013;310(8):804\\u201311.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4254410\",\n",
      "                            \"23982366\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sulkowski MSRTM, Lalezari JP, et al. All-oral therapy with sofosbuvir plus ribavirin for the treatment of HCV genotype 1, 2, and 3 infection in patients co-infected with HIV (PHOTON-1) Hepatology. 2013;58(S1):313A.\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Curry MPFX, Chung RT, et al. Pretransplant Sofosbuvir and Ribavirin to Prevent Recurrence of HCV Infection after Liver Transplantation. HEPATOLOGY. 2013;58(S4):314a.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"25261839\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Charlton MR, G E, Manns MP, et al. Sofosbuvir and Ribavirin for the Treatment of Established Recurrent Hepatitis C Infection After Liver Transplantation: Preliminary Results of a Prospective, Multicenter Stud. Hepatology. 2013;58\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Afdhal N, Reddy KR, Nelson DR, Lawitz E, Gordon SC, Schiff E, et al. Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection. N Engl J Med. 2014\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24725238\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, et al. Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection. N Engl J Med. 2014\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24725239\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kowdley KV, Gordon SC, Reddy KR, Rossaro L, Bernstein DE, Lawitz E, et al. Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis. N Engl J Med. 2014\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24720702\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Lawitz E, Poordad FF, Pang PS, Hyland RH, Ding X, Mo H, et al. Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial. Lancet. 2014;383(9916):515\\u201323.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"24209977\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Cheng G, P B, Corsa A, et al. Antiviral activity and resistance profile of the novel HCV NS5A inhibitor GS-5885. EASL. 2012;2012 EASL.\"\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Lam AM, Espiritu C, Bansal S, Micolochick Steuer HM, Niu C, Zennou V, et al. Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus. Antimicrob Agents Chemother. 2012;56(6):3359\\u201368.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3370800\",\n",
      "                            \"22430955\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Lam AM, Espiritu C, Murakami E, Zennou V, Bansal S, Micolochick Steuer HM, et al. Inhibition of hepatitis C virus replicon RNA synthesis by PSI-352938, a cyclic phosphate prodrug of beta-D-2\\u2032-deoxy-2\\u2032-alpha-fluoro-2\\u2032-beta-C-methylguanosine. Antimicrob Agents Chemother. 2011;55(6):2566\\u201375.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3101412\",\n",
      "                            \"21444700\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Le Pogam S, Jiang WR, Leveque V, Rajyaguru S, Ma H, Kang H, et al. In vitro selected Con1 subgenomic replicons resistant to 2\\u2032-C-methyl-cytidine or to R1479 show lack of cross resistance. Virology. 2006;351(2):349\\u201359.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"16713611\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Migliaccio G, Tomassini JE, Carroll SS, Tomei L, Altamura S, Bhat B, et al. Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro. J Biol Chem. 2003;278(49):49164\\u201370.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"12966103\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Pawlotsky JM, Najera I, Jacobson I. Resistance to mericitabine, a nucleoside analogue inhibitor of HCV RNA-dependent RNA polymerase. Antivir Ther. 2012;17(3):411\\u201323.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"22402762\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Fridell RA, Qiu D, Wang C, Valera L, Gao M. Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system. Antimicrob Agents Chemother. 2010;54(9):3641\\u201350.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2935007\",\n",
      "                            \"20585111\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Lawitz EJ, Gruener D, Hill JM, Marbury T, Moorehead L, Mathias A, et al. A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C. J Hepatol. 2012;57(1):24\\u201331.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"22314425\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Paolucci S, Fiorina L, Mariani B, Gulminetti R, Novati S, Barbarini G, et al. Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naive patients. Virol J. 2013;10:355.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3878512\",\n",
      "                            \"24341898\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Palmer S, Kearney M, Maldarelli F, Halvas EK, Bixby CJ, Bazmi H, et al. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol. 2005;43(1):406\\u201313.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC540111\",\n",
      "                            \"15635002\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Vandenhende MA, Bellecave P, Recordon-Pinson P, Reigadas S, Bidet Y, Bruyand M, et al. Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure. PLoS One. 2014;9(1):e86771.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3903565\",\n",
      "                            \"24475178\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Bae AS, Ku KS, Miller MD, Mo H, Svarovskaia ES. Allele-specific real-time PCR system for detection of subpopulations of genotype 1a and 1b hepatitis C NS5B Y448H mutant viruses in clinical samples. J Clin Microbiol. 2011;49(9):3168\\u201374.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3165570\",\n",
      "                            \"21715590\"\n",
      "                        ]\n",
      "                    }\n",
      "                ]\n",
      "            }\n",
      "        ],\n",
      "        \"History\": [\n",
      "            {\n",
      "                \"Year\": \"2014\",\n",
      "                \"Month\": \"11\",\n",
      "                \"Day\": \"4\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2014\",\n",
      "                \"Month\": \"11\",\n",
      "                \"Day\": \"5\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2014\",\n",
      "                \"Month\": \"12\",\n",
      "                \"Day\": \"30\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2015\",\n",
      "                \"Month\": \"9\",\n",
      "                \"Day\": \"28\"\n",
      "            }\n",
      "        ],\n",
      "        \"PublicationStatus\": \"ppublish\",\n",
      "        \"ArticleIdList\": [\n",
      "            \"25364884\",\n",
      "            \"NIHMS679815\",\n",
      "            \"PMC4586065\",\n",
      "            \"10.7326/M14-1211\",\n",
      "            \"1920503\"\n",
      "        ]\n",
      "    }\n",
      "}\n",
      "{\n",
      "    \"MedlineCitation\": {\n",
      "        \"CitationSubset\": [\n",
      "            \"IM\"\n",
      "        ],\n",
      "        \"OtherAbstract\": [],\n",
      "        \"InvestigatorList\": [],\n",
      "        \"OtherID\": [],\n",
      "        \"KeywordList\": [],\n",
      "        \"SpaceFlightMission\": [],\n",
      "        \"GeneralNote\": [],\n",
      "        \"PMID\": \"23520522\",\n",
      "        \"DateCompleted\": {\n",
      "            \"Year\": \"2013\",\n",
      "            \"Month\": \"09\",\n",
      "            \"Day\": \"10\"\n",
      "        },\n",
      "        \"DateRevised\": {\n",
      "            \"Year\": \"2021\",\n",
      "            \"Month\": \"10\",\n",
      "            \"Day\": \"21\"\n",
      "        },\n",
      "        \"Article\": {\n",
      "            \"ArticleDate\": [\n",
      "                {\n",
      "                    \"Year\": \"2013\",\n",
      "                    \"Month\": \"03\",\n",
      "                    \"Day\": \"08\"\n",
      "                }\n",
      "            ],\n",
      "            \"ELocationID\": [\n",
      "                \"e58586\",\n",
      "                \"10.1371/journal.pone.0058586\"\n",
      "            ],\n",
      "            \"Language\": [\n",
      "                \"eng\"\n",
      "            ],\n",
      "            \"Journal\": {\n",
      "                \"ISSN\": \"1932-6203\",\n",
      "                \"JournalIssue\": {\n",
      "                    \"Volume\": \"8\",\n",
      "                    \"Issue\": \"3\",\n",
      "                    \"PubDate\": {\n",
      "                        \"Year\": \"2013\"\n",
      "                    }\n",
      "                },\n",
      "                \"Title\": \"PloS one\",\n",
      "                \"ISOAbbreviation\": \"PLoS One\"\n",
      "            },\n",
      "            \"ArticleTitle\": \"Identification of human microRNA-like sequences embedded within the protein-encoding genes of the human immunodeficiency virus.\",\n",
      "            \"Pagination\": {\n",
      "                \"StartPage\": \"e58586\",\n",
      "                \"MedlinePgn\": \"e58586\"\n",
      "            },\n",
      "            \"Abstract\": {\n",
      "                \"AbstractText\": [\n",
      "                    \"MicroRNAs (miRNAs) are highly conserved, short (18-22 nts), non-coding RNA molecules that regulate gene expression by binding to the 3' untranslated regions (3'UTRs) of mRNAs. While numerous cellular microRNAs have been associated with the progression of various diseases including cancer, miRNAs associated with retroviruses have not been well characterized. Herein we report identification of microRNA-like sequences in coding regions of several HIV-1 genomes.\",\n",
      "                    \"Based on our earlier proteomics and bioinformatics studies, we have identified 8 cellular miRNAs that are predicted to bind to the mRNAs of multiple proteins that are dysregulated during HIV-infection of CD4+ T-cells in vitro. In silico analysis of the full length and mature sequences of these 8 miRNAs and comparisons with all the genomic and subgenomic sequences of HIV-1 strains in global databases revealed that the first 18/18 sequences of the mature hsa-miR-195 sequence (including the short seed sequence), matched perfectly (100%), or with one nucleotide mismatch, within the envelope (env) genes of five HIV-1 genomes from Africa. In addition, we have identified 4 other miRNA-like sequences (hsa-miR-30d, hsa-miR-30e, hsa-miR-374a and hsa-miR-424) within the env and the gag-pol encoding regions of several HIV-1 strains, albeit with reduced homology. Mapping of the miRNA-homologues of env within HIV-1 genomes localized these sequence to the functionally significant variable regions of the env glycoprotein gp120 designated V1, V2, V4 and V5.\",\n",
      "                    \"We conclude that microRNA-like sequences are embedded within the protein-encoding regions of several HIV-1 genomes. Given that the V1 to V5 regions of HIV-1 envelopes contain specific, well-characterized domains that are critical for immune responses, virus neutralization and disease progression, we propose that the newly discovered miRNA-like sequences within the HIV-1 genomes may have evolved to self-regulate survival of the virus in the host by evading innate immune responses and therefore influencing persistence, replication and/or pathogenicity.\"\n",
      "                ]\n",
      "            },\n",
      "            \"AuthorList\": [\n",
      "                {\n",
      "                    \"AffiliationInfo\": [\n",
      "                        {\n",
      "                            \"Identifier\": [],\n",
      "                            \"Affiliation\": \"Laboratory of Viral Oncology and Proteomics Research, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.\"\n",
      "                        }\n",
      "                    ],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Holland\",\n",
      "                    \"ForeName\": \"Bryan\",\n",
      "                    \"Initials\": \"B\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Wong\",\n",
      "                    \"ForeName\": \"Jonathan\",\n",
      "                    \"Initials\": \"J\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Li\",\n",
      "                    \"ForeName\": \"Meng\",\n",
      "                    \"Initials\": \"M\"\n",
      "                },\n",
      "                {\n",
      "                    \"AffiliationInfo\": [],\n",
      "                    \"Identifier\": [],\n",
      "                    \"LastName\": \"Rasheed\",\n",
      "                    \"ForeName\": \"Suraiya\",\n",
      "                    \"Initials\": \"S\"\n",
      "                }\n",
      "            ],\n",
      "            \"PublicationTypeList\": [\n",
      "                \"Journal Article\",\n",
      "                \"Research Support, Non-U.S. Gov't\"\n",
      "            ]\n",
      "        },\n",
      "        \"MedlineJournalInfo\": {\n",
      "            \"Country\": \"United States\",\n",
      "            \"MedlineTA\": \"PLoS One\",\n",
      "            \"NlmUniqueID\": \"101285081\",\n",
      "            \"ISSNLinking\": \"1932-6203\"\n",
      "        },\n",
      "        \"ChemicalList\": [\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"HIV Envelope Protein gp120\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"MicroRNAs\"\n",
      "            },\n",
      "            {\n",
      "                \"RegistryNumber\": \"0\",\n",
      "                \"NameOfSubstance\": \"RNA, Viral\"\n",
      "            }\n",
      "        ],\n",
      "        \"MeshHeadingList\": [\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Databases, Nucleic Acid\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Genome, Viral\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"genetics\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"HIV Envelope Protein gp120\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"genetics\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"HIV-1\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [],\n",
      "                \"DescriptorName\": \"Humans\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"genetics\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"MicroRNAs\"\n",
      "            },\n",
      "            {\n",
      "                \"QualifierName\": [\n",
      "                    \"genetics\"\n",
      "                ],\n",
      "                \"DescriptorName\": \"RNA, Viral\"\n",
      "            }\n",
      "        ],\n",
      "        \"CoiStatement\": \"<b>Competing Interests: </b>The authors have declared that no competing interests exist.\"\n",
      "    },\n",
      "    \"PubmedData\": {\n",
      "        \"ReferenceList\": [\n",
      "            {\n",
      "                \"ReferenceList\": [],\n",
      "                \"Reference\": [\n",
      "                    {\n",
      "                        \"Citation\": \"Siomi H, Siomi MC (2010) Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell 38: 323\\u2013332.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"20471939\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857\\u2013866.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"17060945\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Dai Y, Huang YS, Tang M, Lv TY, Hu CX, et al. (2007) Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 16: 939\\u2013946.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"18042587\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281\\u2013297.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"14744438\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Doench JG, Sharp PA (2004) Specificity of microRNA target selection in translational repression. Genes Dev 18: 504\\u2013511.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC374233\",\n",
      "                            \"15014042\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kloosterman WP, Plasterk RH (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441\\u2013450.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"17011485\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Wang X, Ye L, Hou W, Zhou Y, Wang YJ, et al. (2009) Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 113: 671\\u2013674.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2628373\",\n",
      "                            \"19015395\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, et al. (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2: 269\\u2013276.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"15782219\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kincaid RP, Burke JM, Sullivan CS (2012) RNA virus microRNA that mimics a B-cell oncomiR. Proc Natl Acad Sci U S A 109: 3077\\u20133082.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3286953\",\n",
      "                            \"22308400\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Hariharan M, Scaria V, Pillai B, Brahmachari SK (2005) Targets for human encoded microRNAs in HIV genes. Biochem Biophys Res Commun 337: 1214\\u20131218.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"16236258\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Ahluwalia JK, Khan SZ, Soni K, Rawat P, Gupta A, et al. (2008) Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 5: 117.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2635386\",\n",
      "                            \"19102781\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Yeung ML, Bennasser Y, Myers TG, Jiang G, Benkirane M, et al. (2005) Changes in microRNA expression profiles in HIV-1-transfected human cells. Retrovirology 2: 81.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC1352379\",\n",
      "                            \"16381609\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Houzet L, Jeang KT (2011) MicroRNAs and human retroviruses. Biochim Biophys Acta 1809(11\\u201312): 686\\u2013693.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3177989\",\n",
      "                            \"21640212\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Gupta A, Nagilla P, Le HS, Bunney C, Zych C, et al. (2011) Comparative expression profile of miRNA and mRNA in primary peripheral blood mononuclear cells infected with human immunodeficiency virus (HIV-1). PLoS One 6: e22730.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3145673\",\n",
      "                            \"21829495\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Pilakka-Kanthikeel S, Saiyed ZM, Napuri J, Nair MP (2011) MicroRNA: implications in HIV, a brief overview. J Neurovirol 17: 416\\u2013423.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4476028\",\n",
      "                            \"21786074\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Bennasser Y, Le SY, Yeung ML, Jeang KT (2004) HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology 1: 43.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC544590\",\n",
      "                            \"15601472\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Lin J, Cullen BR (2007) Analysis of the interaction of primate retroviruses with the human RNA interference machinery. J Virol 81: 12218\\u201312226.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2169020\",\n",
      "                            \"17855543\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Omoto S, Fujii YR (2005) Regulation of human immunodeficiency virus 1 transcription by nef microRNA. J Gen Virol 86: 751\\u2013755.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"15722536\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Kaul D, Ahlawat A, Gupta SD (2009) HIV-1 genome-encoded hiv1-mir-H1 impairs cellular responses to infection. Mol Cell Biochem 323: 143\\u2013148.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"19082544\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Klase Z, Winograd R, Davis J, Carpio L, Hildreth R, et al. (2009) HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology 6: 18.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2654423\",\n",
      "                            \"19220914\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Ouellet DL, Plante I, Landry P, Barat C, Janelle ME, et al. (2008) Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res 36: 2353\\u20132365.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2367715\",\n",
      "                            \"18299284\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Yeung ML, Bennasser Y, Watashi K, Le SY, Houzet L, et al. (2009) Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Res 37: 6575\\u20136586.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2770672\",\n",
      "                            \"19729508\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Schopman NC, Willemsen M, Liu YP, Bradley T, van Kampen A, et al. (2012) Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs. Nucleic Acids Res 40: 414\\u2013427.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3245934\",\n",
      "                            \"21911362\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Hakim ST, Alsayari M, McLean DC, Saleem S, Addanki KC, et al. (2008) A large number of the human microRNAs target lentiviruses, retroviruses, and endogenous retroviruses. Biochem Biophys Res Commun 369: 357\\u2013362.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"18282469\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Rasheed S, Yan JS, Lau A, Chan AS (2008) HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study. PLoS One 3: e3003.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2500163\",\n",
      "                            \"18714345\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Rasheed S, Yan JS, Hussain A, Lai B (2009) Proteomic characterization of HIV-modulated membrane receptors, kinases and signaling proteins involved in novel angiogenic pathways. J Transl Med 7: 75.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2754444\",\n",
      "                            \"19712456\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Gong TW, Besirli CG, Lomax MI (2001) MACF1 gene structure: a hybrid of plectin and dystrophin. Mamm Genome 12: 852\\u2013861.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"11845288\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Wang W, Guo J, Yu D, Vorster PJ, Chen W, et al. (2012) A Dichotomy in Cortical Actin and Chemotactic Actin Activity between Human Memory and Naive T Cells Contributes to Their Differential Susceptibility to HIV-1 Infection. J Biol Chem 287: 35455\\u201335469.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3471682\",\n",
      "                            \"22879601\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Boeras DI, Hraber PT, Hurlston M, Evans-Strickfaden T, Bhattacharya T, et al. (2011) Role of donor genital tract HIV-1 diversity in the transmission bottleneck. Proc Natl Acad Sci U S A 108: E1156\\u20131163.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3219102\",\n",
      "                            \"22065783\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Flavin RJ, Smyth PC, Laios A, O\\u2019Toole SA, Barrett C, et al. (2009) Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma. Mod Pathol 22: 197\\u2013205.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"18677302\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Sun G, Rossi JJ (2011) MicroRNAs and their potential involvement in HIV infection. Trends Pharmacol Sci 32: 675\\u2013681.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3200488\",\n",
      "                            \"21862142\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Li D, Zhao Y, Liu C, Chen X, Qi Y, et al. (2011) Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res 17: 1722\\u20131730.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"21350001\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Zhu H, Yang Y, Wang Y, Li J, Schiller PW, et al. (2011) MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc Res 92: 75\\u201384.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"21622680\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Zhu HC, Wang LM, Wang M, Song B, Tan S, et al. (2012) MicroRNA-195 downregulates Alzheimer\\u2019s disease amyloid-beta production by targeting BACE1. Brain Res Bull 88(6): 596\\u2013601.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"22721728\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Chen H, Untiveros GM, McKee LA, Perez J, Li J, et al. (2012) Micro-RNA-195 and -451 regulate the LKB1/AMPK signaling axis by targeting MO25. PLoS One 7: e41574.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3402395\",\n",
      "                            \"22844503\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15\\u201320.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"15652477\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Bennasser Y, Yeung ML, Jeang KT (2006) HIV-1 TAR RNA subverts RNA interference in transfected cells through sequestration of TAR RNA-binding protein, TRBP. J Biol Chem 281: 27674\\u201327678.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"16887810\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Pantophlet R, Burton DR (2006) GP120: target for neutralizing HIV-1 antibodies. Annu Rev Immunol 24: 739\\u2013769.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"16551265\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Cheng-Mayer C, Quiroga M, Tung JW, Dina D, Levy JA (1990) Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. J Virol 64: 4390\\u20134398.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC247907\",\n",
      "                            \"2384920\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Morikita T, Maeda Y, Fujii S, Matsushita S, Obaru K, et al. (1997) The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism. AIDS Res Hum Retroviruses 13: 1291\\u20131299.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"9339846\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"van Gils MJ, Bunnik EM, Boeser-Nunnink BD, Burger JA, Terlouw-Klein M, et al. (2011) Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies. J Virol 85: 6986\\u20136995.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC3126602\",\n",
      "                            \"21593147\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Rasheed S, Norman GL, Gill PS, Meyer PR, Cheng L, et al. (1986) Virus-neutralizing activity, serologic heterogeneity, and retrovirus isolation from homosexual men in the Los Angeles area. Virology 150: 1\\u20139.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"3006329\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Meissner EG, Coffield VM, Su L (2005) Thymic pathogenicity of an HIV-1 envelope is associated with increased CXCR4 binding efficiency and V5-gp41-dependent activity, but not V1/V2-associated CD4 binding efficiency and viral entry. Virology 336: 184\\u2013197.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC4415377\",\n",
      "                            \"15892960\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Antonov AV, Dietmann S, Wong P, Lutter D, Mewes HW (2009) GeneSet2miRNA: finding the signature of cooperative miRNA activities in the gene lists. Nucleic Acids Res 37: W323\\u2013328.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC2703952\",\n",
      "                            \"19420064\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Karlin S, Altschul SF (1990) Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. Proc Natl Acad Sci U S A 87: 2264\\u20132268.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"PMC53667\",\n",
      "                            \"2315319\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Higgins DG, Sharp PM (1989) Fast and sensitive multiple sequence alignments on a microcomputer. Comput Appl Biosci 5: 151\\u2013153.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"2720464\"\n",
      "                        ]\n",
      "                    },\n",
      "                    {\n",
      "                        \"Citation\": \"Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947\\u20132948.\",\n",
      "                        \"ArticleIdList\": [\n",
      "                            \"17846036\"\n",
      "                        ]\n",
      "                    }\n",
      "                ]\n",
      "            }\n",
      "        ],\n",
      "        \"History\": [\n",
      "            {\n",
      "                \"Year\": \"2012\",\n",
      "                \"Month\": \"8\",\n",
      "                \"Day\": \"22\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2013\",\n",
      "                \"Month\": \"2\",\n",
      "                \"Day\": \"5\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2013\",\n",
      "                \"Month\": \"3\",\n",
      "                \"Day\": \"23\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2013\",\n",
      "                \"Month\": \"3\",\n",
      "                \"Day\": \"23\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2013\",\n",
      "                \"Month\": \"9\",\n",
      "                \"Day\": \"11\",\n",
      "                \"Hour\": \"6\",\n",
      "                \"Minute\": \"0\"\n",
      "            },\n",
      "            {\n",
      "                \"Year\": \"2013\",\n",
      "                \"Month\": \"3\",\n",
      "                \"Day\": \"8\"\n",
      "            }\n",
      "        ],\n",
      "        \"PublicationStatus\": \"ppublish\",\n",
      "        \"ArticleIdList\": [\n",
      "            \"23520522\",\n",
      "            \"PMC3592801\",\n",
      "            \"10.1371/journal.pone.0058586\",\n",
      "            \"PONE-D-12-25252\"\n",
      "        ]\n",
      "    }\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import json\n",
    "from Bio import Entrez\n",
    "\n",
    "# Set the email address to avoid any potential issues with Entrez\n",
    "Entrez.email = 'michael.viroux@gmail.com'\n",
    "\n",
    "# Define lists of authors and topics\n",
    "authors = [] #['Bryan Holland', 'Mehmet Oz', 'Anthony Fauci']  # Example authors, adjust as needed\n",
    "topics = ['RNA', 'cardiovascular']  # Example topics, adjust as needed\n",
    "\n",
    "# Define date range\n",
    "date_range = '(\"2012/03/01\"[Date - Create] : \"2022/12/31\"[Date - Create])'\n",
    "\n",
    "# Build the query dynamically based on the available authors and topics\n",
    "queries = []\n",
    "\n",
    "if authors:\n",
    "    author_queries = ['{}[Author]'.format(author) for author in authors]\n",
    "    queries.append('(' + ' OR '.join(author_queries) + ')')\n",
    "\n",
    "if topics:\n",
    "    topic_queries = ['{}[Title/Abstract]'.format(topic) for topic in topics]\n",
    "    queries.append('(' + ' OR '.join(topic_queries) + ')')\n",
    "\n",
    "full_query = ' AND '.join(queries) + ' AND ' + date_range\n",
    "\n",
    "# Search PubMed for relevant records\n",
    "handle = Entrez.esearch(db='pubmed', retmax=11, term=full_query)\n",
    "record = Entrez.read(handle)\n",
    "id_list = record['IdList']\n",
    "\n",
    "# DataFrame to store the extracted data\n",
    "df = pd.DataFrame(columns=['PMID', 'Title', 'Abstract', 'Authors', 'Journal', 'Keywords', 'URL', 'Affiliations'])\n",
    "\n",
    "# Fetch information for each record in the id_list\n",
    "for pmid in id_list:\n",
    "    handle = Entrez.efetch(db='pubmed', id=pmid, retmode='xml')\n",
    "    records = Entrez.read(handle)\n",
    "\n",
    "    # Process each PubMed article in the response\n",
    "    for record in records['PubmedArticle']:\n",
    "        # Print the record in a formatted JSON style\n",
    "        print(json.dumps(record, indent=4, default=str))  # default=str handles types JSON can't serialize like datetime\n",
    "        title = record['MedlineCitation']['Article']['ArticleTitle']\n",
    "        abstract = ' '.join(record['MedlineCitation']['Article']['Abstract']['AbstractText']) if 'Abstract' in record['MedlineCitation']['Article'] and 'AbstractText' in record['MedlineCitation']['Article']['Abstract'] else ''\n",
    "        authors = ', '.join(author.get('LastName', '') + ' ' + author.get('ForeName', '') for author in record['MedlineCitation']['Article']['AuthorList'])\n",
    "        \n",
    "        affiliations = []\n",
    "        for author in record['MedlineCitation']['Article']['AuthorList']:\n",
    "            if 'AffiliationInfo' in author and author['AffiliationInfo']:\n",
    "                affiliations.append(author['AffiliationInfo'][0]['Affiliation'])\n",
    "        affiliations = '; '.join(set(affiliations))\n",
    "\n",
    "        journal = record['MedlineCitation']['Article']['Journal']['Title']\n",
    "        keywords = ', '.join(keyword['DescriptorName'] for keyword in record['MedlineCitation']['MeshHeadingList']) if 'MeshHeadingList' in record['MedlineCitation'] else ''\n",
    "        url = f\"https://www.ncbi.nlm.nih.gov/pubmed/{pmid}\"\n",
    "\n",
    "        new_row = pd.DataFrame({\n",
    "            'PMID': [pmid],\n",
    "            'Title': [title],\n",
    "            'Abstract': [abstract],\n",
    "            'Authors': [authors],\n",
    "            'Journal': [journal],\n",
    "            'Keywords': [keywords],\n",
    "            'URL': [url],\n",
    "            'Affiliations': [affiliations]\n",
    "        })\n",
    "\n",
    "        df = pd.concat([df, new_row], ignore_index=True)\n",
    "\n",
    "# Save DataFrame to an Excel file\n",
    "df.to_csv('PubMed_resultsx.csv', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "82b6515d-8f59-4c0a-b25c-ef2525244e7c",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
